No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3mg8R, 1.0000, 0.00, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2, 3mg7R, 0.9990, 0.18, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3, 3mg6R, 0.9983, 0.24, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4, 3oevR, 0.9980, 0.26, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
5, 3mg4R, 0.9946, 0.44, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
6, 3mg0R, 0.9940, 0.50, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
7, 4ltcR, 0.9939, 0.49, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
8, 3mg0D, 0.9936, 0.52, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
9, 4q1sR, 0.9935, 0.49, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
10, 4ltcD, 0.9933, 0.51, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
11, 4j70R, 0.9931, 0.51, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
12, 4j70D, 0.9931, 0.52, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
13, 3nzjR, 0.9931, 0.52, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
14, 3nzjD, 0.9931, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
15, 3un4R, 0.9930, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
16, 4jsqR, 0.9929, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
17, 4jsqD, 0.9929, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
18, 4hrcD, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
19, 3un4D, 0.9929, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
20, 3oeuD, 0.9929, 0.52, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
21, 3nzwR, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
22, 3nzwD, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
23, 3hyeR, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
24, 3hyeD, 0.9929, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
25, 4jsuR, 0.9928, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
26, 4jsuD, 0.9928, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
27, 4intR, 0.9928, 0.53, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
28, 4hrdD, 0.9928, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
29, 4hnpR, 0.9928, 0.53, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
30, 4intD, 0.9927, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
31, 4inrR, 0.9927, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
32, 4inrD, 0.9927, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
33, 3gpwR, 0.9926, 0.54, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
34, 2gplR, 0.9926, 0.55, 1.000, 242, 242, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
35, 2gplD, 0.9926, 0.55, 1.000, 242, 242, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
36, 2fakR, 0.9926, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
37, 4jt0R, 0.9925, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
38, 4jt0D, 0.9925, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
39, 4inuD, 0.9925, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
40, 4fzgR, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
41, 4fzgD, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
42, 4fzcR, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
43, 4fzcD, 0.9925, 0.54, 1.000, 242, 242, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
44, 3gpwD, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
45, 3gptR, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
46, 3gptD, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
47, 2fakD, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
48, 2f16R, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
49, 2f16D, 0.9925, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
50, 4gk7R, 0.9924, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
51, 3tddR, 0.9924, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
52, 3tddD, 0.9924, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
53, 4inuR, 0.9923, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
54, 4gk7D, 0.9923, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
55, 3oevD, 0.9923, 0.56, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
56, 3nzxR, 0.9923, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
57, 3nzxD, 0.9923, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
58, 3e47R, 0.9923, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
59, 3e47D, 0.9923, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
60, 4lqiR, 0.9922, 0.56, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
61, 4lqiD, 0.9922, 0.56, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
62, 4hnpD, 0.9922, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
63, 3shjR, 0.9922, 0.55, 1.000, 242, 242, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
64, 3shjD, 0.9922, 0.55, 1.000, 242, 242, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
65, 3dy3R, 0.9922, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
66, 3mg7D, 0.9921, 0.57, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
67, 3dy3D, 0.9921, 0.55, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
68, 3d29R, 0.9921, 0.55, 1.000, 242, 242, PROTEASOME INHIBITION BY FELLUTAMIDE B
69, 3d29D, 0.9921, 0.55, 1.000, 242, 242, PROTEASOME INHIBITION BY FELLUTAMIDE B
70, 2zcyR, 0.9921, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
71, 2zcyD, 0.9921, 0.54, 1.000, 242, 242, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
72, 4q1sD, 0.9920, 0.55, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
73, 3okjR, 0.9920, 0.56, 1.000, 242, 242, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
74, 3un8D, 0.9919, 0.56, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
75, 3okjD, 0.9919, 0.56, 1.000, 242, 242, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
76, 3un8R, 0.9918, 0.57, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
77, 3gpjR, 0.9918, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
78, 3dy4R, 0.9918, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
79, 4hrdR, 0.9917, 0.57, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
80, 3mg8D, 0.9917, 0.59, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
81, 3gpjD, 0.9917, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
82, 3dy4D, 0.9917, 0.56, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
83, 3mg6D, 0.9914, 0.61, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
84, 4hrcR, 0.9912, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
85, 3bdmR, 0.9912, 0.58, 1.000, 242, 242, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
86, 3bdmD, 0.9912, 0.58, 1.000, 242, 242, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
87, 1rypS, 0.9911, 0.59, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
88, 1rypE, 0.9910, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
89, 1g65D, 0.9904, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
90, 1g65R, 0.9902, 0.60, 1.000, 242, 242, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
91, 4eu2S, 0.9901, 0.62, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
92, 1jd2D, 0.9899, 0.62, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
93, 1jd2Y, 0.9898, 0.62, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
94, 3mg4D, 0.9897, 0.65, 1.000, 242, 242, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
95, 4eu2E, 0.9866, 0.82, 1.000, 242, 242, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
96, 3jcpNA, 0.9823, 0.80, 1.000, 242, 242, 
97, 3jcpN, 0.9823, 0.80, 1.000, 242, 242, 
98, 4x6zE, 0.9811, 0.80, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
99, 4x6zS, 0.9794, 1.02, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
100, 3wxrE, 0.9789, 1.04, 1.000, 242, 242, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
101, 3wxrS, 0.9773, 0.58, 1.000, 239, 239, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
102, 3jcoNA, 0.9765, 0.49, 1.000, 238, 238, 
103, 3jcoN, 0.9765, 0.92, 1.000, 242, 242, 
104, 3oeuR, 0.9742, 0.92, 1.000, 242, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
105, 5mp9e, 0.9714, 0.92, 1.000, 242, 242, 26S PROTEASOME IN PRESENCE OF ATP (S1)
106, 1z7qE, 0.9714, 0.18, 1.000, 236, 236, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
107, 5mp9E, 0.9713, 1.18, 1.000, 242, 242, 26S PROTEASOME IN PRESENCE OF ATP (S1)
108, 1z7qS, 0.9713, 1.09, 1.000, 245, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
109, 1fntE, 0.9701, 1.22, 1.000, 242, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
110, 1fntS, 0.9700, 1.09, 1.000, 245, 242, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
111, 5wvkZ, 0.9699, 1.10, 0.996, 244, 242, 
112, 5nifS, 0.9691, 1.11, 0.996, 244, 242, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
113, 4zzgS, 0.9689, 1.04, 1.000, 242, 242, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
114, 5wvkS, 0.9682, 0.47, 1.000, 236, 236, 
115, 4y8sR, 0.9672, 0.48, 1.000, 236, 236, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
116, 4y8sD, 0.9672, 1.10, 1.000, 242, 242, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
117, 4ya2R, 0.9671, 0.38, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
118, 4ya2D, 0.9671, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
119, 4qz7R, 0.9671, 0.39, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
120, 4qz7D, 0.9671, 0.39, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
121, 4qlqR, 0.9671, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
122, 4qlqD, 0.9671, 0.40, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
123, 4y8hR, 0.9669, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
124, 4y8hD, 0.9669, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
125, 4qluR, 0.9669, 0.40, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
126, 4nnwR, 0.9669, 0.40, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
127, 4nnwD, 0.9669, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
128, 4y8gR, 0.9668, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
129, 4y8gD, 0.9668, 0.39, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
130, 4qz0R, 0.9668, 0.40, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
131, 4qz0D, 0.9668, 0.40, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
132, 4qluD, 0.9668, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
133, 4qlsR, 0.9668, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
134, 4qlsD, 0.9668, 0.39, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
135, 5l55R, 0.9666, 0.40, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
136, 5l55D, 0.9666, 0.40, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
137, 5l52R, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
138, 5l52D, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
139, 5fggR, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
140, 5fggD, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
141, 5fg7R, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
142, 5cggR, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
143, 5cggD, 0.9666, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
144, 5ahjR, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
145, 5ahjD, 0.9666, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
146, 4qwlR, 0.9666, 0.41, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
147, 4qwlD, 0.9666, 0.41, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
148, 4qltR, 0.9666, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
149, 4qltD, 0.9666, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
150, 4no9R, 0.9666, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
151, 4no9D, 0.9666, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
152, 4no8R, 0.9666, 0.41, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
153, 5l54R, 0.9665, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
154, 5l54D, 0.9665, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
155, 5jhrR, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
156, 5jhrD, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
157, 5d0zR, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
158, 5d0zD, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
159, 5d0vR, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
160, 5d0vD, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
161, 5d0sR, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
162, 5d0sD, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
163, 5cgiR, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
164, 5cgiD, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
165, 4ya7R, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
166, 4ya7D, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
167, 4y8tR, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
168, 4y8tD, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
169, 4y8pR, 0.9665, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
170, 4y8pD, 0.9665, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
171, 4y84R, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
172, 4y84D, 0.9665, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
173, 4qz6R, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
174, 4qz6D, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
175, 4qz4R, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
176, 4qz4D, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
177, 4qz2R, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
178, 4qz2D, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
179, 4qwxR, 0.9665, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
180, 4qw6R, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
181, 4qw6D, 0.9665, 0.43, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
182, 4qw5R, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
183, 4qw5D, 0.9665, 0.42, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
184, 4qlvR, 0.9665, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
185, 4qlvD, 0.9665, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
186, 4no8D, 0.9665, 0.42, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
187, 5cghR, 0.9664, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
188, 5cghD, 0.9664, 0.41, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
189, 4y9zR, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
190, 4y9zD, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
191, 4y75R, 0.9664, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
192, 4qwxD, 0.9664, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
193, 4qw7R, 0.9664, 0.43, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
194, 4qw7D, 0.9664, 0.43, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
195, 4qvnR, 0.9664, 0.43, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
196, 4qvnD, 0.9664, 0.43, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
197, 4qbyR, 0.9664, 0.44, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
198, 4qbyD, 0.9664, 0.44, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
199, 4nnnR, 0.9664, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
200, 4nnnD, 0.9664, 0.43, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
201, 5mpaE, 0.9663, 0.42, 1.000, 235, 235, 26S PROTEASOME IN PRESENCE OF ATP (S2)
202, 5l6bR, 0.9663, 0.42, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
203, 5l6bD, 0.9663, 1.29, 1.000, 242, 242, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
204, 5fgfR, 0.9663, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
205, 5fgfD, 0.9663, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
206, 5cz9R, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
207, 5cz9D, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
208, 4ya9R, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
209, 4ya9D, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
210, 4y77R, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
211, 4y77D, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
212, 4y75D, 0.9663, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
213, 4qzxR, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
214, 4qzxD, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
215, 4qzwR, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
216, 4qzwD, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
217, 4qz5R, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
218, 4qz5D, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
219, 4qz3R, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
220, 4qz3D, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
221, 4qwfR, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
222, 4qwfD, 0.9663, 0.43, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
223, 5jhsR, 0.9662, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
224, 5jhsD, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
225, 5cz8R, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
226, 5cz8D, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
227, 5bxnR, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
228, 5bxnD, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
229, 4y8kR, 0.9662, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
230, 4y8kD, 0.9662, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
231, 4y70R, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
232, 4y70D, 0.9662, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
233, 4qwuR, 0.9662, 0.44, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
234, 4qwuD, 0.9662, 0.44, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
235, 4qwrR, 0.9662, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
236, 4qwrD, 0.9662, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
237, 4qw1R, 0.9662, 0.44, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
238, 4qw1D, 0.9662, 0.44, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
239, 4no6R, 0.9662, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
240, 4no6D, 0.9662, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
241, 5l6aR, 0.9661, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
242, 5l6aD, 0.9661, 0.43, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
243, 5l5uR, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
244, 5l5uD, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
245, 5l5oR, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
246, 5l5oD, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
247, 5l5hR, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
248, 5l5hD, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
249, 5l5dR, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
250, 5l5dD, 0.9661, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
251, 5l5bR, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
252, 5l5bD, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
253, 5fgeR, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
254, 5fgeD, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
255, 4ya1R, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
256, 4y8qR, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
257, 4y8qD, 0.9661, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
258, 4y8lR, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
259, 4y8lD, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
260, 4y8jR, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
261, 4y8jD, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
262, 4y7wR, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
263, 4y7wD, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
264, 4y74R, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
265, 4y74D, 0.9661, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
266, 4qxjR, 0.9661, 0.44, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
267, 4qxjD, 0.9661, 0.44, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
268, 4qvpR, 0.9661, 0.44, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
269, 4qvpD, 0.9661, 0.44, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
270, 4qv7R, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-A50V MUTANT
271, 4qv5R, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-M45I MUTANT
272, 4qv5D, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-M45I MUTANT
273, 4qv4R, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-M45T MUTANT
274, 4qv3R, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-M45V MUTANT
275, 4qv3D, 0.9661, 0.46, 1.000, 235, 235, YCP BETA5-M45V MUTANT
276, 4qv0R, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
277, 4qv0D, 0.9661, 0.45, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
278, 4no1R, 0.9661, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
279, 4no1D, 0.9661, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
280, 6gopR, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
281, 6gopD, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
282, 5lttR, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
283, 5lttD, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
284, 5l67R, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
285, 5l67D, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
286, 5l66R, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
287, 5l66D, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
288, 5l65R, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
289, 5l65D, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
290, 5l5rR, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
291, 5l5rD, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
292, 5l5fR, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
293, 5l5fD, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
294, 5fhsR, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
295, 5fhsD, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
296, 5fgiR, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
297, 5fgiD, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
298, 5fg7D, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
299, 5d0wR, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
300, 5d0wD, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
301, 5czaR, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
302, 5czaD, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
303, 5cz6R, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
304, 5cz6D, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
305, 4ya4R, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
306, 4ya4D, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
307, 4ya1D, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
308, 4y8rR, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
309, 4y8rD, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
310, 4y82R, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
311, 4y82D, 0.9660, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
312, 4y80R, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
313, 4y80D, 0.9660, 0.44, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
314, 4y7yR, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
315, 4y7yD, 0.9660, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
316, 4qzzR, 0.9660, 0.44, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
317, 4qzzD, 0.9660, 0.44, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
318, 4qwiR, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
319, 4qwiD, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
320, 4qvwR, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
321, 4qvqR, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
322, 4qvqD, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
323, 4qvlR, 0.9660, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
324, 4qvlD, 0.9660, 0.46, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
325, 4qv9R, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-C63F MUTANT
326, 4qv9D, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-C63F MUTANT
327, 4qv8R, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT
328, 4qv8D, 0.9660, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT
329, 4qv7D, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-A50V MUTANT
330, 4qv4D, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45T MUTANT
331, 4qv1R, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45A MUTANT
332, 4qv1D, 0.9660, 0.46, 1.000, 235, 235, YCP BETA5-M45A MUTANT
333, 5l6cR, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
334, 5l6cD, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
335, 5l63R, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
336, 5l63D, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
337, 5l61R, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
338, 5l61D, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
339, 5l5xR, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
340, 5l5xD, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
341, 5l5tR, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
342, 5l5tD, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
343, 5l5qR, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
344, 5l5qD, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
345, 5l5jR, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
346, 5l5jD, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
347, 5l5eR, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
348, 5l5eD, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
349, 5fgaR, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
350, 5fgaD, 0.9659, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
351, 5fg9R, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
352, 5cz7R, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
353, 5cz7D, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
354, 5cz5R, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
355, 5cz5D, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
356, 5cgfR, 0.9659, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
357, 5cgfD, 0.9659, 0.45, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
358, 5bxlR, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
359, 5bxlD, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
360, 4y9yR, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
361, 4y9yD, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
362, 4y8mR, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
363, 4y8mD, 0.9659, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
364, 4r17R, 0.9659, 0.46, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
365, 4r17D, 0.9659, 0.46, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
366, 4r02R, 0.9659, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
367, 4r00R, 0.9659, 0.45, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
368, 4r00D, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
369, 4qz1R, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
370, 4qz1D, 0.9659, 0.47, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
371, 4qw4R, 0.9659, 0.45, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
372, 4qvyR, 0.9659, 0.45, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
373, 4qvyD, 0.9659, 0.45, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
374, 4qvwD, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
375, 4quyR, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
376, 4quyD, 0.9659, 0.46, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
377, 5m2bR, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
378, 5m2bD, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
379, 5l68R, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
380, 5l68D, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
381, 5l64R, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
382, 5l64D, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
383, 5l62R, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
384, 5l62D, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
385, 5l5vR, 0.9658, 0.47, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
386, 5l5vD, 0.9658, 0.47, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
387, 5l5sR, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
388, 5l5sD, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
389, 5l5pR, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
390, 5l5pD, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
391, 5l5iR, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
392, 5l5iD, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
393, 5l5aR, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
394, 5l5aD, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
395, 5fgdR, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
396, 5fgdD, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
397, 5fg9D, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
398, 4z1lR, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
399, 4z1lD, 0.9658, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
400, 4y7xR, 0.9658, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
401, 4qw4D, 0.9658, 0.47, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
402, 4qv6R, 0.9658, 0.46, 1.000, 235, 235, YCP BETA5-A49V MUTANT
403, 4qv6D, 0.9658, 0.45, 1.000, 235, 235, YCP BETA5-A49V MUTANT
404, 5l5zR, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
405, 5l5zD, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
406, 5l5wR, 0.9657, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
407, 5l5wD, 0.9657, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
408, 5d0tR, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
409, 5d0tD, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
410, 4y8iR, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
411, 4y8iD, 0.9657, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
412, 4y81R, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
413, 4y81D, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
414, 4y7xD, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
415, 4y6zR, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
416, 4y6zD, 0.9657, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
417, 4quxR, 0.9657, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
418, 4quxD, 0.9657, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
419, 5dkjR, 0.9656, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
420, 5dkjD, 0.9656, 0.47, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
421, 4y8oR, 0.9656, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
422, 4y8oD, 0.9656, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
423, 4y78R, 0.9656, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
424, 4y78D, 0.9656, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
425, 4qwkR, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
426, 4qwkD, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
427, 4qwjR, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
428, 4qwjD, 0.9656, 0.46, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
429, 5l5yR, 0.9655, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
430, 5l5yD, 0.9655, 0.46, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
431, 4y8uR, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
432, 4y8uD, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
433, 4y6vR, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
434, 4y6vD, 0.9655, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
435, 4qwsR, 0.9655, 0.48, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
436, 4qw0R, 0.9655, 0.48, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
437, 4qw0D, 0.9655, 0.47, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
438, 5nifE, 0.9654, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
439, 5l69R, 0.9654, 0.48, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
440, 5l60R, 0.9654, 0.45, 1.000, 236, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
441, 5l60D, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
442, 5d0xR, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
443, 5d0xD, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
444, 5bouR, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
445, 5bouD, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
446, 4rurR, 0.9654, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
447, 4r18R, 0.9654, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
448, 4qwsD, 0.9654, 0.49, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
449, 5lajR, 0.9653, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
450, 5lajD, 0.9653, 0.47, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
451, 5l69D, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
452, 4y8nR, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
453, 4y8nD, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
454, 4y6aR, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
455, 4y6aD, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
456, 4y69R, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
457, 4y69D, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
458, 4rurD, 0.9653, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
459, 4r18D, 0.9653, 0.49, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
460, 4r02D, 0.9653, 0.49, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
461, 4qvmR, 0.9653, 0.49, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
462, 4qvmD, 0.9653, 0.47, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
463, 5laiR, 0.9652, 0.49, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
464, 5laiD, 0.9652, 0.49, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
465, 4zzgE, 0.9652, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
466, 4ya5R, 0.9652, 0.49, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
467, 4ya5D, 0.9652, 0.46, 1.000, 236, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
468, 4qvvR, 0.9652, 0.50, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
469, 4qvvD, 0.9652, 0.50, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
470, 5fghR, 0.9651, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
471, 5fghD, 0.9651, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
472, 5dkiR, 0.9648, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
473, 5dkiD, 0.9648, 0.50, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
474, 5cz4R, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
475, 5cz4D, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
476, 4ya3R, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
477, 4ya3D, 0.9648, 0.51, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
478, 4qwgR, 0.9647, 0.51, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
479, 4qwgD, 0.9647, 0.51, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
480, 4qw3R, 0.9646, 0.50, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
481, 4qw3D, 0.9646, 0.50, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
482, 4ya0R, 0.9645, 0.52, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
483, 4ya0D, 0.9645, 0.52, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
484, 4g4sE, 0.9641, 0.52, 1.000, 235, 235, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
485, 4cr2E, 0.9630, 0.52, 1.000, 235, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
486, 5mpae, 0.9627, 1.29, 0.992, 249, 239, 26S PROTEASOME IN PRESENCE OF ATP (S2)
487, 3sdkD, 0.9598, 1.22, 1.000, 243, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
488, 4v7oMA, 0.9592, 1.36, 1.000, 242, 241, 
489, 4v7oE, 0.9592, 0.33, 1.000, 233, 233, 
490, 4v7oAB, 0.9592, 1.36, 1.000, 250, 242, 
491, 4v7oS, 0.9590, 1.36, 1.000, 250, 242, 
492, 3sdkR, 0.9580, 1.36, 1.000, 250, 242, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
493, 5mpbE, 0.9534, 1.37, 1.000, 250, 242, 
494, 5mpcE, 0.9525, 0.15, 1.000, 232, 232, 
495, 5mpbS, 0.9476, 1.36, 1.000, 242, 242, 
496, 5wviH, 0.9470, 1.36, 1.000, 242, 242, 
497, 5wviBA, 0.9462, 1.45, 1.000, 242, 242, 
498, 4cr4E, 0.9462, 1.52, 1.000, 243, 242, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
499, 1g0uD, 0.9453, 1.51, 1.000, 243, 242, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
500, 1g0uR, 0.9452, 1.38, 0.971, 243, 241, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
501, 3sdiR, 0.9445, 0.44, 0.983, 230, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
502, 3sdiD, 0.9395, 0.44, 0.983, 230, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
503, 5mpcS, 0.9392, 0.25, 1.000, 229, 229, 
504, 5lezR, 0.9372, 0.31, 1.000, 228, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
505, 5lezD, 0.9368, 1.57, 1.000, 242, 242, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
506, 5leyR, 0.9365, 1.26, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
507, 5lexR, 0.9365, 1.32, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
508, 5le5R, 0.9364, 1.31, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
509, 5gjqF, 0.9364, 1.30, 0.601, 233, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
510, 5leyD, 0.9363, 1.33, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
511, 6avoM, 0.9362, 1.30, 0.601, 234, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
512, 5lf6R, 0.9362, 1.35, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
513, 5lf7R, 0.9361, 1.29, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
514, 5lf6D, 0.9361, 1.30, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
515, 5lf4R, 0.9361, 1.32, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
516, 5lf1R, 0.9361, 1.35, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
517, 5lf0R, 0.9361, 1.31, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
518, 5lexD, 0.9361, 1.33, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
519, 5gjql, 0.9361, 1.32, 0.601, 233, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
520, 6avoH, 0.9360, 1.35, 0.601, 233, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
521, 5lf3R, 0.9360, 1.31, 0.601, 234, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
522, 5a5bE, 0.9359, 1.30, 0.601, 233, 233, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
523, 4cr3E, 0.9359, 1.31, 0.601, 233, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
524, 5lf4D, 0.9358, 1.68, 1.000, 243, 242, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
525, 5lf0D, 0.9358, 1.68, 1.000, 243, 242, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
526, 3unbf, 0.9358, 1.37, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
527, 3unbD, 0.9358, 1.36, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
528, 5lf3D, 0.9356, 1.32, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
529, 5lf1D, 0.9356, 1.32, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
530, 5lf7D, 0.9355, 1.36, 0.601, 233, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
531, 5le5D, 0.9355, 1.38, 0.601, 233, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
532, 5gjrKA, 0.9355, 1.37, 0.601, 233, 233, 
533, 5gjrW, 0.9351, 1.38, 0.601, 233, 233, 
534, 4r67u, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
535, 4r67S, 0.9348, 1.34, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
536, 4r67g, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
537, 4r67E, 0.9348, 1.33, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
538, 3unbR, 0.9348, 1.33, 0.601, 234, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
539, 5l4gS, 0.9342, 1.33, 0.601, 234, 233, 
540, 4r3oS, 0.9340, 1.36, 0.601, 233, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
541, 4r3oE, 0.9340, 1.35, 0.601, 234, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
542, 3unbt, 0.9340, 1.33, 0.601, 234, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
543, 1iruS, 0.9332, 1.33, 0.601, 234, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
544, 1iruE, 0.9332, 1.37, 0.601, 233, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
545, 5l4gE, 0.9325, 1.36, 0.601, 234, 233, 
546, 3uneR, 0.9307, 1.36, 0.601, 234, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
547, 3uneD, 0.9301, 1.34, 0.601, 234, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
548, 3unet, 0.9297, 1.38, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
549, 3unfR, 0.9295, 1.42, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
550, 3unfD, 0.9295, 1.42, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
551, 3unhD, 0.9293, 1.41, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME
552, 3unhR, 0.9292, 1.41, 0.601, 233, 233, MOUSE 20S IMMUNOPROTEASOME
553, 3unef, 0.9285, 1.42, 0.601, 233, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
554, 5m32R, 0.9208, 1.42, 0.601, 233, 233, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
555, 5m32D, 0.9208, 1.42, 0.601, 233, 233, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
556, 3unfP, 0.9121, 1.51, 0.547, 233, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
557, 3unfB, 0.9121, 1.51, 0.547, 233, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
558, 3unhP, 0.9118, 1.85, 0.343, 248, 236, MOUSE 20S IMMUNOPROTEASOME
559, 3unhB, 0.9118, 1.85, 0.343, 248, 236, MOUSE 20S IMMUNOPROTEASOME
560, 5le5B, 0.9115, 1.86, 0.343, 248, 236, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
561, 5lf7B, 0.9114, 1.86, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
562, 3unbd, 0.9111, 1.87, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
563, 5lf4B, 0.9110, 1.87, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
564, 5lezB, 0.9107, 1.87, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
565, 5leyB, 0.9107, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
566, 5lf3B, 0.9106, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
567, 5lf1B, 0.9106, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
568, 5lexB, 0.9105, 1.88, 0.343, 248, 236, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
569, 3unbB, 0.9103, 1.88, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
570, 5lf0B, 0.9102, 1.88, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
571, 5lf6B, 0.9099, 1.89, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
572, 5le5P, 0.9099, 1.89, 0.343, 248, 236, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
573, 5gjqD, 0.9099, 1.89, 0.343, 248, 236, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
574, 4r3oQ, 0.9096, 1.90, 0.343, 247, 236, HUMAN CONSTITUTIVE 20S PROTEASOME
575, 4r3oC, 0.9096, 1.88, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME
576, 4r67s, 0.9092, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
577, 4r67Q, 0.9092, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
578, 4r67e, 0.9092, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
579, 4r67C, 0.9092, 1.91, 0.343, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
580, 5lezP, 0.9090, 1.91, 0.343, 250, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
581, 5lf7P, 0.9086, 1.91, 0.343, 250, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
582, 3unbP, 0.9086, 1.92, 0.343, 247, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
583, 3uneP, 0.9085, 1.92, 0.343, 247, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
584, 5lf4P, 0.9084, 1.91, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
585, 5lf1P, 0.9084, 1.89, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
586, 3unbr, 0.9082, 1.93, 0.343, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
587, 5lf6P, 0.9081, 1.93, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
588, 5ln3E, 0.9080, 1.92, 0.343, 248, 236, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
589, 5lf0P, 0.9080, 1.93, 0.343, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
590, 5leyP, 0.9079, 1.47, 0.595, 232, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
591, 5lexP, 0.9079, 1.94, 0.343, 248, 236, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
592, 3uner, 0.9079, 1.94, 0.343, 247, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
593, 5lf3P, 0.9078, 1.93, 0.343, 247, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
594, 1iruQ, 0.9075, 1.91, 0.343, 248, 236, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
595, 1iruC, 0.9075, 1.93, 0.343, 248, 236, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
596, 3uned, 0.9068, 1.91, 0.339, 250, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
597, 3uneB, 0.9065, 1.91, 0.339, 250, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
598, 5gjqj, 0.9064, 1.92, 0.343, 248, 236, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
599, 5vfsE, 0.9059, 1.93, 0.343, 248, 236, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
600, 5vfsDA, 0.9052, 1.93, 0.343, 250, 236, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
601, 4r02P, 0.9051, 1.13, 0.612, 228, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
602, 4intP, 0.9051, 1.81, 0.319, 238, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
603, 4q1sP, 0.9050, 1.15, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
604, 5vftK, 0.9049, 1.81, 0.358, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
605, 4intB, 0.9049, 1.81, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
606, 4inrP, 0.9045, 1.81, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
607, 5vfuV, 0.9044, 1.18, 0.612, 228, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
608, 5t0cW, 0.9044, 1.81, 0.358, 244, 232, 
609, 5t0cCB, 0.9044, 1.82, 0.358, 244, 232, 
610, 3wxrQ, 0.9044, 1.19, 0.612, 228, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
611, 4lqiP, 0.9043, 1.17, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
612, 4inuP, 0.9042, 1.17, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
613, 4inrB, 0.9042, 1.86, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
614, 4hnpP, 0.9042, 1.82, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
615, 4lqiB, 0.9041, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
616, 4hrcP, 0.9041, 1.82, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
617, 4fzcP, 0.9041, 1.85, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
618, 4fzcB, 0.9040, 1.82, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
619, 5lajP, 0.9039, 1.86, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
620, 4jsqP, 0.9039, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
621, 4jsqB, 0.9039, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
622, 4j70P, 0.9039, 1.82, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
623, 3nzjP, 0.9039, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
624, 1g65P, 0.9039, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
625, 5lajB, 0.9038, 1.84, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
626, 4nnwP, 0.9038, 1.82, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
627, 4nnwB, 0.9038, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
628, 4jsuP, 0.9038, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
629, 4jsuB, 0.9038, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
630, 4inuB, 0.9038, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
631, 2gplP, 0.9038, 1.83, 0.358, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
632, 4no9P, 0.9037, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
633, 4no9B, 0.9037, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
634, 4hnpB, 0.9037, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
635, 3nzjB, 0.9037, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
636, 2gplB, 0.9037, 1.84, 0.358, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
637, 4r18P, 0.9036, 1.84, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
638, 4r18B, 0.9036, 1.82, 0.358, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
639, 4gk7P, 0.9036, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
640, 3tddP, 0.9036, 1.82, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
641, 3hyeP, 0.9036, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
642, 1g65B, 0.9036, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
643, 4gk7B, 0.9035, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
644, 3tddB, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
645, 3nzwP, 0.9035, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
646, 3hyeB, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
647, 3dy4P, 0.9035, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
648, 5cgiP, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
649, 4y9zP, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
650, 4y9zB, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
651, 4y8sP, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
652, 4y8sB, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
653, 4y8jP, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
654, 4y8jB, 0.9034, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
655, 4y8iP, 0.9034, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
656, 4y7yP, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
657, 4y7yB, 0.9034, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
658, 4qzxP, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
659, 4qzxB, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
660, 4qz6P, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
661, 4qz6B, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
662, 4qz2P, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
663, 4qz2B, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
664, 4qw6P, 0.9034, 1.83, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
665, 4hrdP, 0.9034, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
666, 4fzgP, 0.9034, 1.84, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
667, 3nzwB, 0.9034, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
668, 3dy4B, 0.9034, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
669, 5jhrP, 0.9033, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
670, 5fgfP, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
671, 5fgfB, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
672, 5cz8P, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
673, 5cz8B, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
674, 5cgiB, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
675, 4y8lP, 0.9033, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
676, 4y8lB, 0.9033, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
677, 4y8iB, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
678, 4y8hP, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
679, 4y8hB, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
680, 4y84P, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
681, 4y84B, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
682, 4y80P, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
683, 4y7wP, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
684, 4y7wB, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
685, 4y70P, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
686, 4y70B, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
687, 4qz5P, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
688, 4qz0P, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
689, 4qz0B, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
690, 4qxjP, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
691, 4qwrP, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
692, 4qwfP, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
693, 4qw7P, 0.9033, 1.83, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
694, 4qw7B, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
695, 4qw6B, 0.9033, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
696, 4qlsP, 0.9033, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
697, 4qlsB, 0.9033, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
698, 4ltcP, 0.9033, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
699, 4j70B, 0.9033, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
700, 4hrcB, 0.9033, 1.83, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
701, 4fzgB, 0.9033, 1.84, 0.358, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
702, 3dy3P, 0.9033, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
703, 3dy3B, 0.9033, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
704, 3d29P, 0.9033, 1.84, 0.358, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
705, 3d29B, 0.9033, 1.83, 0.358, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
706, 5l52P, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
707, 5jhsP, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
708, 5jhrB, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
709, 4ya9P, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
710, 4ya9B, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
711, 4ya7P, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
712, 4y8uP, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
713, 4y8kP, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
714, 4y8gP, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
715, 4y8gB, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
716, 4y80B, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
717, 4y78P, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
718, 4y78B, 0.9032, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
719, 4qzwP, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
720, 4qzwB, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
721, 4qz5B, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
722, 4qz4P, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
723, 4qz4B, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
724, 4qxjB, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
725, 4qwrB, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
726, 4qwfB, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
727, 4qw5P, 0.9032, 1.83, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
728, 4qlqP, 0.9032, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
729, 4qlqB, 0.9032, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
730, 4nnnP, 0.9032, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH MG132
731, 3un8P, 0.9032, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
732, 3e47P, 0.9032, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
733, 5vftk, 0.9031, 1.83, 0.358, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
734, 5l52B, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
735, 5jhsB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
736, 5d0zP, 0.9031, 1.21, 0.612, 228, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
737, 5d0zB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
738, 5d0vP, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
739, 5d0vB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
740, 5cz9P, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
741, 5cz9B, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
742, 5cgfP, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
743, 5cgfB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
744, 4z1lP, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
745, 4z1lB, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
746, 4ya7B, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
747, 4y8uB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
748, 4y8pP, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
749, 4y8pB, 0.9031, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
750, 4y8kB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
751, 4y7xP, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
752, 4y74P, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
753, 4qz3P, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
754, 4qz3B, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
755, 4qwxP, 0.9031, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
756, 4qwxB, 0.9031, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
757, 4qwjP, 0.9031, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
758, 4qwiP, 0.9031, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
759, 4qwiB, 0.9031, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
760, 4qw5B, 0.9031, 1.83, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
761, 4qw4P, 0.9031, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
762, 4nnnB, 0.9031, 1.83, 0.358, 244, 232, YCP IN COMPLEX WITH MG132
763, 3un4P, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
764, 3un4B, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
765, 3mg4P, 0.9031, 1.83, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
766, 3e47B, 0.9031, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
767, 3bdmP, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
768, 3bdmB, 0.9031, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
769, 2fakP, 0.9031, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
770, 5lttP, 0.9030, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
771, 5l5tP, 0.9030, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
772, 5fhsP, 0.9030, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
773, 5fhsB, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
774, 5fgeP, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
775, 5fgdP, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
776, 5fgdB, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
777, 5fgaP, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
778, 5fgaB, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
779, 5dkjP, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
780, 5dkjB, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
781, 4y8qP, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
782, 4y7xB, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
783, 4y77P, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
784, 4y74B, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
785, 4y69P, 0.9030, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
786, 4y69B, 0.9030, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
787, 4qz1P, 0.9030, 1.83, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
788, 4qwlP, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
789, 4qwlB, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
790, 4qwjB, 0.9030, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
791, 4qw4B, 0.9030, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
792, 4eu2Q, 0.9030, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
793, 3mg0P, 0.9030, 1.84, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
794, 2fakB, 0.9030, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
795, 5lttB, 0.9029, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
796, 5l5tB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
797, 5l5eP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
798, 5l5eB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
799, 5l55P, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
800, 5l55B, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
801, 5fgiP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
802, 5fgiB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
803, 5fggP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
804, 5fggB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
805, 5fgeB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
806, 5d0tP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
807, 5d0tB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
808, 5d0sP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
809, 5cz7P, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
810, 5cz5P, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
811, 5cz5B, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
812, 5cggP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
813, 4y9yP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
814, 4y8tP, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
815, 4y8tB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
816, 4y8qB, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
817, 4y82P, 0.9029, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
818, 4y82B, 0.9029, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
819, 4y77B, 0.9029, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
820, 4r00P, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
821, 4r00B, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
822, 4qz7P, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
823, 4qz7B, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
824, 4qz1B, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
825, 4qwuP, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
826, 4qwuB, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
827, 4qwkP, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
828, 4qwkB, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
829, 4qw0P, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
830, 4qvqP, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
831, 4qvpP, 0.9029, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
832, 3shjP, 0.9029, 1.84, 0.358, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
833, 3gpwP, 0.9029, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
834, 5l68P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
835, 5l68B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
836, 5l65P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
837, 5l60P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
838, 5l60B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
839, 5l5sP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
840, 5l5sB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
841, 5l5oP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
842, 5l5jP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
843, 5l5jB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
844, 5l5iP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
845, 5l5iB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
846, 5fg9P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
847, 5fg9B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
848, 5fg7P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
849, 5d0xP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
850, 5d0xB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
851, 5d0sB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
852, 5cz7B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
853, 5cggB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
854, 5bxlP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
855, 4ya5P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
856, 4ya5B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
857, 4ya3P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
858, 4ya1P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
859, 4ya0P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
860, 4ya0B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
861, 4y9yB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
862, 4y8oP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
863, 4y8oB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
864, 4y6zP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
865, 4y6vP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
866, 4y6aP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
867, 4x6zQ, 0.9028, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
868, 4rurP, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
869, 4qw1P, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
870, 4qw0B, 0.9028, 1.83, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
871, 4qvwP, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
872, 4qvwB, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
873, 4qvvP, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
874, 4qvvB, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
875, 4qvqB, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
876, 4qvpB, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
877, 4qv8P, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT
878, 4qv7P, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT
879, 4qv3P, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT
880, 4quxP, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT
881, 4quxB, 0.9028, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT
882, 4jt0P, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
883, 4jt0B, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
884, 3shjB, 0.9028, 1.84, 0.358, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
885, 3gpwB, 0.9028, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
886, 2zcyP, 0.9028, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
887, 2zcyB, 0.9028, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
888, 2f16P, 0.9028, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
889, 5l65B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
890, 5l5xP, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
891, 5l5xB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
892, 5l5vP, 0.9027, 1.84, 0.358, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
893, 5l5vB, 0.9027, 1.84, 0.358, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
894, 5l5qP, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
895, 5l5oB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
896, 5l54P, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
897, 5l54B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
898, 5fg7B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
899, 5dkiP, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
900, 5dkiB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
901, 5bxlB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
902, 5bouP, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
903, 5bouB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
904, 4ya3B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
905, 4ya2P, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
906, 4ya2B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
907, 4ya1B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
908, 4y8nP, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
909, 4y8nB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
910, 4y8mP, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
911, 4y81P, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
912, 4y81B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
913, 4y75P, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
914, 4y75B, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
915, 4y6zB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
916, 4y6vB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
917, 4y6aB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
918, 4rurB, 0.9027, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
919, 4qwsP, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
920, 4qwsB, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
921, 4qw1B, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
922, 4qvyP, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
923, 4qvyB, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
924, 4qv8B, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-C52F MUTANT
925, 4qv7B, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A50V MUTANT
926, 4qv3B, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT
927, 4qv0P, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
928, 4qv0B, 0.9027, 1.84, 0.358, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
929, 3nzxP, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
930, 3nzxB, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
931, 2f16B, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
932, 1rypQ, 0.9027, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
933, 5l6bP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
934, 5l6bB, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
935, 5l67P, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
936, 5l5zP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
937, 5l5yP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
938, 5l5qB, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
939, 5l5hP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
940, 5l5hB, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
941, 5l5fP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
942, 5l5fB, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
943, 5fghP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
944, 5czaP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
945, 5czaB, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
946, 5cz6P, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
947, 5cz6B, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
948, 5cz4P, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
949, 5cz4B, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
950, 5cghP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
951, 4y8rP, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
952, 4y8mB, 0.9026, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
953, 4r17P, 0.9026, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
954, 4qzzP, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH OMURALIDE
955, 4qzzB, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH OMURALIDE
956, 4qvnP, 0.9026, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
957, 4qvnB, 0.9026, 1.84, 0.358, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
958, 4qvmP, 0.9026, 1.84, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
959, 4qvmB, 0.9026, 1.85, 0.358, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
960, 4qvlP, 0.9026, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
961, 4qluP, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
962, 4qltP, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
963, 4qltB, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
964, 4no6P, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
965, 4no6B, 0.9026, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
966, 5laiP, 0.9025, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
967, 5l6cP, 0.9025, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
968, 5l6cB, 0.9025, 1.83, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
969, 5l67B, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
970, 5l64P, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
971, 5l63P, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
972, 5l62P, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
973, 5l62B, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
974, 5l5zB, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
975, 5l5yB, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
976, 5l5pP, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
977, 5l5pB, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
978, 5fghB, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
979, 5d0wP, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
980, 5cghB, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
981, 5ahjP, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
982, 4ya4P, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
983, 4ya4B, 0.9025, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
984, 4y8rB, 0.9025, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
985, 4r17B, 0.9025, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
986, 4qvlB, 0.9025, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
987, 4qv9P, 0.9025, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT
988, 4quyP, 0.9025, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT
989, 4quyB, 0.9025, 1.84, 0.358, 244, 232, YCP BETA5-A49S-MUTANT
990, 4qluB, 0.9025, 1.84, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
991, 3okjP, 0.9025, 1.84, 0.358, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
992, 3okjB, 0.9025, 1.84, 0.358, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
993, 6gopP, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
994, 6gopB, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
995, 5laiB, 0.9024, 1.84, 0.358, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
996, 5l66P, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
997, 5l66B, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
998, 5l64B, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
999, 5l63B, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1000, 5l61P, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1001, 5l5uP, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1002, 5l5uB, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1003, 5l5dP, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1004, 5l5dB, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1005, 5l5aP, 0.9024, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1006, 5l5aB, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1007, 5d0wB, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1008, 5ahjB, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1009, 4qv9B, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-C63F MUTANT
1010, 4qv5P, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT
1011, 4qv4P, 0.9024, 1.85, 0.358, 244, 232, YCP BETA5-M45T MUTANT
1012, 4qv4B, 0.9024, 1.84, 0.358, 244, 232, YCP BETA5-M45T MUTANT
1013, 3un8B, 0.9024, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1014, 3gptP, 0.9024, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1015, 5l69P, 0.9023, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1016, 5l69B, 0.9023, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1017, 5l61B, 0.9023, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1018, 5l5wP, 0.9023, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1019, 5l5wB, 0.9023, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1020, 4qw3P, 0.9023, 1.85, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1021, 4qv5B, 0.9023, 1.84, 0.358, 244, 232, YCP BETA5-M45I MUTANT
1022, 4qv1P, 0.9023, 1.85, 0.358, 244, 232, YCP BETA5-M45A MUTANT
1023, 4qv1B, 0.9023, 1.85, 0.358, 244, 232, YCP BETA5-M45A MUTANT
1024, 3gptB, 0.9023, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1025, 5m2bP, 0.9022, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1026, 5m2bB, 0.9022, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1027, 4qwgP, 0.9022, 1.85, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1028, 4qwgB, 0.9022, 1.85, 0.358, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1029, 4qw3B, 0.9022, 1.85, 0.358, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1030, 4hrdB, 0.9022, 1.84, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1031, 5l6aP, 0.9021, 1.84, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1032, 5l5bP, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1033, 5bxnP, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1034, 5bxnB, 0.9021, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1035, 5l6aB, 0.9020, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1036, 5l5bB, 0.9020, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1037, 4ltcB, 0.9020, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1038, 5l5rP, 0.9019, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1039, 5l5rB, 0.9019, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1040, 4zzgC, 0.9019, 1.86, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1041, 4r02B, 0.9019, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1042, 4qv6P, 0.9019, 1.85, 0.358, 244, 232, YCP BETA5-A49V MUTANT
1043, 4q1sB, 0.9019, 1.86, 0.358, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1044, 5nifC, 0.9018, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1045, 4qv6B, 0.9018, 1.85, 0.358, 244, 232, YCP BETA5-A49V MUTANT
1046, 4qlvP, 0.9018, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1047, 3gpjP, 0.9018, 1.86, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1048, 4qlvB, 0.9017, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1049, 3gpjB, 0.9017, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1050, 4no1P, 0.9016, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1051, 5nifQ, 0.9015, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1052, 4zzgQ, 0.9015, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1053, 4qbyP, 0.9015, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1054, 4no8P, 0.9015, 1.87, 0.358, 242, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1055, 4no8B, 0.9015, 1.86, 0.358, 242, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1056, 4no1B, 0.9015, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1057, 5vfuJA, 0.9014, 1.85, 0.358, 244, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1058, 4qbyB, 0.9014, 1.85, 0.358, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1059, 3wxrC, 0.9014, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1060, 3mg0B, 0.9014, 1.26, 0.612, 228, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1061, 4x6zC, 0.9012, 1.85, 0.358, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1062, 5vfok, 0.9011, 1.86, 0.349, 242, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1063, 1rypC, 0.9011, 1.86, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1064, 4eu2C, 0.9006, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1065, 1jd2W, 0.9005, 1.15, 0.611, 228, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1066, 3mg4B, 0.9004, 1.86, 0.358, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1067, 1jd2B, 0.9003, 1.86, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1068, 5vfpCA, 0.8999, 1.87, 0.358, 244, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1069, 5vfrk, 0.8998, 1.86, 0.358, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1070, 5mp9c, 0.8995, 1.87, 0.358, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1071, 5vfqDA, 0.8994, 1.17, 0.611, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1072, 5mp9C, 0.8986, 1.17, 0.606, 228, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1073, 1z7qQ, 0.8985, 1.85, 0.358, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1074, 1z7qC, 0.8985, 1.18, 0.606, 228, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1075, 3jcpLA, 0.8980, 1.86, 0.358, 244, 232, 
1076, 3jcpL, 0.8980, 1.82, 0.358, 243, 232, 
1077, 5mpac, 0.8978, 1.82, 0.358, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1078, 5mpaC, 0.8975, 1.90, 0.358, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1079, 5vfrI, 0.8974, 1.90, 0.358, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1080, 5vfqC, 0.8971, 1.90, 0.358, 244, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1081, 5vfoI, 0.8971, 1.87, 0.358, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1082, 4g4sC, 0.8970, 1.89, 0.358, 244, 232, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1083, 1g0uO, 0.8969, 1.94, 0.339, 248, 236, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1084, 1g0uA, 0.8968, 1.95, 0.339, 248, 236, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1085, 1fntC, 0.8968, 2.26, 0.343, 239, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1086, 1jd2V, 0.8967, 1.96, 0.339, 248, 236, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1087, 1fntQ, 0.8966, 1.76, 0.357, 237, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1088, 5vfrK, 0.8963, 1.44, 0.330, 246, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1089, 5t0gK, 0.8962, 1.44, 0.330, 246, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1090, 3sdiO, 0.8961, 1.84, 0.358, 241, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1091, 5vfpC, 0.8959, 1.43, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1092, 3mg7O, 0.8959, 1.84, 0.358, 241, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1093, 3mg8O, 0.8956, 1.24, 0.602, 228, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1094, 1jd2A, 0.8956, 1.31, 0.612, 228, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1095, 5vfqE, 0.8955, 1.44, 0.330, 246, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1096, 3oeuO, 0.8955, 1.17, 0.611, 228, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1097, 1rypP, 0.8955, 1.96, 0.339, 248, 236, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1098, 4intO, 0.8954, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1099, 3mg4O, 0.8954, 1.45, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1100, 3sdkO, 0.8953, 1.45, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1101, 5vfpE, 0.8951, 1.25, 0.602, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1102, 4inuO, 0.8950, 1.91, 0.317, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1103, 4intA, 0.8950, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1104, 4inrO, 0.8950, 1.45, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1105, 1rypB, 0.8950, 1.45, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1106, 4hnpO, 0.8949, 1.45, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1107, 3oevO, 0.8949, 1.46, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1108, 3e47O, 0.8949, 1.26, 0.606, 228, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1109, 1g65O, 0.8949, 2.48, 0.330, 240, 233, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1110, 5vfoK, 0.8948, 1.45, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1111, 4qv5O, 0.8948, 1.45, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1112, 4qv5A, 0.8948, 1.45, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1113, 4jsqO, 0.8948, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1114, 4jsqA, 0.8948, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1115, 3wxrP, 0.8948, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1116, 3mg6O, 0.8948, 1.46, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1117, 3e47A, 0.8948, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1118, 4inuA, 0.8947, 1.26, 0.606, 228, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1119, 4inrA, 0.8947, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1120, 3mg0O, 0.8947, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1121, 2gplO, 0.8947, 1.46, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1122, 4fzcO, 0.8946, 1.46, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1123, 3un8O, 0.8946, 1.47, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1124, 3un4O, 0.8946, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1125, 3un4A, 0.8946, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1126, 2gplA, 0.8946, 1.46, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1127, 4fzcA, 0.8945, 1.46, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1128, 1g65A, 0.8945, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1129, 5ahjO, 0.8944, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1130, 5ahjA, 0.8944, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1131, 4qv3O, 0.8944, 1.46, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1132, 3sdiA, 0.8944, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1133, 3mg7A, 0.8944, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1134, 3mg6A, 0.8944, 1.46, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1135, 1z7qP, 0.8944, 1.46, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1136, 1z7qB, 0.8944, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1137, 1j2qB, 0.8944, 1.47, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1138, 5l5rO, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1139, 5l5rA, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1140, 5l5bO, 0.8943, 1.47, 0.330, 246, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1141, 5fggO, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1142, 4qv3A, 0.8943, 1.47, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1143, 4no1O, 0.8943, 1.59, 0.328, 249, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1144, 4ltcO, 0.8943, 1.59, 0.328, 249, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1145, 4jsuO, 0.8943, 2.03, 0.408, 237, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1146, 4jsuA, 0.8943, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1147, 4hrcO, 0.8943, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1148, 4fzgO, 0.8943, 1.47, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1149, 2fakO, 0.8943, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1150, 2f16O, 0.8943, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1151, 5l5bA, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1152, 5l55O, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1153, 5fggA, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1154, 4qv4O, 0.8942, 1.47, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1155, 4qv4A, 0.8942, 1.47, 0.330, 249, 227, YCP BETA5-M45T MUTANT
1156, 4no1A, 0.8942, 1.46, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1157, 4jt0O, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1158, 4jt0A, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1159, 4fzgA, 0.8942, 1.47, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1160, 3un8A, 0.8942, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1161, 3sdkA, 0.8942, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1162, 3mg8A, 0.8942, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1163, 3mg4A, 0.8942, 1.47, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1164, 2fakA, 0.8942, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1165, 2f16A, 0.8942, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1166, 5mpbQ, 0.8941, 1.47, 0.330, 250, 227, 
1167, 5l6aO, 0.8941, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1168, 5l6aA, 0.8941, 1.46, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1169, 5l55A, 0.8941, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1170, 5cggO, 0.8941, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1171, 4qv1O, 0.8941, 1.47, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1172, 4g4sB, 0.8941, 1.47, 0.330, 250, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1173, 3okjO, 0.8941, 1.47, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1174, 3oevA, 0.8941, 1.93, 0.358, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1175, 3oeuA, 0.8941, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1176, 3mg7P, 0.8941, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1177, 5d0wO, 0.8940, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1178, 5d0wA, 0.8940, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1179, 5cggA, 0.8940, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1180, 4ya9O, 0.8940, 1.47, 0.330, 246, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1181, 4ya9A, 0.8940, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1182, 4qv1A, 0.8940, 1.47, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1183, 4nnnO, 0.8940, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1184, 4nnnA, 0.8940, 1.70, 0.360, 235, 228, YCP IN COMPLEX WITH MG132
1185, 3wxrB, 0.8940, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1186, 3shjO, 0.8940, 1.48, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1187, 3okjA, 0.8940, 1.47, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1188, 1j2qF, 0.8940, 1.47, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1189, 1j2qD, 0.8940, 1.47, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1190, 6gopA, 0.8939, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1191, 5l5uO, 0.8939, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1192, 5l5uA, 0.8939, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1193, 5l5dO, 0.8939, 1.48, 0.330, 249, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1194, 5jhrO, 0.8939, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1195, 4zzgB, 0.8939, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1196, 4r02O, 0.8939, 2.04, 0.408, 237, 233, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1197, 4qz7O, 0.8939, 2.04, 0.408, 237, 233, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1198, 4qz4O, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1199, 4qz4A, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1200, 4qvnO, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1201, 4qv9O, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1202, 4qv9A, 0.8939, 1.47, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1203, 4qv0O, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1204, 4qv0A, 0.8939, 1.47, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1205, 4quyO, 0.8939, 1.48, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1206, 4no8O, 0.8939, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1207, 4no8A, 0.8939, 1.47, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1208, 4no6O, 0.8939, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1209, 4no6A, 0.8939, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1210, 3tddO, 0.8939, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1211, 3shjA, 0.8939, 1.48, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1212, 1j2qG, 0.8939, 1.48, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1213, 6gopO, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1214, 5l5hO, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1215, 5l5dA, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1216, 5jhrA, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1217, 5bxnO, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1218, 5bxnA, 0.8938, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1219, 4ya7O, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1220, 4ya7A, 0.8938, 2.04, 0.408, 237, 233, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1221, 4ya4O, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1222, 4ya4A, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1223, 4y8sO, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1224, 4y8sA, 0.8938, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1225, 4y8pO, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1226, 4y8pA, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1227, 4y75O, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1228, 4y75A, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1229, 4qz7A, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1230, 4qz0O, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1231, 4qz0A, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1232, 4qvnA, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1233, 4qv7O, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1234, 4qv7A, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1235, 4quyA, 0.8938, 1.48, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1236, 4qluO, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1237, 4qluA, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1238, 4no9O, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1239, 4nnwO, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1240, 4nnwA, 0.8938, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1241, 3tddA, 0.8938, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1242, 3oevP, 0.8938, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1243, 3nzxO, 0.8938, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1244, 3jcoLA, 0.8938, 1.48, 0.330, 250, 227, 
1245, 3jcoL, 0.8938, 1.48, 0.330, 250, 227, 
1246, 3hyeO, 0.8938, 1.47, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1247, 3gptO, 0.8938, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1248, 2zcyO, 0.8938, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1249, 1j2qE, 0.8938, 1.47, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1250, 1j2qA, 0.8938, 1.70, 0.360, 235, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1251, 5l63O, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1252, 5l5hA, 0.8937, 1.95, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1253, 5czaO, 0.8937, 1.95, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1254, 5czaA, 0.8937, 1.95, 0.358, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1255, 5cghO, 0.8937, 1.47, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1256, 5cghA, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1257, 5bxlO, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1258, 5bxlA, 0.8937, 2.04, 0.408, 237, 233, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1259, 4qv8O, 0.8937, 2.04, 0.408, 237, 233, YCP BETA5-C52F MUTANT
1260, 4qv8A, 0.8937, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1261, 4qlsO, 0.8937, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1262, 4qlsA, 0.8937, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1263, 4no9A, 0.8937, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1264, 4ltcA, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1265, 4hnpA, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1266, 4gk7O, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1267, 4gk7A, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1268, 3oeuP, 0.8937, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1269, 3nzxA, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1270, 3nzwO, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1271, 3hyeA, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1272, 3dy3O, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1273, 3dy3A, 0.8937, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1274, 2zcyA, 0.8937, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1275, 5nifB, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1276, 5m2bO, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1277, 5l6bO, 0.8936, 1.70, 0.360, 235, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1278, 5l6bA, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1279, 5l63A, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1280, 5l61O, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1281, 5l5wO, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1282, 5l5wA, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1283, 5l5oO, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1284, 5l5oA, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1285, 5l52O, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1286, 5l52A, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1287, 4ya2O, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1288, 4ya2A, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1289, 4ya1O, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1290, 4ya1A, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1291, 4y8kO, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1292, 4y8kA, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1293, 4y8gO, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1294, 4y8gA, 0.8936, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1295, 4qz6O, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1296, 4qz6A, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1297, 4qwxO, 0.8936, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1298, 4qwxA, 0.8936, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1299, 4qwuO, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1300, 4qwlO, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1301, 4qwlA, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1302, 4qv6O, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1303, 4qv6A, 0.8936, 1.48, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1304, 3nzwA, 0.8936, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1305, 3gptA, 0.8936, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1306, 1j2qC, 0.8936, 1.48, 0.330, 250, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1307, 5m2bA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1308, 5l61A, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1309, 5d0vO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1310, 5d0vA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1311, 5d0sO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1312, 5d0sA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1313, 4zzgP, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1314, 4y9zO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1315, 4y9zA, 0.8935, 2.04, 0.408, 237, 233, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1316, 4y8tO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1317, 4y8tA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1318, 4y8rO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1319, 4y8rA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1320, 4y8hO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1321, 4y8hA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1322, 4y77O, 0.8935, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1323, 4qzzO, 0.8935, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1324, 4qzzA, 0.8935, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1325, 4qwuA, 0.8935, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1326, 4qw6O, 0.8935, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1327, 4qw6A, 0.8935, 1.48, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1328, 4lqiO, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1329, 4lqiA, 0.8935, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1330, 3sdiP, 0.8935, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1331, 3mg6P, 0.8935, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1332, 3gpwO, 0.8935, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1333, 5t0hK, 0.8934, 1.48, 0.330, 250, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1334, 5nifP, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1335, 5l65O, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1336, 5l65A, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1337, 5l64O, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1338, 5l62O, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1339, 5l5tO, 0.8934, 1.69, 0.360, 235, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1340, 5l5tA, 0.8934, 1.71, 0.360, 235, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1341, 5l5sO, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1342, 5l5sA, 0.8934, 1.35, 0.612, 228, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1343, 5l5pO, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1344, 5l5pA, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1345, 5l5jO, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1346, 4y9yO, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1347, 4y9yA, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1348, 4y77A, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1349, 4x6zP, 0.8934, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1350, 4hrdO, 0.8934, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1351, 3nzjO, 0.8934, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1352, 3mg0A, 0.8934, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1353, 3gpwA, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1354, 3gpjO, 0.8934, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1355, 3gpjA, 0.8934, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1356, 3bdmO, 0.8934, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1357, 5vfoi, 0.8933, 1.48, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1358, 5l6cO, 0.8933, 1.49, 0.330, 249, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1359, 5l6cA, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1360, 5l67O, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1361, 5l67A, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1362, 5l66O, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1363, 5l66A, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1364, 5l64A, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1365, 5l62A, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1366, 5l5qO, 0.8933, 2.04, 0.339, 250, 236, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1367, 5l5qA, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1368, 5l5jA, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1369, 5l5aO, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1370, 5l5aA, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1371, 5d0zO, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1372, 5d0zA, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1373, 5cz9O, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1374, 5cz9A, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1375, 5cz6O, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1376, 5cz6A, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1377, 4qz3O, 0.8933, 1.49, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1378, 4qz3A, 0.8933, 1.49, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1379, 4qwfO, 0.8933, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1380, 4qwfA, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1381, 4qw7O, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1382, 4qw5O, 0.8933, 1.48, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1383, 4qvlO, 0.8933, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1384, 4qvlA, 0.8933, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1385, 4qltO, 0.8933, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1386, 4qltA, 0.8933, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1387, 4q1sO, 0.8933, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1388, 3nzjA, 0.8933, 1.48, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1389, 3mg8P, 0.8933, 1.48, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1390, 3dy4O, 0.8933, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1391, 3d29O, 0.8933, 1.49, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1392, 3bdmA, 0.8933, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1393, 5lttO, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1394, 5lttA, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1395, 5l69O, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1396, 5l69A, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1397, 5l68O, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1398, 5l68A, 0.8932, 1.70, 0.360, 235, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1399, 5l5xO, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1400, 5l5xA, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1401, 5l5iO, 0.8932, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1402, 5fgaO, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1403, 5fgaA, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1404, 5cgiO, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1405, 5cgiA, 0.8932, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1406, 4r18O, 0.8932, 1.49, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1407, 4r18A, 0.8932, 1.49, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1408, 4r00O, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1409, 4qz2O, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1410, 4qz2A, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1411, 4qw7A, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1412, 4qw5A, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1413, 4qw1O, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1414, 4qw1A, 0.8932, 1.49, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1415, 4qlqO, 0.8932, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1416, 4qlqA, 0.8932, 1.48, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1417, 4qbyO, 0.8932, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1418, 4qbyA, 0.8932, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1419, 3dy4A, 0.8932, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1420, 3d29A, 0.8932, 1.49, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1421, 5l5iA, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1422, 5jhsO, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1423, 5fg7O, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1424, 5fg7A, 0.8931, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1425, 4y74O, 0.8931, 1.48, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1426, 4y74A, 0.8931, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1427, 4r00A, 0.8931, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1428, 4qzwO, 0.8931, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1429, 4qzwA, 0.8931, 1.48, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1430, 5vfpAA, 0.8930, 1.49, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1431, 5l5zO, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1432, 5l5zA, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1433, 5l5vO, 0.8930, 1.49, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1434, 5l5vA, 0.8930, 1.49, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1435, 5l5fO, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1436, 5l5fA, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1437, 5jhsA, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1438, 5fgfO, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1439, 5fgfA, 0.8930, 2.03, 0.339, 250, 236, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1440, 4y8mO, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1441, 4y8mA, 0.8930, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1442, 4r17O, 0.8930, 1.49, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1443, 4r17A, 0.8930, 1.49, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1444, 4qz5O, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1445, 4qz5A, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1446, 4qvyO, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1447, 4qvyA, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1448, 4qvwO, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1449, 4qvwA, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1450, 4quxO, 0.8930, 1.49, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1451, 4quxA, 0.8930, 1.49, 0.330, 249, 227, YCP BETA5-A49T-MUTANT
1452, 5l5yO, 0.8929, 1.49, 0.330, 249, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1453, 5l5yA, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1454, 5l54O, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1455, 5l54A, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1456, 5fg9O, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1457, 5fg9A, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1458, 5cgfO, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1459, 5cgfA, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1460, 4y84O, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1461, 4y70O, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1462, 4y70A, 0.8929, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1463, 4qwrO, 0.8929, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1464, 4qvpO, 0.8929, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1465, 4qvpA, 0.8929, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1466, 5lajO, 0.8928, 1.49, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1467, 5lajA, 0.8928, 1.49, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1468, 5l60O, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1469, 5l60A, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1470, 5l5eO, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1471, 5l5eA, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1472, 5fgeO, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1473, 5fgeA, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1474, 5cz7O, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1475, 5cz7A, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1476, 4y84A, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1477, 4y82O, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1478, 4y82A, 0.8928, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1479, 4qwrA, 0.8928, 1.49, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1480, 3sdkP, 0.8928, 1.49, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1481, 5bouO, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1482, 5bouA, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1483, 4y8lO, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1484, 4y8lA, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1485, 4y8jO, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1486, 4y8jA, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1487, 4y7wO, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1488, 4y7wA, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1489, 4qw4O, 0.8927, 1.71, 0.360, 235, 228, YCP IN COMPLEX WITH CARFILZOMIB
1490, 4qw4A, 0.8927, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH CARFILZOMIB
1491, 4qvqO, 0.8927, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1492, 4qvqA, 0.8927, 1.49, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1493, 4q1sA, 0.8927, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1494, 4hrdA, 0.8927, 1.49, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1495, 5vfqBA, 0.8926, 1.49, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1496, 5fgiO, 0.8926, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1497, 5cz8O, 0.8926, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1498, 4z1lO, 0.8926, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1499, 4z1lA, 0.8926, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1500, 5fhsO, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1501, 5fhsA, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1502, 5fgiA, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1503, 5dkjO, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1504, 5dkjA, 0.8925, 2.04, 0.339, 250, 236, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1505, 5cz8A, 0.8925, 1.50, 0.330, 249, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1506, 4y8qO, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1507, 4y8qA, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1508, 4y80O, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1509, 4y80A, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1510, 4y7xO, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1511, 4y7xA, 0.8925, 1.50, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1512, 4y6zO, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1513, 4y6zA, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1514, 4y6vO, 0.8925, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1515, 4y6vA, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1516, 4rurO, 0.8925, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1517, 4r02A, 0.8925, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1518, 4qz1O, 0.8925, 1.49, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1519, 4qlvO, 0.8925, 1.49, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1520, 4y8uO, 0.8924, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1521, 4y8uA, 0.8924, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1522, 4y8iA, 0.8924, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1523, 4y81O, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1524, 4y81A, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1525, 4y6aO, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1526, 4y6aA, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1527, 4rurA, 0.8924, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1528, 4qzxO, 0.8924, 1.49, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1529, 4qzxA, 0.8924, 1.50, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1530, 4qz1A, 0.8924, 1.50, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1531, 4qlvA, 0.8924, 1.50, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1532, 4hrcA, 0.8924, 1.50, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1533, 5fgdO, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1534, 5fgdA, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1535, 4y8oO, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1536, 4y8oA, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1537, 4y8iO, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1538, 4y7yO, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1539, 4y7yA, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1540, 4y69O, 0.8923, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1541, 4y69A, 0.8923, 1.49, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1542, 4qxjO, 0.8923, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1543, 4qwiO, 0.8923, 1.50, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1544, 4j70O, 0.8923, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1545, 5d0tO, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1546, 5cz5O, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1547, 4y8nO, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1548, 4y8nA, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1549, 4qxjA, 0.8922, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1550, 4qwiA, 0.8922, 1.50, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1551, 4j70A, 0.8922, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1552, 1g0uP, 0.8922, 1.50, 0.330, 250, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1553, 5d0tA, 0.8921, 1.49, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1554, 5cz5A, 0.8921, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1555, 4qw0O, 0.8921, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1556, 4qw0A, 0.8921, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1557, 5vfsC, 0.8920, 1.50, 0.330, 250, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1558, 4ya5A, 0.8920, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1559, 4qwkO, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1560, 4qwkA, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1561, 4qvmO, 0.8920, 1.71, 0.360, 235, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1562, 4qvmA, 0.8920, 1.50, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1563, 4eu2P, 0.8920, 1.50, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1564, 5d0xO, 0.8919, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1565, 5d0xA, 0.8919, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1566, 4ya5O, 0.8919, 2.11, 0.335, 250, 236, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1567, 4y78O, 0.8919, 2.18, 0.343, 239, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1568, 4y78A, 0.8919, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1569, 5vfri, 0.8918, 1.50, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1570, 5laiO, 0.8918, 1.50, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1571, 5laiA, 0.8918, 1.50, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1572, 5fghO, 0.8917, 1.50, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1573, 5fghA, 0.8917, 1.45, 0.327, 249, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1574, 5mp9B, 0.8915, 1.51, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1575, 4qwjO, 0.8915, 1.51, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1576, 4qwjA, 0.8915, 1.50, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1577, 4qwsO, 0.8914, 1.50, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1578, 4qwsA, 0.8914, 1.50, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1579, 5dkiO, 0.8913, 2.04, 0.339, 250, 236, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1580, 5dkiA, 0.8913, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1581, 4qvvO, 0.8912, 1.51, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1582, 5cz4O, 0.8911, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1583, 5cz4A, 0.8911, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1584, 4qwgO, 0.8911, 1.49, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1585, 4qwgA, 0.8911, 1.51, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1586, 4qvvA, 0.8911, 1.51, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1587, 1g0uB, 0.8911, 1.51, 0.330, 250, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1588, 4ya3O, 0.8910, 1.51, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1589, 4ya3A, 0.8910, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1590, 4qw3O, 0.8910, 1.52, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1591, 4qw3A, 0.8910, 1.52, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1592, 3mg8B, 0.8910, 1.52, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1593, 3jcpKA, 0.8910, 1.52, 0.330, 250, 227, 
1594, 3jcpK, 0.8910, 1.52, 0.330, 250, 227, 
1595, 4ya0O, 0.8908, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1596, 4ya0A, 0.8908, 1.52, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1597, 3mg6B, 0.8906, 1.72, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1598, 3unbe, 0.8905, 1.52, 0.330, 250, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1599, 1fntP, 0.8905, 1.52, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1600, 1fntB, 0.8905, 1.52, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1601, 5vfsBA, 0.8902, 1.52, 0.330, 250, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1602, 3sdkB, 0.8901, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1603, 3oevB, 0.8900, 1.52, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1604, 3sdiB, 0.8899, 1.52, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1605, 5gjqm, 0.8898, 1.52, 0.330, 250, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1606, 5gjrV, 0.8897, 1.52, 0.330, 250, 227, 
1607, 5gjrJA, 0.8897, 1.52, 0.330, 250, 227, 
1608, 3oeuB, 0.8897, 1.73, 0.360, 235, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1609, 3mg7B, 0.8897, 1.97, 0.343, 239, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1610, 3unhQ, 0.8896, 1.66, 0.328, 247, 229, MOUSE 20S IMMUNOPROTEASOME
1611, 3unhC, 0.8896, 1.66, 0.328, 247, 229, MOUSE 20S IMMUNOPROTEASOME
1612, 5gjqG, 0.8895, 2.12, 0.335, 250, 236, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1613, 5gjqE, 0.8895, 1.73, 0.360, 235, 228, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1614, 4r3oR, 0.8895, 1.74, 0.360, 235, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
1615, 4r3oD, 0.8895, 1.73, 0.360, 235, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
1616, 5mp9b, 0.8893, 1.82, 0.313, 238, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1617, 5lf3O, 0.8893, 1.98, 0.339, 243, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1618, 5lf0O, 0.8893, 1.99, 0.339, 243, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1619, 3unfQ, 0.8893, 1.73, 0.360, 235, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1620, 3unfC, 0.8893, 1.74, 0.360, 235, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1621, 1z7qD, 0.8893, 1.99, 0.348, 238, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1622, 6epfC, 0.8892, 1.99, 0.348, 238, 233, GROUND STATE 26S PROTEASOME (GS1)
1623, 5lezO, 0.8892, 1.79, 0.313, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1624, 1z7qR, 0.8892, 2.00, 0.339, 243, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1625, 5leyO, 0.8891, 1.99, 0.339, 243, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1626, 3uneq, 0.8891, 1.99, 0.339, 243, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1627, 5lexO, 0.8890, 1.54, 0.330, 250, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1628, 5mpbC, 0.8889, 1.45, 0.311, 230, 225, 
1629, 5lf1O, 0.8889, 1.45, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1630, 4q1sC, 0.8889, 1.99, 0.348, 238, 233, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1631, 5wvkX, 0.8888, 1.99, 0.348, 238, 233, 
1632, 5lf7O, 0.8888, 1.99, 0.342, 241, 234, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1633, 5lezA, 0.8888, 2.09, 0.336, 249, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1634, 4eu2B, 0.8888, 1.45, 0.311, 230, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1635, 3unbC, 0.8888, 1.99, 0.342, 241, 234, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1636, 5vfuT, 0.8887, 1.45, 0.311, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1637, 5vftI, 0.8887, 1.55, 0.310, 233, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1638, 5lf6O, 0.8887, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1639, 5lf0A, 0.8886, 1.98, 0.358, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1640, 3unbQ, 0.8886, 1.46, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1641, 3sdiC, 0.8886, 2.00, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1642, 5vfqB, 0.8885, 1.93, 0.353, 244, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1643, 5lf4O, 0.8885, 1.46, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1644, 5lexA, 0.8885, 1.46, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1645, 4r67t, 0.8885, 1.50, 0.327, 249, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1646, 4r67f, 0.8885, 2.00, 0.343, 239, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1647, 3uneO, 0.8885, 2.13, 0.335, 250, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
1648, 5mpab, 0.8884, 2.13, 0.335, 250, 236, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1649, 4r67D, 0.8884, 1.46, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1650, 3uneQ, 0.8884, 1.46, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
1651, 5le5O, 0.8883, 2.00, 0.339, 239, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1652, 4x6zB, 0.8883, 2.00, 0.335, 238, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1653, 4r67R, 0.8883, 2.04, 0.339, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1654, 5lf3A, 0.8881, 1.65, 0.307, 230, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1655, 4r3oP, 0.8881, 1.46, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
1656, 4r3oB, 0.8881, 1.46, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
1657, 3oeuC, 0.8881, 2.01, 0.339, 243, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1658, 6avoP, 0.8880, 2.01, 0.339, 243, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1659, 6avob, 0.8880, 1.57, 0.310, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1660, 5lf6A, 0.8880, 1.54, 0.330, 250, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1661, 5lf1A, 0.8880, 2.01, 0.339, 243, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1662, 5leyA, 0.8880, 1.99, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1663, 3unbs, 0.8880, 1.47, 0.311, 230, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1664, 3sdkC, 0.8880, 1.51, 0.327, 248, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1665, 5lf4A, 0.8879, 2.01, 0.339, 243, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1666, 1fntD, 0.8879, 1.47, 0.311, 230, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1667, 5wvkY, 0.8878, 1.59, 0.310, 233, 226, 
1668, 1g0uC, 0.8878, 1.59, 0.310, 233, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1669, 1fntR, 0.8878, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1670, 5lf7A, 0.8877, 1.48, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1671, 5le5A, 0.8877, 1.48, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1672, 4r67r, 0.8877, 1.47, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1673, 4r67P, 0.8877, 1.47, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1674, 4r67d, 0.8876, 1.47, 0.311, 230, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1675, 4r67B, 0.8875, 2.01, 0.339, 239, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1676, 3uneA, 0.8875, 2.04, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1677, 5m32P, 0.8874, 1.47, 0.311, 230, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1678, 3unec, 0.8874, 1.98, 0.342, 239, 234, MOUSE CONSTITUTIVE 20S PROTEASOME
1679, 3dy4C, 0.8873, 2.00, 0.339, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1680, 2zcyC, 0.8873, 2.01, 0.335, 238, 233, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1681, 2zcyQ, 0.8872, 1.99, 0.342, 239, 234, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1682, 1iruP, 0.8872, 1.47, 0.311, 230, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1683, 5wvkW, 0.8871, 1.47, 0.311, 230, 225, 
1684, 4eu2D, 0.8871, 1.59, 0.310, 233, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1685, 3uneC, 0.8871, 1.59, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1686, 3dy4Q, 0.8871, 1.60, 0.310, 233, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1687, 5vfoH, 0.8870, 1.60, 0.310, 233, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1688, 5l4gP, 0.8870, 1.57, 0.310, 233, 226, 
1689, 5l4gD, 0.8870, 2.13, 0.338, 244, 234, 
1690, 6avoZ, 0.8869, 1.57, 0.310, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1691, 6avoO, 0.8869, 2.01, 0.335, 241, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1692, 3un8C, 0.8869, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1693, 3mg8C, 0.8869, 2.02, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1694, 3mg6C, 0.8869, 1.62, 0.310, 233, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1695, 3d29C, 0.8869, 1.54, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1696, 4zzgD, 0.8868, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1697, 3un8Q, 0.8868, 1.99, 0.348, 239, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1698, 3jcoKA, 0.8868, 2.02, 0.335, 241, 233, 
1699, 3jcoK, 0.8868, 1.69, 0.307, 230, 228, 
1700, 3dy3C, 0.8868, 1.56, 0.310, 233, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1701, 3d29Q, 0.8868, 2.03, 0.343, 243, 233, PROTEASOME INHIBITION BY FELLUTAMIDE B
1702, 1rypD, 0.8868, 1.88, 0.339, 240, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1703, 3dy3Q, 0.8867, 1.88, 0.339, 240, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1704, 5lf7C, 0.8866, 2.03, 0.335, 241, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1705, 4inrC, 0.8866, 2.06, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1706, 4hnpC, 0.8866, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1707, 1j2pF, 0.8866, 2.02, 0.335, 241, 233, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1708, 1g0uQ, 0.8866, 2.04, 0.335, 241, 233, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1709, 5nifD, 0.8865, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1710, 5vfrH, 0.8864, 1.58, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1711, 5le5C, 0.8864, 1.58, 0.330, 250, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1712, 3bdmC, 0.8864, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1713, 1j2pG, 0.8864, 2.02, 0.335, 241, 233, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1714, 1j2pE, 0.8864, 2.02, 0.335, 241, 233, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1715, 1j2pC, 0.8864, 2.02, 0.335, 241, 233, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1716, 1j2pA, 0.8864, 2.02, 0.335, 241, 233, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1717, 5lf3C, 0.8863, 1.93, 0.346, 236, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1718, 4r67v, 0.8863, 2.03, 0.335, 241, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1719, 4r67T, 0.8863, 2.03, 0.335, 241, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1720, 4inuC, 0.8863, 2.18, 0.402, 243, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1721, 3gpjC, 0.8863, 2.02, 0.335, 238, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1722, 3bdmQ, 0.8863, 2.05, 0.335, 241, 233, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1723, 1j2pD, 0.8863, 1.69, 0.307, 230, 228, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1724, 1j2pB, 0.8863, 1.93, 0.351, 236, 231, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1725, 1iruT, 0.8863, 2.02, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1726, 5gjqC, 0.8862, 2.18, 0.402, 243, 234, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1727, 4inrQ, 0.8862, 2.18, 0.402, 243, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1728, 4hrcC, 0.8862, 2.18, 0.402, 243, 234, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1729, 3gpjQ, 0.8862, 2.18, 0.402, 243, 234, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1730, 1rypR, 0.8862, 1.94, 0.346, 236, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1731, 5lf4C, 0.8861, 1.97, 0.312, 238, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1732, 5l4gB, 0.8861, 1.98, 0.312, 238, 231, 
1733, 4r3oF, 0.8861, 2.03, 0.335, 241, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1734, 4q1sQ, 0.8861, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1735, 4intC, 0.8861, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1736, 3unbS, 0.8861, 2.19, 0.402, 243, 234, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1737, 4jsqQ, 0.8860, 2.18, 0.402, 243, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1738, 4jsqC, 0.8860, 1.98, 0.312, 238, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1739, 3unbq, 0.8860, 1.62, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1740, 1g65C, 0.8860, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1741, 5wvkP, 0.8859, 2.04, 0.335, 241, 233, 
1742, 5vfpB, 0.8859, 2.02, 0.335, 241, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1743, 4lqiC, 0.8859, 2.02, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1744, 4jsuQ, 0.8859, 1.94, 0.346, 236, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1745, 4jsuC, 0.8859, 1.68, 0.310, 233, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1746, 4inuQ, 0.8859, 1.82, 0.313, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1747, 4intQ, 0.8859, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1748, 3un4Q, 0.8859, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1749, 3un4C, 0.8859, 1.85, 0.313, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1750, 3nzwC, 0.8859, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1751, 3gptC, 0.8859, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1752, 5t0gI, 0.8858, 1.44, 0.312, 231, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1753, 5lf0C, 0.8858, 2.03, 0.335, 241, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1754, 5lezC, 0.8858, 1.57, 0.330, 250, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1755, 5leyC, 0.8858, 1.69, 0.307, 230, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1756, 4zzgR, 0.8858, 2.27, 0.343, 239, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1757, 4lqiQ, 0.8858, 2.03, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1758, 4gk7C, 0.8858, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1759, 4fzcC, 0.8858, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1760, 3shjQ, 0.8858, 2.04, 0.335, 241, 233, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1761, 3shjC, 0.8858, 2.04, 0.335, 241, 233, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1762, 3nzwQ, 0.8858, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1763, 3mg7C, 0.8858, 2.04, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1764, 3hyeC, 0.8858, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1765, 3gptQ, 0.8858, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1766, 4r67h, 0.8857, 2.12, 0.335, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1767, 4gk7Q, 0.8857, 1.94, 0.351, 236, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1768, 4fzcQ, 0.8857, 1.94, 0.351, 236, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1769, 4eu2R, 0.8857, 1.94, 0.346, 236, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1770, 3unbu, 0.8857, 2.06, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1771, 3nzjC, 0.8857, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1772, 3gpwC, 0.8857, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1773, 5lf1C, 0.8856, 2.04, 0.335, 241, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1774, 4r67F, 0.8856, 2.03, 0.335, 241, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1775, 3tddC, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1776, 3nzxC, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1777, 3nzjQ, 0.8856, 2.08, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1778, 3hyeQ, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1779, 3gpwQ, 0.8856, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1780, 4jt0Q, 0.8855, 1.85, 0.313, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1781, 4jt0C, 0.8855, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1782, 4j70C, 0.8855, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1783, 3unes, 0.8855, 2.04, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1784, 3unbc, 0.8855, 1.86, 0.313, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1785, 3unbA, 0.8855, 2.03, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1786, 3tddQ, 0.8855, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1787, 3nzxQ, 0.8855, 1.95, 0.346, 236, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1788, 5nifR, 0.8854, 1.86, 0.313, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1789, 4r3oT, 0.8854, 2.03, 0.335, 241, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1790, 4hrdC, 0.8854, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1791, 3unhS, 0.8854, 2.03, 0.335, 241, 233, MOUSE 20S IMMUNOPROTEASOME
1792, 3unhE, 0.8854, 2.03, 0.335, 241, 233, MOUSE 20S IMMUNOPROTEASOME
1793, 3okjC, 0.8854, 2.03, 0.335, 241, 233, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1794, 3oevC, 0.8854, 2.05, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1795, 3mg0C, 0.8854, 2.05, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1796, 3e47C, 0.8854, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1797, 5mpcC, 0.8853, 2.01, 0.343, 239, 233, 
1798, 5a5bC, 0.8853, 1.45, 0.312, 231, 224, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
1799, 4x6zD, 0.8853, 1.45, 0.312, 231, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1800, 4hnpQ, 0.8853, 2.03, 0.335, 241, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1801, 4cr3C, 0.8853, 2.04, 0.335, 241, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1802, 3unbO, 0.8853, 2.06, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1803, 3okjQ, 0.8853, 1.86, 0.313, 238, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1804, 3e47Q, 0.8853, 2.05, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1805, 5lexC, 0.8852, 1.85, 0.313, 238, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1806, 4ltcC, 0.8852, 1.85, 0.313, 238, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1807, 4j70Q, 0.8852, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1808, 4cr4C, 0.8852, 2.08, 0.335, 241, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1809, 5lf6C, 0.8851, 2.05, 0.335, 241, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1810, 3wxrD, 0.8851, 2.04, 0.335, 241, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1811, 3unfS, 0.8851, 2.02, 0.353, 244, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1812, 3unfE, 0.8851, 2.19, 0.352, 245, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1813, 3unee, 0.8851, 2.04, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1814, 3mg0Q, 0.8851, 2.04, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1815, 2fakC, 0.8851, 2.19, 0.352, 245, 233, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1816, 2f16C, 0.8851, 1.45, 0.312, 231, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1817, 4fzgC, 0.8850, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1818, 3uneS, 0.8850, 2.04, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1819, 2f16Q, 0.8850, 1.95, 0.351, 236, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1820, 5l4gR, 0.8849, 2.05, 0.335, 241, 233, 
1821, 4fzgQ, 0.8849, 2.04, 0.335, 241, 233, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1822, 2fakQ, 0.8849, 2.08, 0.352, 245, 233, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1823, 1g65Q, 0.8848, 1.95, 0.351, 236, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1824, 5t0jI, 0.8847, 2.08, 0.335, 241, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1825, 5gjrHA, 0.8847, 1.86, 0.313, 238, 230, 
1826, 5gjrT, 0.8845, 1.86, 0.313, 238, 230, 
1827, 4ltcQ, 0.8845, 2.02, 0.348, 239, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1828, 3sdiQ, 0.8845, 2.05, 0.335, 241, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1829, 5lf0S, 0.8844, 2.04, 0.335, 241, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1830, 3mg4C, 0.8843, 2.04, 0.335, 241, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1831, 1iruR, 0.8843, 2.04, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1832, 1iruD, 0.8843, 1.87, 0.313, 238, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1833, 5t0iI, 0.8842, 2.04, 0.335, 241, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1834, 5gjrGA, 0.8842, 2.06, 0.339, 243, 233, 
1835, 5gjqk, 0.8842, 2.04, 0.335, 241, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1836, 3uneu, 0.8842, 2.05, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1837, 3uneE, 0.8842, 2.04, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1838, 2gplC, 0.8842, 2.08, 0.331, 250, 236, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1839, 1iruB, 0.8842, 1.45, 0.312, 231, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1840, 2gplQ, 0.8841, 1.45, 0.312, 231, 224, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1841, 6gopQ, 0.8840, 2.06, 0.335, 241, 233, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1842, 6gopC, 0.8840, 2.05, 0.335, 238, 233, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1843, 4hrcQ, 0.8840, 1.68, 0.316, 237, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1844, 1jd2C, 0.8840, 2.06, 0.335, 241, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1845, 5vfrl, 0.8839, 2.03, 0.343, 243, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1846, 4x6zR, 0.8839, 2.03, 0.343, 243, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1847, 1iruF, 0.8839, 2.13, 0.339, 250, 236, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1848, 5vfol, 0.8838, 1.99, 0.263, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1849, 5m32O, 0.8838, 2.05, 0.343, 243, 233, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1850, 5m32A, 0.8838, 1.91, 0.313, 238, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1851, 5lexS, 0.8838, 1.90, 0.313, 238, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1852, 3unbg, 0.8838, 2.05, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1853, 5vfoL, 0.8837, 1.69, 0.310, 233, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1854, 4qv9Q, 0.8837, 2.05, 0.335, 241, 233, YCP BETA5-C63F MUTANT
1855, 4qv9C, 0.8837, 2.01, 0.341, 240, 232, YCP BETA5-C63F MUTANT
1856, 5mpcQ, 0.8836, 2.01, 0.341, 240, 232, 
1857, 5lf4S, 0.8836, 2.06, 0.335, 241, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1858, 5gjrS, 0.8836, 2.05, 0.335, 241, 233, 
1859, 5d0tQ, 0.8836, 1.90, 0.317, 238, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1860, 5d0tC, 0.8836, 2.08, 0.335, 241, 233, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1861, 4qv0Q, 0.8836, 1.90, 0.313, 238, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1862, 4qv0C, 0.8836, 1.92, 0.317, 238, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1863, 6epfE, 0.8835, 1.51, 0.311, 230, 225, GROUND STATE 26S PROTEASOME (GS1)
1864, 5lf6S, 0.8835, 1.51, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1865, 4qv7Q, 0.8835, 1.69, 0.316, 235, 228, YCP BETA5-A50V MUTANT
1866, 4qv7C, 0.8835, 1.90, 0.313, 238, 230, YCP BETA5-A50V MUTANT
1867, 4qv3C, 0.8835, 1.88, 0.313, 238, 230, YCP BETA5-M45V MUTANT
1868, 3uneg, 0.8835, 2.02, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
1869, 1jd2X, 0.8835, 2.02, 0.341, 240, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1870, 5lf7S, 0.8834, 1.93, 0.349, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1871, 5l4gO, 0.8834, 1.70, 0.316, 237, 228, 
1872, 5gjqh, 0.8834, 2.00, 0.263, 244, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1873, 4r00C, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1874, 4qzzQ, 0.8834, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH OMURALIDE
1875, 4qzzC, 0.8834, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH OMURALIDE
1876, 4qw1Q, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1877, 4qw1C, 0.8834, 1.96, 0.592, 233, 233, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1878, 4qvpC, 0.8834, 1.70, 0.316, 237, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1879, 4qv6Q, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT
1880, 4qv6C, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT
1881, 4qv3Q, 0.8834, 2.02, 0.341, 240, 232, YCP BETA5-M45V MUTANT
1882, 4hrdQ, 0.8834, 1.89, 0.313, 238, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1883, 3unbE, 0.8834, 2.05, 0.335, 241, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1884, 5dkjQ, 0.8833, 1.69, 0.311, 237, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1885, 5dkjC, 0.8833, 1.98, 0.263, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1886, 5cgfC, 0.8833, 2.00, 0.263, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1887, 4r00Q, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1888, 4qwuQ, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1889, 4qwuC, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1890, 4qwlC, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1891, 4qvvQ, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1892, 4qvvC, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1893, 4qvpQ, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1894, 4qv8Q, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT
1895, 4qv8C, 0.8833, 2.02, 0.341, 240, 232, YCP BETA5-C52F MUTANT
1896, 4cr2C, 0.8833, 2.07, 0.335, 241, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1897, 5lf3S, 0.8832, 1.91, 0.313, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1898, 5lf1S, 0.8832, 2.02, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1899, 5lezS, 0.8832, 2.02, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1900, 5leyS, 0.8832, 2.02, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1901, 5fgaQ, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1902, 5fgaC, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1903, 5fg7C, 0.8832, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1904, 5cgfQ, 0.8832, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1905, 4qz6C, 0.8832, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1906, 4qz5Q, 0.8832, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1907, 4qz5C, 0.8832, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1908, 4qwlQ, 0.8832, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1909, 5vfrL, 0.8831, 2.02, 0.341, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1910, 5vfqEA, 0.8831, 2.13, 0.352, 245, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1911, 5l54C, 0.8831, 1.70, 0.316, 237, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1912, 5fg7Q, 0.8831, 1.70, 0.316, 237, 228, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1913, 5d0xC, 0.8831, 1.70, 0.316, 237, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1914, 5cz8Q, 0.8831, 1.70, 0.316, 235, 228, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1915, 5cz8C, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1916, 4z1lQ, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1917, 4z1lC, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1918, 4ya2Q, 0.8831, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1919, 4ya2C, 0.8831, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1920, 4qz6Q, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1921, 4qz3Q, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1922, 4qz3C, 0.8831, 2.03, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1923, 4qv4C, 0.8831, 1.90, 0.317, 238, 230, YCP BETA5-M45T MUTANT
1924, 4qv1Q, 0.8831, 1.91, 0.317, 238, 230, YCP BETA5-M45A MUTANT
1925, 4qv1C, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-M45A MUTANT
1926, 4quyQ, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-A49S-MUTANT
1927, 4quyC, 0.8831, 2.02, 0.341, 240, 232, YCP BETA5-A49S-MUTANT
1928, 5l54Q, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1929, 5d0xQ, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1930, 5d0wQ, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1931, 5d0wC, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1932, 5d0sQ, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1933, 5d0sC, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1934, 4y8sQ, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1935, 4y8sC, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1936, 4y8rQ, 0.8830, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1937, 4y8rC, 0.8830, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1938, 4qwjC, 0.8830, 2.02, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1939, 4qvqQ, 0.8830, 2.02, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1940, 4qvqC, 0.8830, 2.02, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1941, 4qvlQ, 0.8830, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH BORTEZOMIB
1942, 4qvlC, 0.8830, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH BORTEZOMIB
1943, 4qv5Q, 0.8830, 2.02, 0.341, 240, 232, YCP BETA5-M45I MUTANT
1944, 4qv5C, 0.8830, 2.02, 0.341, 240, 232, YCP BETA5-M45I MUTANT
1945, 4qv4Q, 0.8830, 2.02, 0.341, 240, 232, YCP BETA5-M45T MUTANT
1946, 5lajC, 0.8829, 2.03, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1947, 5l4gA, 0.8829, 2.03, 0.341, 240, 232, 
1948, 5gjqB, 0.8829, 2.02, 0.341, 240, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1949, 5dkiQ, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1950, 5dkiC, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1951, 5d0zQ, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1952, 5d0zC, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1953, 5czaQ, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1954, 5czaC, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1955, 5bxnC, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1956, 4y9yQ, 0.8829, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1957, 4y9yC, 0.8829, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1958, 4qzwQ, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1959, 4qzwC, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1960, 4qz7Q, 0.8829, 2.02, 0.341, 240, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1961, 4qz7C, 0.8829, 2.00, 0.263, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1962, 4qwjQ, 0.8829, 2.02, 0.263, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1963, 4qw7C, 0.8829, 2.02, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1964, 4qw0Q, 0.8829, 2.02, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1965, 4qw0C, 0.8829, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1966, 4qltC, 0.8829, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1967, 3uneG, 0.8829, 2.02, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
1968, 3mg8Q, 0.8829, 2.02, 0.341, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1969, 1iruO, 0.8829, 2.03, 0.341, 240, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1970, 5lajQ, 0.8828, 2.02, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1971, 5l55C, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1972, 5l52Q, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1973, 5l52C, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1974, 5jhsQ, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1975, 5jhsC, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1976, 5fggQ, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1977, 5fggC, 0.8828, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1978, 5fg9Q, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1979, 5fg9C, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1980, 5bxnQ, 0.8828, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1981, 4y7yC, 0.8828, 2.00, 0.263, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1982, 4r02C, 0.8828, 2.11, 0.335, 241, 233, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1983, 4qw7Q, 0.8828, 2.02, 0.263, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1984, 4qw6C, 0.8828, 2.02, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1985, 4qvyC, 0.8828, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1986, 4qvwQ, 0.8828, 2.03, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1987, 4qvwC, 0.8828, 2.03, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1988, 4qltQ, 0.8828, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1989, 1iruA, 0.8828, 2.03, 0.341, 240, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1990, 5vfpDA, 0.8827, 2.03, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1991, 5l55Q, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1992, 5fhsQ, 0.8827, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1993, 5fhsC, 0.8827, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1994, 5cz5Q, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1995, 5cz5C, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1996, 5cggQ, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1997, 5cggC, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1998, 4ya4Q, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1999, 4ya4C, 0.8827, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2000, 4y9zQ, 0.8827, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2001, 4y9zC, 0.8827, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2002, 4y8lC, 0.8827, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2003, 4y8jQ, 0.8827, 2.02, 0.263, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2004, 4y8jC, 0.8827, 1.92, 0.317, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2005, 4y7yQ, 0.8827, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2006, 4qwiQ, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2007, 4qwiC, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2008, 4qw6Q, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2009, 4qw5Q, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2010, 4qw5C, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2011, 4qvyQ, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2012, 4qvnC, 0.8827, 2.03, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2013, 5wvkQ, 0.8826, 2.03, 0.341, 240, 232, 
2014, 5le5S, 0.8826, 2.03, 0.341, 240, 232, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2015, 5fghQ, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2016, 5fghC, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2017, 5cz9Q, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2018, 5cz9C, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2019, 5cgiQ, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2020, 5cgiC, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2021, 5bxlQ, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2022, 5bxlC, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2023, 4ya7C, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2024, 4ya1Q, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2025, 4ya1C, 0.8826, 2.02, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2026, 4y8uQ, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2027, 4y8uC, 0.8826, 2.03, 0.353, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2028, 4y8lQ, 0.8826, 1.75, 0.316, 237, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2029, 4y7wC, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2030, 4y70C, 0.8826, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2031, 4qzxQ, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2032, 4qzxC, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2033, 4qwkQ, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2034, 4qwkC, 0.8826, 2.03, 0.341, 240, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2035, 4qvnQ, 0.8826, 2.02, 0.341, 240, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2036, 4nnnQ, 0.8826, 2.02, 0.341, 240, 232, YCP IN COMPLEX WITH MG132
2037, 4nnnC, 0.8826, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH MG132
2038, 5jhrC, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2039, 5fgiQ, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2040, 5fgiC, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2041, 5d0vC, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2042, 5cz7Q, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2043, 4ya7Q, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2044, 4y8iC, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2045, 4y7wQ, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2046, 4y70Q, 0.8825, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2047, 4qz4C, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2048, 4qz2C, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2049, 4qxjQ, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2050, 4qxjC, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2051, 4qwrQ, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2052, 4qwrC, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2053, 4qw4C, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH CARFILZOMIB
2054, 4quxQ, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT
2055, 4quxC, 0.8825, 2.03, 0.341, 240, 232, YCP BETA5-A49T-MUTANT
2056, 4no8C, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2057, 4no1Q, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2058, 4no1C, 0.8825, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2059, 6avoL, 0.8824, 2.03, 0.341, 240, 232, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2060, 6avoG, 0.8824, 2.03, 0.341, 240, 232, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2061, 5jhrQ, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2062, 5gjqi, 0.8824, 2.03, 0.341, 240, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2063, 5d0vQ, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2064, 5cz7C, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2065, 5cz6Q, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2066, 5cz6C, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2067, 5ahjC, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2068, 4y8mQ, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2069, 4y8mC, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2070, 4y8iQ, 0.8824, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2071, 4qz4Q, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2072, 4qz2Q, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2073, 4qz0C, 0.8824, 1.65, 0.317, 234, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2074, 4qwfQ, 0.8824, 1.65, 0.317, 234, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2075, 4qwfC, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2076, 4qw4Q, 0.8824, 1.48, 0.312, 231, 224, YCP IN COMPLEX WITH CARFILZOMIB
2077, 4qvmQ, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2078, 4qvmC, 0.8824, 2.03, 0.341, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2079, 4no8Q, 0.8824, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2080, 5vfuW, 0.8823, 2.03, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2081, 5vfsF, 0.8823, 2.04, 0.341, 240, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2082, 5fgdC, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2083, 5ahjQ, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2084, 4y8qQ, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2085, 4y8qC, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2086, 4y8hQ, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2087, 4y8hC, 0.8823, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2088, 4y80Q, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2089, 4y80C, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2090, 4y78Q, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2091, 4y78C, 0.8823, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2092, 4r18Q, 0.8823, 2.03, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2093, 4r18C, 0.8823, 2.03, 0.341, 240, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2094, 4qz0Q, 0.8823, 1.93, 0.313, 238, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2095, 4qlsQ, 0.8823, 1.82, 0.319, 238, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2096, 4qlsC, 0.8823, 2.61, 0.333, 240, 234, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2097, 5fgfQ, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2098, 5fgfC, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2099, 5fgeQ, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2100, 5fgeC, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2101, 5fgdQ, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2102, 5cghQ, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2103, 5cghC, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2104, 4ya9C, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2105, 4ya3Q, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2106, 4ya3C, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2107, 4ya0Q, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2108, 4ya0C, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2109, 4y8pQ, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2110, 4y8pC, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2111, 4y69Q, 0.8822, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2112, 4y69C, 0.8822, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2113, 4qlqQ, 0.8822, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2114, 4qlqC, 0.8822, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2115, 4no6Q, 0.8822, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2116, 4no6C, 0.8822, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2117, 5vfsAA, 0.8821, 2.04, 0.341, 240, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2118, 5mpaB, 0.8821, 2.04, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2119, 4ya9Q, 0.8821, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2120, 4ya5C, 0.8821, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2121, 4y84Q, 0.8821, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2122, 4y77Q, 0.8821, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2123, 4y77C, 0.8821, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2124, 4qwxQ, 0.8821, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2125, 4qwxC, 0.8821, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2126, 4qw3C, 0.8821, 2.03, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2127, 3mg6Q, 0.8821, 2.03, 0.341, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2128, 3mg4Q, 0.8821, 2.03, 0.341, 240, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2129, 5vfqAA, 0.8820, 2.03, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2130, 5vfpF, 0.8820, 2.03, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2131, 5cz4Q, 0.8820, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2132, 5cz4C, 0.8820, 1.64, 0.310, 232, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2133, 4ya5Q, 0.8820, 1.64, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2134, 4y8gQ, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2135, 4y8gC, 0.8820, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2136, 4y84C, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2137, 4y82C, 0.8820, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2138, 4r3oO, 0.8820, 2.04, 0.341, 240, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2139, 4qw3Q, 0.8820, 2.04, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2140, 5vfuHA, 0.8819, 2.04, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2141, 5vftL, 0.8819, 2.03, 0.341, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2142, 5vfti, 0.8819, 2.12, 0.335, 241, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2143, 4y8nQ, 0.8819, 2.09, 0.335, 241, 233, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2144, 4y8nC, 0.8819, 1.63, 0.310, 232, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2145, 4y82Q, 0.8819, 1.92, 0.317, 238, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2146, 4y7xQ, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2147, 4y7xC, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2148, 4y75Q, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2149, 4y75C, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2150, 4y74Q, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2151, 4y74C, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2152, 4y6vQ, 0.8819, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2153, 4y6vC, 0.8819, 2.02, 0.263, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2154, 4y6aQ, 0.8819, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2155, 4y6aC, 0.8819, 2.21, 0.335, 250, 236, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2156, 4qwsC, 0.8819, 1.80, 0.319, 238, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2157, 3sdkQ, 0.8819, 2.21, 0.335, 250, 236, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2158, 3oevQ, 0.8819, 2.03, 0.341, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2159, 5vfuGA, 0.8818, 2.03, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2160, 5vfth, 0.8818, 2.04, 0.341, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2161, 5mp9D, 0.8818, 2.04, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2162, 4rurQ, 0.8818, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2163, 4rurC, 0.8818, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2164, 4qwsQ, 0.8818, 2.04, 0.341, 240, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2165, 4qbyQ, 0.8818, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2166, 4qbyC, 0.8818, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2167, 3unhO, 0.8818, 2.03, 0.341, 240, 232, MOUSE 20S IMMUNOPROTEASOME
2168, 3unhA, 0.8818, 2.03, 0.341, 240, 232, MOUSE 20S IMMUNOPROTEASOME
2169, 5vfqF, 0.8817, 2.04, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2170, 5bouQ, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2171, 5bouC, 0.8817, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2172, 4y8tQ, 0.8817, 2.11, 0.335, 241, 233, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2173, 4y8tC, 0.8817, 2.12, 0.335, 241, 233, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2174, 4y8oQ, 0.8817, 1.79, 0.308, 232, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2175, 4y8oC, 0.8817, 1.79, 0.308, 232, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2176, 4y8kQ, 0.8817, 2.01, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2177, 4y8kC, 0.8817, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2178, 4no9Q, 0.8817, 2.03, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2179, 4no9C, 0.8817, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2180, 3unfO, 0.8817, 2.04, 0.345, 240, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2181, 3unfA, 0.8817, 2.04, 0.345, 240, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2182, 4y81Q, 0.8816, 1.45, 0.314, 230, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2183, 4y81C, 0.8816, 1.45, 0.314, 230, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2184, 4r3oA, 0.8816, 1.93, 0.317, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2185, 4qlvC, 0.8816, 2.39, 0.332, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2186, 4qz1Q, 0.8815, 2.03, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2187, 4qz1C, 0.8815, 2.03, 0.341, 240, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2188, 4qlvQ, 0.8815, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2189, 3uneU, 0.8815, 2.04, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2190, 5vfsB, 0.8814, 2.04, 0.341, 240, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2191, 4y6zQ, 0.8814, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2192, 4y6zC, 0.8814, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2193, 4r67q, 0.8814, 2.04, 0.341, 240, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2194, 4r67O, 0.8814, 2.04, 0.341, 240, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2195, 4r67c, 0.8814, 2.04, 0.341, 240, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2196, 4r67A, 0.8814, 1.46, 0.314, 230, 223, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2197, 5vfoh, 0.8813, 1.46, 0.314, 230, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2198, 5mp9d, 0.8813, 2.04, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2199, 4r17Q, 0.8813, 2.04, 0.341, 240, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2200, 4r17C, 0.8813, 2.03, 0.263, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2201, 5vfsEA, 0.8812, 2.04, 0.341, 240, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2202, 5vfrh, 0.8812, 2.04, 0.341, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2203, 5l5wQ, 0.8812, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2204, 5l5wC, 0.8812, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2205, 3unew, 0.8812, 2.02, 0.263, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2206, 5vfpZ, 0.8811, 2.12, 0.335, 250, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2207, 5gjqX, 0.8811, 1.65, 0.310, 232, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2208, 4qluQ, 0.8811, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2209, 4qluC, 0.8811, 2.04, 0.341, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2210, 4nnwQ, 0.8811, 2.03, 0.263, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2211, 4nnwC, 0.8811, 2.03, 0.263, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2212, 5laiQ, 0.8810, 2.03, 0.263, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2213, 5laiC, 0.8810, 2.03, 0.263, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2214, 5l5zQ, 0.8810, 1.64, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2215, 5l5zC, 0.8810, 2.03, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2216, 5l5xQ, 0.8810, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2217, 5l5xC, 0.8810, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2218, 5l5uQ, 0.8810, 1.81, 0.319, 238, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2219, 5l5uC, 0.8810, 1.64, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2220, 5a0qQ, 0.8810, 2.04, 0.341, 240, 232, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2221, 5a0qC, 0.8810, 2.04, 0.341, 240, 232, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2222, 6epdC, 0.8809, 2.03, 0.259, 244, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2223, 5lttQ, 0.8809, 1.65, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2224, 5lttC, 0.8809, 2.43, 0.342, 243, 234, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2225, 5l64Q, 0.8809, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2226, 5l64C, 0.8809, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2227, 5l60Q, 0.8809, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2228, 5l60C, 0.8809, 2.04, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2229, 4qwgQ, 0.8809, 2.04, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2230, 4qwgC, 0.8809, 2.04, 0.341, 240, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2231, 5l62Q, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2232, 5l62C, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2233, 5l5fQ, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2234, 5l5fC, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2235, 5l5eQ, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2236, 5l5eC, 0.8808, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2237, 3unbG, 0.8808, 1.84, 0.346, 237, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2238, 5l65Q, 0.8807, 1.84, 0.346, 237, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2239, 5l65C, 0.8807, 2.15, 0.343, 249, 236, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2240, 5l61Q, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2241, 5l61C, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2242, 5l5yQ, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2243, 5l5yC, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2244, 5l5bQ, 0.8807, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2245, 5gjqn, 0.8807, 2.05, 0.341, 240, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2246, 4r02Q, 0.8807, 2.05, 0.341, 240, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2247, 5l6bQ, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2248, 5l63Q, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2249, 5l63C, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2250, 5l5sQ, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2251, 5l5sC, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2252, 5l5bC, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2253, 5l5aQ, 0.8806, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2254, 5l5aC, 0.8806, 1.98, 0.260, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2255, 3unei, 0.8806, 2.05, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2256, 5l6bC, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2257, 5l67Q, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2258, 5l67C, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2259, 5l66Q, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2260, 5l66C, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2261, 5l5vQ, 0.8805, 2.05, 0.341, 240, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2262, 5l5vC, 0.8805, 2.41, 0.342, 243, 234,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2263, 5l5rQ, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2264, 5l5rC, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2265, 5l5hQ, 0.8805, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2266, 5vfuKA, 0.8804, 2.05, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2267, 5vftl, 0.8804, 2.05, 0.341, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2268, 5lf0E, 0.8804, 2.05, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2269, 5l6cQ, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2270, 5l6cC, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2271, 5l5qQ, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2272, 5l5qC, 0.8804, 2.04, 0.263, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2273, 5l5pQ, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2274, 5l5pC, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2275, 5l5iC, 0.8804, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2276, 5l5hC, 0.8804, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2277, 3unbi, 0.8804, 2.05, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2278, 5vfuS, 0.8803, 2.06, 0.341, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2279, 5vftH, 0.8803, 2.05, 0.341, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2280, 5lf4E, 0.8803, 2.05, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2281, 5l6aQ, 0.8803, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2282, 5l6aC, 0.8803, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2283, 5l5tQ, 0.8803, 1.83, 0.314, 238, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2284, 5l5tC, 0.8803, 1.83, 0.314, 238, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2285, 5l5iQ, 0.8803, 1.60, 0.314, 233, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2286, 5l4gG, 0.8803, 2.06, 0.341, 240, 232, 
2287, 3mg7Q, 0.8803, 2.06, 0.341, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2288, 5l5oQ, 0.8802, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2289, 5l5oC, 0.8802, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2290, 3jcpMA, 0.8802, 2.06, 0.341, 240, 232, 
2291, 3jcpM, 0.8802, 2.06, 0.341, 240, 232, 
2292, 5lf6E, 0.8801, 2.05, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2293, 5l5jQ, 0.8801, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2294, 5l5jC, 0.8801, 1.99, 0.260, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2295, 5l5dQ, 0.8801, 1.64, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2296, 5l5dC, 0.8801, 1.64, 0.310, 232, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2297, 3oeuQ, 0.8801, 1.60, 0.314, 233, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2298, 5t0hI, 0.8800, 2.06, 0.341, 240, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2299, 5m2bQ, 0.8800, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2300, 5m2bC, 0.8800, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2301, 5lf7E, 0.8800, 2.06, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2302, 5l68Q, 0.8800, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2303, 6avoQ, 0.8799, 2.35, 0.346, 242, 234, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2304, 6avoJ, 0.8799, 2.14, 0.339, 241, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2305, 5lf1E, 0.8799, 2.06, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2306, 5leyE, 0.8799, 2.06, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2307, 5lexE, 0.8799, 2.11, 0.335, 241, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2308, 5l68C, 0.8799, 2.11, 0.335, 241, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2309, 5gjrMA, 0.8798, 2.11, 0.335, 241, 233, 
2310, 5lf3E, 0.8797, 1.60, 0.314, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2311, 5le5E, 0.8797, 2.06, 0.341, 240, 232, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2312, 5l69Q, 0.8797, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2313, 5l69C, 0.8797, 2.06, 0.341, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2314, 5t0cZA, 0.8796, 2.06, 0.341, 240, 232, 
2315, 5t0cT, 0.8796, 2.15, 0.335, 241, 233, 
2316, 5gjrY, 0.8796, 2.19, 0.339, 250, 236, 
2317, 3unbw, 0.8793, 2.06, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2318, 5mpad, 0.8792, 2.06, 0.341, 240, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2319, 3unbU, 0.8792, 1.60, 0.314, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2320, 5lezE, 0.8791, 2.06, 0.341, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2321, 5l4gU, 0.8789, 2.36, 0.343, 239, 233, 
2322, 3unhU, 0.8785, 2.36, 0.343, 239, 233, MOUSE 20S IMMUNOPROTEASOME
2323, 3unhG, 0.8785, 1.61, 0.314, 233, 226, MOUSE 20S IMMUNOPROTEASOME
2324, 3wxrR, 0.8784, 1.61, 0.314, 233, 226, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2325, 5t0gL, 0.8783, 1.60, 0.314, 233, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2326, 4r3oG, 0.8782, 2.06, 0.341, 240, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2327, 4r3oU, 0.8780, 2.38, 0.342, 243, 234, HUMAN CONSTITUTIVE 20S PROTEASOME
2328, 3unfU, 0.8780, 1.61, 0.314, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2329, 3unfG, 0.8780, 1.61, 0.314, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2330, 3unbv, 0.8780, 2.06, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2331, 3unbT, 0.8780, 2.06, 0.341, 240, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2332, 4cr4B, 0.8778, 1.66, 0.310, 232, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2333, 3sdiT, 0.8777, 1.66, 0.310, 232, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2334, 5t0gH, 0.8776, 2.38, 0.342, 243, 234, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2335, 5l63T, 0.8775, 2.01, 0.260, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2336, 5l63F, 0.8775, 2.05, 0.341, 240, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2337, 4r02F, 0.8775, 2.01, 0.260, 243, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2338, 5l6aT, 0.8774, 1.61, 0.314, 233, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2339, 5l6aF, 0.8774, 2.39, 0.346, 241, 234, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2340, 5l64T, 0.8774, 2.01, 0.264, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2341, 5l64F, 0.8774, 2.01, 0.264, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2342, 5l61T, 0.8774, 2.17, 0.335, 241, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2343, 5l61F, 0.8774, 1.94, 0.313, 238, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2344, 4r18T, 0.8774, 2.42, 0.346, 245, 234, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2345, 4r18F, 0.8774, 2.42, 0.346, 245, 234, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2346, 5m2bT, 0.8773, 2.02, 0.264, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2347, 5m2bF, 0.8773, 2.02, 0.264, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2348, 5l62T, 0.8773, 2.37, 0.348, 244, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2349, 5l62F, 0.8773, 2.37, 0.348, 244, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2350, 5l5wT, 0.8773, 1.90, 0.329, 250, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2351, 5l5wF, 0.8773, 2.30, 0.332, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2352, 5l5oT, 0.8773, 1.71, 0.310, 233, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2353, 5l5oF, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2354, 5l5dT, 0.8773, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2355, 5l5dF, 0.8773, 2.30, 0.328, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2356, 3jcoMA, 0.8773, 2.31, 0.332, 243, 232, 
2357, 3jcoM, 0.8773, 2.31, 0.332, 243, 232, 
2358, 5l6cT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2359, 5l6cF, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2360, 5l66T, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2361, 5l66F, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2362, 5l5tT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2363, 5l5tF, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2364, 5l5rT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2365, 5l5rF, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2366, 5l5pT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2367, 5l5pF, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2368, 5l5hT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2369, 5l5hF, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2370, 5fggT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2371, 5fggF, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2372, 5ahjT, 0.8772, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2373, 4qvnT, 0.8772, 2.31, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2374, 4qvnF, 0.8772, 2.15, 0.335, 241, 233, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2375, 5l6bT, 0.8771, 2.15, 0.335, 241, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2376, 5l6bF, 0.8771, 2.15, 0.335, 241, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2377, 5l69T, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2378, 5l67T, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2379, 5l67F, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2380, 5l65T, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2381, 5l65F, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2382, 5l60T, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2383, 5l5yT, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2384, 5l5yF, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2385, 5l5uT, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2386, 5l5uF, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2387, 5l5qT, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2388, 5l5qF, 0.8771, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2389, 5l5jT, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2390, 5l5jF, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2391, 5ahjF, 0.8771, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2392, 5lajT, 0.8770, 2.31, 0.332, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2393, 5lajF, 0.8770, 2.32, 0.332, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2394, 5l69F, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2395, 5l68T, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2396, 5l60F, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2397, 5l5zT, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2398, 5l5zF, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2399, 5l5xT, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2400, 5l5vT, 0.8770, 2.31, 0.332, 243, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2401, 5l5vF, 0.8770, 2.31, 0.332, 243, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2402, 5l5sT, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2403, 5l5sF, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2404, 5l5iT, 0.8770, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2405, 5l5iF, 0.8770, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2406, 5l5bT, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2407, 5l5bF, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2408, 5cghT, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2409, 5cghF, 0.8770, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2410, 4r02T, 0.8770, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2411, 4eu2G, 0.8770, 2.31, 0.332, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2412, 5l68F, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2413, 5l5xF, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2414, 5l5fT, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2415, 5l5fF, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2416, 5cz9T, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2417, 5cz9F, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2418, 5cggT, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2419, 5cggF, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2420, 5bxnT, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2421, 5bxnF, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2422, 4zzgU, 0.8769, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2423, 3unbF, 0.8769, 2.31, 0.332, 243, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2424, 5mp9g, 0.8768, 2.31, 0.332, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2425, 5lttT, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2426, 5l5eT, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2427, 5l5eF, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2428, 5fgiT, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2429, 5fgeT, 0.8768, 2.32, 0.328, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2430, 5d0vT, 0.8768, 2.29, 0.332, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2431, 5d0sT, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2432, 5d0sF, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2433, 4zzgG, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2434, 4ya9T, 0.8768, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2435, 4ya9F, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2436, 4y8kT, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2437, 4y8gT, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2438, 4y8gF, 0.8768, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2439, 4r67U, 0.8768, 2.32, 0.332, 243, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2440, 4r67G, 0.8768, 2.32, 0.332, 243, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2441, 4qz7T, 0.8768, 2.28, 0.328, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2442, 4qz7F, 0.8768, 2.40, 0.348, 244, 233, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2443, 4qz0T, 0.8768, 2.29, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2444, 4qwfT, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2445, 4qwfF, 0.8768, 2.31, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2446, 4qw6T, 0.8768, 2.31, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2447, 4qw6F, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2448, 4qw5T, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2449, 4qvwT, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2450, 4qvwF, 0.8768, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2451, 3uneF, 0.8768, 2.32, 0.332, 243, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2452, 5mpcP, 0.8767, 2.25, 0.323, 244, 232, 
2453, 5lttF, 0.8767, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2454, 5l5aT, 0.8767, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2455, 5l5aF, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2456, 5fgiF, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2457, 5fgeF, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2458, 5d0zT, 0.8767, 2.37, 0.343, 245, 233, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2459, 5d0zF, 0.8767, 2.37, 0.343, 245, 233, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2460, 5d0vF, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2461, 5cz7T, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2462, 5cz7F, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2463, 5bxlT, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2464, 5bxlF, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2465, 4ya4T, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2466, 4ya4F, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2467, 4y8tT, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2468, 4y8tF, 0.8767, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2469, 4y8pT, 0.8767, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2470, 4y8pF, 0.8767, 2.27, 0.349, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2471, 4y8kF, 0.8767, 1.85, 0.332, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2472, 4y75T, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2473, 4y75F, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2474, 4y6aT, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2475, 4y6aF, 0.8767, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2476, 4r67w, 0.8767, 2.32, 0.332, 243, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2477, 4r67i, 0.8767, 2.32, 0.332, 243, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2478, 4qzzT, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH OMURALIDE
2479, 4qzzF, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH OMURALIDE
2480, 4qz0F, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2481, 4qwlT, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2482, 4qwlF, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2483, 4qw7T, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2484, 4qw7F, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2485, 4qw5F, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2486, 4qw1T, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2487, 4qw1F, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2488, 4qvyT, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2489, 4qvyF, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2490, 4qvqT, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2491, 4qvqF, 0.8767, 2.31, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2492, 4qvpT, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2493, 4qvpF, 0.8767, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2494, 4qlsT, 0.8767, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2495, 4qlsF, 0.8767, 2.37, 0.343, 245, 233, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2496, 4hnpF, 0.8767, 2.37, 0.343, 245, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2497, 3sdiF, 0.8767, 2.32, 0.332, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2498, 5nifU, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2499, 5lezT, 0.8766, 2.32, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2500, 5lexT, 0.8766, 2.32, 0.332, 243, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2501, 5l55T, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2502, 5l55F, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2503, 5jhsT, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2504, 5jhsF, 0.8766, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2505, 5cz6F, 0.8766, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2506, 5bouT, 0.8766, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2507, 5bouF, 0.8766, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2508, 4qz6T, 0.8766, 2.31, 0.332, 243, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2509, 4qz6F, 0.8766, 2.31, 0.332, 243, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2510, 4qz4T, 0.8766, 2.31, 0.332, 243, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2511, 4qz4F, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2512, 4qwxT, 0.8766, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2513, 4qwxF, 0.8766, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2514, 4qvlT, 0.8766, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH BORTEZOMIB
2515, 4qvlF, 0.8766, 2.29, 0.332, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
2516, 4qv5T, 0.8766, 2.28, 0.332, 242, 232, YCP BETA5-M45I MUTANT
2517, 4qv5F, 0.8766, 2.29, 0.328, 244, 232, YCP BETA5-M45I MUTANT
2518, 4qv4T, 0.8766, 2.45, 0.342, 240, 234, YCP BETA5-M45T MUTANT
2519, 4qv4F, 0.8766, 2.40, 0.339, 240, 233, YCP BETA5-M45T MUTANT
2520, 4qv1T, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT
2521, 4qv1F, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT
2522, 4qv0F, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2523, 4quxF, 0.8766, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT
2524, 5nifG, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2525, 5jhrT, 0.8765, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2526, 5jhrF, 0.8765, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2527, 5fgfT, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2528, 5fgfF, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2529, 5fgdT, 0.8765, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2530, 5fgdF, 0.8765, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2531, 5d0wT, 0.8765, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2532, 5d0wF, 0.8765, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2533, 5czaT, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2534, 5czaF, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2535, 5cz6T, 0.8765, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2536, 4ya1T, 0.8765, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2537, 4ya1F, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2538, 4y8uT, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2539, 4y8uF, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2540, 4y8hT, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2541, 4y8hF, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2542, 4y77T, 0.8765, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2543, 4y77F, 0.8765, 2.25, 0.323, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2544, 4qw4T, 0.8765, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH CARFILZOMIB
2545, 4qv8T, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT
2546, 4qv8F, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT
2547, 4qv7T, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT
2548, 4qv7F, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A50V MUTANT
2549, 4qv6F, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT
2550, 4qv0T, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2551, 4quyT, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT
2552, 4quyF, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT
2553, 4quxT, 0.8765, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT
2554, 5fgaF, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2555, 4y9yT, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2556, 4y9yF, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2557, 4y8sT, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2558, 4y8sF, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2559, 4y8mT, 0.8764, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2560, 4y8mF, 0.8764, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2561, 4y84T, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2562, 4y84F, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2563, 4y6vF, 0.8764, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2564, 4y69T, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2565, 4y69F, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2566, 4rurT, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2567, 4rurF, 0.8764, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2568, 4qz2T, 0.8764, 2.27, 0.328, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2569, 4qz2F, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2570, 4qwuT, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2571, 4qwuF, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2572, 4qw4F, 0.8764, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH CARFILZOMIB
2573, 4qvmT, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2574, 4qvmF, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2575, 4qv6T, 0.8764, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT
2576, 4qlvT, 0.8764, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2577, 4qlvF, 0.8764, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2578, 3unev, 0.8764, 2.32, 0.332, 243, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2579, 3unbh, 0.8764, 2.32, 0.332, 243, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2580, 5l52T, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2581, 5l52F, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2582, 5fgaT, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2583, 5fg9T, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2584, 5fg9F, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2585, 5fg7T, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2586, 5fg7F, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2587, 4ya7T, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2588, 4ya7F, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2589, 4ya2T, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2590, 4y8nT, 0.8763, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2591, 4y8nF, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2592, 4y82T, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2593, 4y81T, 0.8763, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2594, 4y81F, 0.8763, 2.27, 0.328, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2595, 4y7xT, 0.8763, 2.30, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2596, 4y7xF, 0.8763, 2.30, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2597, 4y6vT, 0.8763, 2.28, 0.349, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2598, 4r00T, 0.8763, 2.25, 0.349, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2599, 4qzwT, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2600, 4qzwF, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2601, 4qz3T, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2602, 4qz3F, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2603, 4qwrT, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2604, 4qwrF, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2605, 4qwkT, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2606, 4qwkF, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2607, 4qw0T, 0.8763, 2.32, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2608, 4qw0F, 0.8763, 2.33, 0.332, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2609, 4nnwT, 0.8763, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2610, 4nnwF, 0.8763, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2611, 4hrcF, 0.8763, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2612, 6gopT, 0.8762, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2613, 6gopF, 0.8762, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2614, 5mpaD, 0.8762, 2.32, 0.332, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2615, 5le5T, 0.8762, 2.32, 0.332, 243, 232, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2616, 5fhsT, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2617, 5fhsF, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2618, 5dkjT, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2619, 5d0tT, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2620, 5d0tF, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2621, 5cgiT, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2622, 5cgiF, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2623, 4ya5T, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2624, 4ya5F, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2625, 4ya2F, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2626, 4y8rT, 0.8762, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2627, 4y8rF, 0.8762, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2628, 4y82F, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2629, 4y6zT, 0.8762, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2630, 4y6zF, 0.8762, 2.24, 0.328, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2631, 4r17T, 0.8762, 2.28, 0.328, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2632, 4r17F, 0.8762, 2.28, 0.328, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2633, 4r00F, 0.8762, 2.08, 0.336, 240, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2634, 4qz1T, 0.8762, 2.50, 0.342, 240, 234, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2635, 4qz1F, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2636, 4qwiT, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2637, 4qwiF, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2638, 4qv9F, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT
2639, 4qv3T, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT
2640, 4qv3F, 0.8762, 2.32, 0.332, 243, 232, YCP BETA5-M45V MUTANT
2641, 4no9T, 0.8762, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2642, 4no9F, 0.8762, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2643, 4hrdF, 0.8762, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2644, 5fghT, 0.8761, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2645, 5fghF, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2646, 5dkjF, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2647, 5d0xT, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2648, 5cz5T, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2649, 5cz5F, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2650, 5cgfT, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2651, 5cgfF, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2652, 4y8qT, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2653, 4y8qF, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2654, 4y8oT, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2655, 4y74T, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2656, 4y74F, 0.8761, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2657, 4qwsT, 0.8761, 2.33, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2658, 4qwsF, 0.8761, 2.33, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2659, 4qv9T, 0.8761, 2.33, 0.332, 243, 232, YCP BETA5-C63F MUTANT
2660, 4q1sF, 0.8761, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2661, 3unhF, 0.8761, 2.33, 0.332, 243, 232, MOUSE 20S IMMUNOPROTEASOME
2662, 5mp9G, 0.8760, 2.29, 0.332, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2663, 5d0xF, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2664, 4y9zT, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2665, 4y9zF, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2666, 4y8oF, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2667, 4y8lT, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2668, 4y8lF, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2669, 4x6zU, 0.8760, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2670, 4qz5T, 0.8760, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2671, 4qz5F, 0.8760, 2.32, 0.332, 243, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2672, 4qltT, 0.8760, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2673, 4no1T, 0.8760, 2.31, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2674, 4no1F, 0.8760, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2675, 4nnnT, 0.8760, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH MG132
2676, 3unhT, 0.8760, 2.32, 0.332, 243, 232, MOUSE 20S IMMUNOPROTEASOME
2677, 5vfsD, 0.8759, 2.32, 0.332, 243, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2678, 5laiT, 0.8759, 2.33, 0.332, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2679, 5laiF, 0.8759, 2.31, 0.332, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2680, 5cz8T, 0.8759, 2.29, 0.349, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2681, 5cz8F, 0.8759, 2.26, 0.332, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2682, 4z1lT, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2683, 4z1lF, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2684, 4y8iT, 0.8759, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2685, 4y8iF, 0.8759, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2686, 4qwgT, 0.8759, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2687, 4qwgF, 0.8759, 2.32, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2688, 4qw3T, 0.8759, 2.26, 0.328, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2689, 4qw3F, 0.8759, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2690, 4qluT, 0.8759, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2691, 4qluF, 0.8759, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2692, 4qltF, 0.8759, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2693, 4nnnF, 0.8759, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH MG132
2694, 5lf0F, 0.8758, 2.32, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2695, 5l54T, 0.8758, 2.29, 0.349, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2696, 5l54F, 0.8758, 1.15, 0.612, 228, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2697, 4y80T, 0.8758, 2.15, 0.339, 239, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2698, 4y80F, 0.8758, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2699, 4x6zG, 0.8758, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2700, 4qzxT, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2701, 4qzxF, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2702, 4qxjT, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2703, 4qxjF, 0.8758, 2.32, 0.332, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2704, 4qlqT, 0.8758, 2.31, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2705, 4qlqF, 0.8758, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2706, 4hnpT, 0.8758, 2.31, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2707, 3un8F, 0.8758, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2708, 5lexF, 0.8757, 2.31, 0.332, 243, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2709, 4y8jT, 0.8757, 2.31, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2710, 4y8jF, 0.8757, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2711, 4qvvT, 0.8757, 2.33, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2712, 4qvvF, 0.8757, 2.33, 0.332, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2713, 4no8T, 0.8757, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2714, 4no8F, 0.8757, 2.51, 0.342, 239, 234, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2715, 4no6T, 0.8757, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2716, 4no6F, 0.8757, 2.33, 0.332, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2717, 3un8T, 0.8757, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2718, 5cz4T, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2719, 5cz4F, 0.8756, 2.30, 0.328, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2720, 4ya3T, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2721, 4ya3F, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2722, 4y7wT, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2723, 4y7wF, 0.8756, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2724, 4y70T, 0.8756, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2725, 4y70F, 0.8756, 2.33, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2726, 4qwjT, 0.8756, 2.32, 0.332, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2727, 4qwjF, 0.8756, 2.32, 0.332, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2728, 4ltcT, 0.8756, 2.28, 0.341, 239, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2729, 4hrcT, 0.8756, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2730, 5lf3F, 0.8755, 2.32, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2731, 5lf1T, 0.8755, 2.32, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2732, 4y78T, 0.8755, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2733, 4ltcF, 0.8755, 2.33, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2734, 3uneh, 0.8755, 2.33, 0.332, 243, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2735, 3nzjT, 0.8755, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2736, 5lezF, 0.8754, 2.32, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2737, 4ya0T, 0.8754, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2738, 4ya0F, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2739, 4y7yT, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2740, 4y7yF, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2741, 4y78F, 0.8754, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2742, 4qbyT, 0.8754, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2743, 4qbyF, 0.8754, 2.32, 0.332, 243, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2744, 3nzjF, 0.8754, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2745, 3mg4F, 0.8754, 2.32, 0.332, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2746, 5dkiT, 0.8753, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2747, 4j70F, 0.8753, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2748, 5lf7T, 0.8752, 2.32, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2749, 5dkiF, 0.8752, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2750, 4q1sT, 0.8752, 2.46, 0.342, 239, 234, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2751, 4intT, 0.8752, 2.47, 0.346, 240, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2752, 4inrT, 0.8752, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2753, 4inrF, 0.8752, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2754, 4hrdT, 0.8752, 2.30, 0.349, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2755, 3mg4T, 0.8752, 2.32, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2756, 3mg0T, 0.8752, 2.29, 0.341, 239, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2757, 5lf4T, 0.8751, 2.32, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2758, 4j70T, 0.8751, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2759, 4intF, 0.8751, 2.32, 0.332, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2760, 3gptT, 0.8751, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2761, 3gptF, 0.8751, 2.32, 0.332, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2762, 1jd21, 0.8751, 2.33, 0.332, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2763, 5lf7F, 0.8750, 2.33, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2764, 4v7oQ, 0.8750, 2.32, 0.332, 244, 232, 
2765, 3unfT, 0.8750, 2.32, 0.332, 244, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2766, 3unfF, 0.8750, 2.27, 0.328, 243, 232, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2767, 3uneT, 0.8750, 2.32, 0.332, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
2768, 3nzwT, 0.8750, 2.48, 0.346, 240, 234, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2769, 3nzwF, 0.8750, 2.27, 0.328, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2770, 1jd2F, 0.8750, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2771, 4v7oYA, 0.8749, 2.32, 0.332, 244, 232, 
2772, 4v7oKA, 0.8749, 2.33, 0.332, 244, 232, 
2773, 4v7oC, 0.8749, 2.33, 0.332, 244, 232, 
2774, 4lqiF, 0.8749, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2775, 4inuT, 0.8749, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2776, 4inuF, 0.8749, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2777, 3hyeT, 0.8749, 2.52, 0.342, 240, 234, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2778, 3hyeF, 0.8749, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2779, 5lf6T, 0.8748, 2.32, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2780, 5lf0T, 0.8748, 2.33, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2781, 5leyT, 0.8748, 2.32, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2782, 4lqiT, 0.8748, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2783, 4jsqT, 0.8748, 2.40, 0.343, 239, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2784, 4jsqF, 0.8748, 1.83, 0.342, 232, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2785, 4fzgT, 0.8748, 2.16, 0.351, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2786, 4fzgF, 0.8748, 2.16, 0.351, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2787, 4cr2B, 0.8748, 2.32, 0.349, 244, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2788, 5lf1F, 0.8747, 2.33, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2789, 5leyF, 0.8747, 2.33, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2790, 5le5F, 0.8747, 2.33, 0.332, 244, 232, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2791, 3tddT, 0.8747, 1.84, 0.342, 232, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2792, 3tddF, 0.8747, 1.84, 0.342, 232, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2793, 5lf3T, 0.8746, 1.84, 0.342, 232, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2794, 3e47T, 0.8746, 2.37, 0.328, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2795, 3e47F, 0.8746, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2796, 3d29T, 0.8746, 2.33, 0.332, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2797, 3d29F, 0.8746, 2.33, 0.332, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2798, 2fakT, 0.8746, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2799, 6epcC, 0.8745, 2.33, 0.332, 244, 232, GROUND STATE 26S PROTEASOME (GS2)
2800, 5wvkR, 0.8745, 2.48, 0.346, 240, 234, 
2801, 3gpwT, 0.8745, 2.49, 0.346, 240, 234, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2802, 3gpwF, 0.8745, 2.48, 0.346, 240, 234, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2803, 2fakF, 0.8745, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2804, 1rypG, 0.8745, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2805, 4jt0T, 0.8744, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2806, 4jt0F, 0.8744, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2807, 4jsuT, 0.8744, 2.32, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2808, 4jsuF, 0.8744, 1.88, 0.329, 250, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2809, 3nzxT, 0.8744, 2.41, 0.343, 239, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2810, 3nzxF, 0.8744, 2.41, 0.343, 239, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2811, 3dy3T, 0.8744, 2.40, 0.343, 239, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2812, 3dy3F, 0.8744, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2813, 5lf6F, 0.8743, 2.33, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2814, 5lf4F, 0.8743, 2.48, 0.346, 240, 234, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2815, 4eu2U, 0.8743, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2816, 3mg0F, 0.8743, 2.33, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2817, 2gplT, 0.8743, 2.33, 0.332, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2818, 2gplF, 0.8743, 2.33, 0.332, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2819, 1z7qG, 0.8743, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2820, 1rypU, 0.8743, 2.31, 0.339, 249, 236, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2821, 1g0uF, 0.8743, 2.21, 0.339, 241, 233, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2822, 5lf1Q, 0.8742, 2.33, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2823, 4gk7T, 0.8742, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2824, 4gk7F, 0.8742, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2825, 3okjT, 0.8742, 2.32, 0.332, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2826, 3okjF, 0.8742, 2.33, 0.332, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2827, 3mg4U, 0.8742, 2.33, 0.332, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2828, 1z7qU, 0.8742, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2829, 5mpcB, 0.8741, 2.34, 0.332, 244, 232, 
2830, 5m32S, 0.8740, 2.33, 0.332, 244, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2831, 5lf6Q, 0.8740, 2.33, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2832, 3un4T, 0.8740, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2833, 3un4F, 0.8740, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2834, 1g0uT, 0.8740, 2.41, 0.343, 239, 233, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2835, 6avoR, 0.8739, 2.41, 0.343, 239, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2836, 4v7oG, 0.8739, 2.35, 0.332, 244, 232, 
2837, 3shjT, 0.8739, 2.34, 0.332, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2838, 3shjF, 0.8739, 2.33, 0.332, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2839, 3mg7U, 0.8739, 2.33, 0.332, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2840, 3gpjT, 0.8739, 2.29, 0.332, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2841, 2f16T, 0.8739, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2842, 2f16F, 0.8739, 2.32, 0.332, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2843, 5wviDA, 0.8738, 2.15, 0.345, 238, 232, 
2844, 4v7oU, 0.8738, 2.33, 0.332, 244, 232, 
2845, 3gpjF, 0.8738, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2846, 3dy4T, 0.8738, 2.33, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2847, 3bdmT, 0.8738, 2.33, 0.332, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2848, 3bdmF, 0.8738, 2.09, 0.241, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2849, 5lf4Q, 0.8737, 2.29, 0.332, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2850, 4v7oOA, 0.8737, 1.85, 0.332, 250, 229, 
2851, 4v7oCB, 0.8737, 1.92, 0.316, 238, 228, 
2852, 4fzcF, 0.8737, 2.15, 0.345, 238, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2853, 3sdkU, 0.8737, 2.34, 0.332, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2854, 3dy4F, 0.8737, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2855, 2zcyT, 0.8737, 2.32, 0.332, 242, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2856, 5vfuU, 0.8736, 2.09, 0.261, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2857, 5vftJ, 0.8736, 2.37, 0.328, 244, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2858, 4fzcT, 0.8736, 2.34, 0.332, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2859, 2zcyF, 0.8736, 2.34, 0.332, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2860, 3un8U, 0.8735, 2.10, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2861, 1iruU, 0.8735, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2862, 1iruG, 0.8735, 2.34, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2863, 5wviOA, 0.8734, 2.34, 0.332, 244, 232, 
2864, 1g65T, 0.8734, 1.93, 0.325, 250, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2865, 5wvkBA, 0.8732, 2.37, 0.328, 244, 232, 
2866, 5lf7Q, 0.8732, 2.35, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2867, 5leyQ, 0.8732, 2.35, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2868, 3mg6U, 0.8732, 2.35, 0.332, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2869, 1g65F, 0.8732, 2.35, 0.332, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2870, 5lf3Q, 0.8731, 2.16, 0.345, 238, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2871, 3mg8U, 0.8731, 2.37, 0.328, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2872, 3mg7G, 0.8731, 2.37, 0.328, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2873, 6avoK, 0.8730, 2.34, 0.332, 244, 232, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2874, 5mpbB, 0.8730, 2.10, 0.241, 243, 232, 
2875, 5lf0Q, 0.8730, 2.35, 0.332, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2876, 5mpag, 0.8729, 2.35, 0.332, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2877, 3wxrO, 0.8729, 2.16, 0.343, 239, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2878, 3oeuU, 0.8729, 2.16, 0.343, 239, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2879, 6epcE, 0.8728, 2.34, 0.332, 244, 232, GROUND STATE 26S PROTEASOME (GS2)
2880, 5vfsCA, 0.8725, 2.35, 0.332, 244, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2881, 4q1sU, 0.8725, 2.11, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2882, 4hnpU, 0.8724, 2.45, 0.346, 245, 234, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2883, 4g4sG, 0.8724, 2.45, 0.346, 245, 234, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2884, 3oevU, 0.8724, 1.94, 0.329, 250, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2885, 1rypO, 0.8724, 2.32, 0.332, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2886, 4ltcU, 0.8723, 2.24, 0.328, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2887, 4j70U, 0.8721, 2.16, 0.345, 238, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2888, 3un8G, 0.8721, 2.17, 0.345, 239, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2889, 3sdkG, 0.8721, 2.10, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2890, 5m32E, 0.8720, 2.32, 0.332, 244, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2891, 3mg6G, 0.8720, 2.16, 0.345, 238, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2892, 5dsvF, 0.8719, 2.10, 0.237, 243, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2893, 3oeuG, 0.8719, 2.12, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2894, 5dsvN, 0.8718, 2.10, 0.261, 240, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2895, 5dsvL, 0.8718, 1.99, 0.329, 250, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2896, 4jsqU, 0.8718, 2.17, 0.345, 238, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2897, 4hrcU, 0.8718, 2.36, 0.336, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2898, 3h4pD, 0.8718, 2.10, 0.241, 243, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2899, 4jsqG, 0.8717, 2.11, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2900, 4inrU, 0.8717, 2.18, 0.592, 233, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2901, 3oevG, 0.8717, 2.18, 0.343, 239, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2902, 1rypA, 0.8717, 2.12, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2903, 5dsvB, 0.8716, 2.11, 0.237, 243, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2904, 4j70G, 0.8716, 2.18, 0.335, 246, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2905, 4intU, 0.8716, 2.12, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2906, 3tddU, 0.8716, 2.13, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2907, 3tddG, 0.8715, 2.12, 0.237, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2908, 3mg8G, 0.8715, 2.13, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2909, 3mg0U, 0.8715, 2.13, 0.237, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2910, 5mpbP, 0.8714, 2.13, 0.241, 243, 232, 
2911, 5dsvA, 0.8714, 1.84, 0.322, 234, 227, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2912, 4jsuU, 0.8714, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2913, 4jsuG, 0.8714, 2.55, 0.346, 244, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2914, 5dsvD, 0.8713, 2.13, 0.241, 243, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2915, 3un4U, 0.8713, 2.56, 0.346, 244, 234, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2916, 3shjU, 0.8713, 2.56, 0.346, 245, 234, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2917, 1jd22, 0.8713, 2.13, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2918, 4v7oO, 0.8712, 2.11, 0.237, 243, 232, 
2919, 4v7oIA, 0.8712, 2.29, 0.430, 232, 230, 
2920, 4v7oA, 0.8712, 2.13, 0.237, 243, 232, 
2921, 4jt0U, 0.8712, 2.13, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2922, 4jt0G, 0.8712, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2923, 4hrdU, 0.8712, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2924, 3un4G, 0.8712, 2.56, 0.346, 245, 234, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2925, 3shjG, 0.8712, 2.14, 0.237, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2926, 3nzxU, 0.8712, 2.13, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2927, 3nzjU, 0.8712, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2928, 3mg4G, 0.8712, 2.14, 0.241, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2929, 1fntU, 0.8712, 2.13, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2930, 1fntG, 0.8712, 2.13, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2931, 5dsvE, 0.8711, 1.79, 0.330, 250, 227, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2932, 4v7oWA, 0.8711, 2.56, 0.346, 244, 234, 
2933, 4lqiU, 0.8711, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2934, 4inrG, 0.8711, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2935, 3h4pL, 0.8711, 2.57, 0.346, 244, 234, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2936, 1g65U, 0.8711, 2.13, 0.241, 243, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2937, 5a5bD, 0.8710, 2.14, 0.241, 243, 232, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2938, 4cr3D, 0.8710, 2.14, 0.237, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2939, 3wxrA, 0.8710, 2.37, 0.328, 244, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2940, 3sdiU, 0.8710, 2.14, 0.241, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2941, 3nzxG, 0.8710, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2942, 3nzjG, 0.8710, 1.36, 1.000, 250, 242, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2943, 3gpwU, 0.8710, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2944, 5vfoG, 0.8709, 2.14, 0.241, 243, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2945, 4lqiG, 0.8709, 2.14, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2946, 3gpwG, 0.8709, 2.13, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2947, 4inuU, 0.8708, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2948, 3jcpPA, 0.8708, 2.14, 0.241, 243, 232, 
2949, 3jcpP, 0.8708, 2.14, 0.237, 243, 232, 
2950, 3hyeU, 0.8708, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2951, 3e47U, 0.8708, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2952, 2fakU, 0.8708, 2.34, 0.332, 240, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2953, 2fakG, 0.8708, 2.34, 0.332, 240, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2954, 5m32Q, 0.8707, 2.57, 0.346, 245, 234, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2955, 4ltcG, 0.8707, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2956, 4fzcU, 0.8707, 2.14, 0.237, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2957, 3okjU, 0.8707, 2.14, 0.237, 243, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2958, 3hyeG, 0.8707, 2.29, 0.430, 232, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2959, 3gptU, 0.8707, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2960, 3gpjU, 0.8707, 2.12, 0.332, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2961, 5wviNA, 0.8706, 2.12, 0.332, 242, 232, 
2962, 5t0iL, 0.8706, 2.14, 0.241, 243, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2963, 4fzcG, 0.8706, 2.14, 0.250, 240, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2964, 3nzwU, 0.8706, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2965, 3gptG, 0.8706, 2.14, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2966, 3gpjG, 0.8706, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2967, 3e47G, 0.8706, 2.05, 0.273, 239, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2968, 3bdmU, 0.8706, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2969, 3bdmG, 0.8706, 2.15, 0.241, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2970, 5t0iH, 0.8705, 2.14, 0.237, 243, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2971, 4fzgU, 0.8705, 2.31, 0.323, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2972, 3okjG, 0.8705, 2.31, 0.323, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2973, 3nzwG, 0.8705, 2.30, 0.323, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2974, 5dsvG, 0.8704, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2975, 4inuG, 0.8704, 2.13, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2976, 4intG, 0.8704, 2.15, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2977, 4fzgG, 0.8704, 2.15, 0.237, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2978, 3h4pH, 0.8704, 2.10, 0.343, 235, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2979, 2gplU, 0.8704, 2.14, 0.237, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2980, 2f16U, 0.8704, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2981, 5t0jK, 0.8703, 2.14, 0.237, 243, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2982, 5dsvK, 0.8703, 2.15, 0.241, 243, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2983, 3h4pA, 0.8703, 2.15, 0.241, 243, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2984, 2gplG, 0.8703, 2.16, 0.241, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2985, 2f16G, 0.8703, 2.22, 0.356, 245, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2986, 5t0hL, 0.8702, 2.04, 0.317, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2987, 5m32C, 0.8702, 2.14, 0.237, 243, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2988, 3jcpJA, 0.8702, 2.15, 0.241, 243, 232, 
2989, 3jcpJ, 0.8702, 2.15, 0.241, 243, 232, 
2990, 1g0uU, 0.8702, 2.16, 0.241, 243, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2991, 5vfrG, 0.8701, 2.14, 0.241, 243, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2992, 5t0jL, 0.8701, 2.16, 0.241, 243, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2993, 5dsvI, 0.8701, 2.16, 0.241, 243, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2994, 4q1sG, 0.8700, 1.83, 0.310, 233, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2995, 4gk7U, 0.8699, 2.14, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2996, 3d29U, 0.8699, 2.15, 0.237, 243, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2997, 3d29G, 0.8699, 2.15, 0.241, 243, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2998, 4gk7G, 0.8697, 2.58, 0.346, 242, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2999, 3h4pE, 0.8697, 2.15, 0.237, 243, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3000, 1g65G, 0.8697, 2.14, 0.237, 243, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3001, 5ln3C, 0.8696, 2.14, 0.237, 243, 232, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3002, 4x6zA, 0.8696, 2.18, 0.432, 232, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3003, 3h4pN, 0.8695, 2.15, 0.241, 243, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3004, 3h4pJ, 0.8695, 2.15, 0.241, 243, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3005, 3h4pC, 0.8695, 1.73, 0.604, 228, 227, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3006, 3dy3U, 0.8695, 2.50, 0.343, 244, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3007, 3dy3G, 0.8695, 2.04, 0.430, 232, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3008, 1g0uG, 0.8695, 2.15, 0.241, 243, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3009, 3h4pF, 0.8694, 2.15, 0.241, 243, 232, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3010, 3dy4U, 0.8694, 2.03, 0.317, 238, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3011, 3dy4G, 0.8694, 2.08, 0.349, 234, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3012, 2zcyU, 0.8694, 2.16, 0.237, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3013, 2zcyG, 0.8694, 2.16, 0.237, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3014, 5fggU, 0.8692, 2.16, 0.237, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3015, 4qv9U, 0.8692, 2.16, 0.250, 240, 232, YCP BETA5-C63F MUTANT
3016, 4qv9G, 0.8692, 2.05, 0.273, 239, 231, YCP BETA5-C63F MUTANT
3017, 3h4pI, 0.8692, 2.04, 0.313, 238, 230, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3018, 5wviCA, 0.8691, 2.50, 0.343, 244, 233, 
3019, 5t0cV, 0.8691, 2.16, 0.241, 243, 232, 
3020, 5t0cBB, 0.8691, 2.15, 0.237, 243, 232, 
3021, 5fggG, 0.8691, 2.17, 0.237, 243, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3022, 5vfsA, 0.8690, 2.17, 0.237, 243, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3023, 5l5bU, 0.8690, 2.15, 0.237, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3024, 5l5bG, 0.8690, 2.06, 0.430, 232, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3025, 5ahjU, 0.8690, 2.17, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3026, 4hrdG, 0.8690, 2.20, 0.328, 261, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3027, 4hnpG, 0.8690, 2.16, 0.237, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3028, 5vfqA, 0.8689, 2.06, 0.430, 232, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3029, 5ahjG, 0.8689, 2.19, 0.432, 232, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3030, 4qv3U, 0.8689, 2.06, 0.430, 232, 228, YCP BETA5-M45V MUTANT
3031, 4qv3G, 0.8689, 2.17, 0.241, 243, 232, YCP BETA5-M45V MUTANT
3032, 4no8U, 0.8689, 2.18, 0.241, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3033, 4no8G, 0.8689, 2.17, 0.250, 240, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3034, 3sdiG, 0.8689, 2.19, 0.432, 232, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3035, 5vfog, 0.8688, 2.17, 0.241, 243, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3036, 5l55U, 0.8688, 2.17, 0.241, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3037, 5d0wU, 0.8688, 2.17, 0.241, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3038, 5d0wG, 0.8688, 2.17, 0.241, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3039, 4y8hU, 0.8688, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3040, 4y8hG, 0.8688, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3041, 4no1U, 0.8688, 2.11, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3042, 5nifA, 0.8687, 2.08, 0.430, 232, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3043, 5l55G, 0.8687, 2.21, 0.352, 245, 233, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3044, 5czaU, 0.8687, 2.18, 0.343, 239, 233, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3045, 5czaG, 0.8687, 2.18, 0.343, 239, 233, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3046, 5cggU, 0.8687, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3047, 5cggG, 0.8687, 1.64, 0.310, 232, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3048, 4ya4U, 0.8687, 2.15, 0.264, 240, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3049, 4ya4G, 0.8687, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3050, 4no9U, 0.8687, 2.12, 0.242, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3051, 4no9G, 0.8687, 2.11, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3052, 4no1G, 0.8687, 2.16, 0.237, 243, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3053, 1jd2G, 0.8687, 2.16, 0.237, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3054, 5vfpA, 0.8686, 1.63, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3055, 4nnnU, 0.8686, 2.06, 0.268, 239, 231, YCP IN COMPLEX WITH MG132
3056, 3h4pK, 0.8686, 2.11, 0.238, 241, 231, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3057, 5vfsZ, 0.8685, 2.12, 0.242, 241, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3058, 5mpaG, 0.8685, 2.12, 0.242, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3059, 5jhrU, 0.8685, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3060, 5d0sU, 0.8685, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3061, 4zzgA, 0.8685, 2.18, 0.250, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3062, 4qwlU, 0.8685, 2.10, 0.268, 240, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3063, 4nnnG, 0.8685, 2.11, 0.238, 241, 231, YCP IN COMPLEX WITH MG132
3064, 4hrcG, 0.8685, 2.12, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3065, 5l5rU, 0.8684, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3066, 5jhrG, 0.8684, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3067, 5fg7U, 0.8684, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3068, 5fg7G, 0.8684, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3069, 5d0sG, 0.8684, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3070, 4ya1U, 0.8684, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3071, 4ya1G, 0.8684, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3072, 4y8rU, 0.8684, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3073, 4y8rG, 0.8684, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3074, 4qwlG, 0.8684, 2.11, 0.238, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3075, 5vfom, 0.8683, 2.13, 0.242, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3076, 5l5rG, 0.8683, 2.12, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3077, 5cgfU, 0.8683, 2.11, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3078, 4qv7U, 0.8683, 2.11, 0.238, 241, 231, YCP BETA5-A50V MUTANT
3079, 4qv7G, 0.8683, 2.12, 0.238, 241, 231, YCP BETA5-A50V MUTANT
3080, 4quyU, 0.8683, 2.18, 0.241, 243, 232, YCP BETA5-A49S-MUTANT
3081, 4quyG, 0.8683, 2.03, 0.339, 250, 236, YCP BETA5-A49S-MUTANT
3082, 3mg0G, 0.8683, 2.08, 0.268, 239, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3083, 5l52U, 0.8682, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3084, 5l52G, 0.8682, 2.20, 0.432, 232, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3085, 5cgfG, 0.8682, 2.15, 0.264, 240, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3086, 4qv5U, 0.8682, 2.30, 0.333, 243, 231, YCP BETA5-M45I MUTANT
3087, 4qv5G, 0.8682, 2.12, 0.238, 241, 231, YCP BETA5-M45I MUTANT
3088, 3h4pM, 0.8682, 2.11, 0.238, 241, 231, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3089, 3h4pB, 0.8682, 2.13, 0.242, 241, 231, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3090, 5wvkV, 0.8681, 2.12, 0.238, 241, 231, 
3091, 5fgfU, 0.8681, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3092, 5fgaU, 0.8681, 2.17, 0.237, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3093, 5bxlG, 0.8681, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3094, 4ya2U, 0.8681, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3095, 4ya2G, 0.8681, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3096, 4y8tU, 0.8681, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3097, 4y8tG, 0.8681, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3098, 5l5uU, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3099, 5l5uG, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3100, 5fgfG, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3101, 5fgaG, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3102, 5bxlU, 0.8680, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3103, 4ya7U, 0.8680, 2.47, 0.330, 240, 233, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3104, 4ya7G, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3105, 4y8sU, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3106, 4y8gU, 0.8680, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3107, 4qz6U, 0.8680, 2.13, 0.242, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3108, 4qwuU, 0.8680, 2.13, 0.242, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3109, 4qwuG, 0.8680, 2.13, 0.242, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3110, 4qv1U, 0.8680, 2.18, 0.241, 243, 232, YCP BETA5-M45A MUTANT
3111, 4qv1G, 0.8680, 2.12, 0.238, 241, 231, YCP BETA5-M45A MUTANT
3112, 3h4pG, 0.8680, 2.12, 0.238, 241, 231, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3113, 5l6aU, 0.8679, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3114, 5l6aG, 0.8679, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3115, 5bxnU, 0.8679, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3116, 4y8sG, 0.8679, 2.09, 0.430, 232, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3117, 4y8pU, 0.8679, 2.09, 0.430, 232, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3118, 4y8pG, 0.8679, 2.15, 0.237, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3119, 4y8gG, 0.8679, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3120, 4qz6G, 0.8679, 2.13, 0.242, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3121, 4qv4U, 0.8679, 2.14, 0.242, 241, 231, YCP BETA5-M45T MUTANT
3122, 4qv4G, 0.8679, 2.13, 0.238, 241, 231, YCP BETA5-M45T MUTANT
3123, 4qluU, 0.8679, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3124, 5vfuX, 0.8678, 2.14, 0.238, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3125, 5vftM, 0.8678, 2.14, 0.238, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3126, 5d0zU, 0.8678, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3127, 5d0zG, 0.8678, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3128, 5cz9U, 0.8678, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3129, 5bxnG, 0.8678, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3130, 4y8kU, 0.8678, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3131, 4y8kG, 0.8678, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3132, 4qz0U, 0.8678, 2.13, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3133, 4qz0G, 0.8678, 2.13, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3134, 4qv8U, 0.8678, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT
3135, 4qv0U, 0.8678, 2.12, 0.238, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3136, 4qluG, 0.8678, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3137, 6gopU, 0.8677, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3138, 5vfoM, 0.8677, 2.13, 0.242, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3139, 5cz9G, 0.8677, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3140, 4r00U, 0.8677, 2.08, 0.430, 232, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3141, 4qzzU, 0.8677, 2.13, 0.242, 241, 231, YCP IN COMPLEX WITH OMURALIDE
3142, 4qzzG, 0.8677, 2.13, 0.242, 241, 231, YCP IN COMPLEX WITH OMURALIDE
3143, 4qvnU, 0.8677, 2.13, 0.242, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3144, 4qvnG, 0.8677, 2.13, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3145, 4qv8G, 0.8677, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT
3146, 4qv0G, 0.8677, 2.13, 0.238, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3147, 5vfrg, 0.8676, 2.13, 0.238, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3148, 5nifO, 0.8676, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3149, 5fhsU, 0.8676, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3150, 5fhsG, 0.8676, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3151, 4z1lU, 0.8676, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3152, 4z1lG, 0.8676, 2.43, 0.343, 240, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3153, 4y8mU, 0.8676, 2.43, 0.343, 240, 233, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3154, 4y8mG, 0.8676, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3155, 4r17U, 0.8676, 2.12, 0.238, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3156, 4r17G, 0.8676, 2.12, 0.238, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3157, 4r00G, 0.8676, 2.13, 0.242, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3158, 4no6U, 0.8676, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3159, 4no6G, 0.8676, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3160, 6gopG, 0.8675, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3161, 4y9zU, 0.8675, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3162, 4y9zG, 0.8675, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3163, 4y9yU, 0.8675, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3164, 4y9yG, 0.8675, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3165, 4qltU, 0.8675, 2.13, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3166, 4qlsU, 0.8675, 2.38, 0.332, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3167, 4qlsG, 0.8675, 2.12, 0.238, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3168, 4g4sF, 0.8675, 2.13, 0.238, 241, 231, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3169, 5vfuR, 0.8674, 2.13, 0.238, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3170, 5vftG, 0.8674, 2.13, 0.238, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3171, 5vfqG, 0.8674, 2.13, 0.242, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3172, 5t0cYA, 0.8674, 2.13, 0.242, 241, 231, 
3173, 5t0cS, 0.8674, 2.13, 0.242, 241, 231, 
3174, 5lttU, 0.8674, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3175, 5fg9U, 0.8674, 2.10, 0.268, 240, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3176, 5fg9G, 0.8674, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3177, 5d0vU, 0.8674, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3178, 4zzgO, 0.8674, 2.12, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3179, 4y75U, 0.8674, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3180, 4r02U, 0.8674, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3181, 4qz3U, 0.8674, 2.14, 0.242, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3182, 4qz3G, 0.8674, 2.14, 0.242, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3183, 4qltG, 0.8674, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3184, 4nnwU, 0.8674, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3185, 3jcoJA, 0.8674, 2.13, 0.238, 241, 231, 
3186, 5lttG, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3187, 5jhsU, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3188, 5jhsG, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3189, 5d0vG, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3190, 5cz8U, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3191, 5cz8G, 0.8673, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3192, 4ya9U, 0.8673, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3193, 4ya9G, 0.8673, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3194, 4y75G, 0.8673, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3195, 4qw7U, 0.8673, 2.14, 0.238, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3196, 4qw7G, 0.8673, 1.63, 0.341, 234, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3197, 4qw6U, 0.8673, 2.16, 0.264, 240, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3198, 4qw5U, 0.8673, 2.16, 0.264, 240, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3199, 4qw5G, 0.8673, 2.37, 0.336, 240, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3200, 4qv6U, 0.8673, 2.12, 0.268, 240, 231, YCP BETA5-A49V MUTANT
3201, 4qv6G, 0.8673, 2.12, 0.268, 240, 231, YCP BETA5-A49V MUTANT
3202, 4nnwG, 0.8673, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3203, 3jcoJ, 0.8673, 2.14, 0.242, 241, 231, 
3204, 5vfqZ, 0.8672, 2.14, 0.242, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3205, 5vfpG, 0.8672, 2.13, 0.238, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3206, 5l6bU, 0.8672, 2.14, 0.242, 242, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3207, 5l6bG, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3208, 5l5hU, 0.8672, 2.13, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3209, 5l5hG, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3210, 5l5aU, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3211, 5l5aG, 0.8672, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3212, 5fgeU, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3213, 5fgeG, 0.8672, 2.17, 0.237, 243, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3214, 5cghU, 0.8672, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3215, 5cghG, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3216, 4qz5U, 0.8672, 2.13, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3217, 4qz5G, 0.8672, 2.13, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3218, 4qw6G, 0.8672, 2.13, 0.238, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3219, 4intE, 0.8672, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3220, 5l67U, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3221, 5l5oU, 0.8671, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3222, 5l5oG, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3223, 5l54U, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3224, 5l54G, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3225, 5cz7U, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3226, 5cz7G, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3227, 4y8lU, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3228, 4y8lG, 0.8671, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3229, 4y77U, 0.8671, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3230, 4y77G, 0.8671, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3231, 4qz7U, 0.8671, 2.17, 0.237, 243, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3232, 4qvpU, 0.8671, 2.17, 0.237, 243, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3233, 5mpaf, 0.8670, 2.11, 0.264, 240, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3234, 5l67G, 0.8670, 2.37, 0.332, 240, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3235, 5l63U, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3236, 5l63G, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3237, 5l61U, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3238, 5l5dU, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3239, 5dsvH, 0.8670, 2.14, 0.242, 241, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3240, 4x6zO, 0.8670, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3241, 4qzwU, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3242, 4qzwG, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3243, 4qz7G, 0.8670, 2.13, 0.242, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3244, 4qz4U, 0.8670, 2.13, 0.242, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3245, 4qwrU, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3246, 4qwrG, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3247, 4qw1U, 0.8670, 2.13, 0.238, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3248, 4qw1G, 0.8670, 1.61, 0.341, 233, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3249, 4qvyU, 0.8670, 2.14, 0.242, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3250, 4qvpG, 0.8670, 2.14, 0.242, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3251, 4qvlU, 0.8670, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
3252, 4qvlG, 0.8670, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
3253, 4intS, 0.8670, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3254, 5vfpY, 0.8669, 2.14, 0.242, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3255, 5vfpEA, 0.8669, 2.14, 0.242, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3256, 5mp9F, 0.8669, 2.13, 0.238, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3257, 5l64U, 0.8669, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3258, 5l64G, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3259, 5l61G, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3260, 5l5pU, 0.8669, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3261, 5l5dG, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3262, 5cz6U, 0.8669, 1.60, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3263, 5cz6G, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3264, 5cgiU, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3265, 4y84U, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3266, 4y7wU, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3267, 4y70U, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3268, 4y70G, 0.8669, 2.26, 0.348, 239, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3269, 4r18U, 0.8669, 2.14, 0.238, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3270, 4r18G, 0.8669, 2.13, 0.238, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3271, 4qz4G, 0.8669, 2.13, 0.238, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3272, 4qvyG, 0.8669, 2.14, 0.238, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3273, 4quxU, 0.8669, 2.14, 0.238, 241, 231, YCP BETA5-A49T-MUTANT
3274, 4quxG, 0.8669, 2.14, 0.238, 241, 231, YCP BETA5-A49T-MUTANT
3275, 4qbyU, 0.8669, 2.14, 0.238, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3276, 4qbyG, 0.8669, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3277, 3un8S, 0.8669, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3278, 5lajU, 0.8668, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3279, 5l6cU, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3280, 5l6cG, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3281, 5l66U, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3282, 5l66G, 0.8668, 1.61, 0.341, 233, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3283, 5l65U, 0.8668, 2.13, 0.268, 240, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3284, 5l65G, 0.8668, 2.48, 0.330, 240, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3285, 5l62U, 0.8668, 1.60, 0.345, 233, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3286, 5l5wU, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3287, 5l5pG, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3288, 5l5fU, 0.8668, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3289, 5l5fG, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3290, 5cgiG, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3291, 4y8uU, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3292, 4y8qU, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3293, 4y8qG, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3294, 4y84G, 0.8668, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3295, 4y7yU, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3296, 4y7yG, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3297, 4y7wG, 0.8668, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3298, 4qzxU, 0.8668, 2.14, 0.242, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3299, 4qzxG, 0.8668, 2.15, 0.242, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3300, 4cr2D, 0.8668, 2.14, 0.238, 241, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3301, 3un8E, 0.8668, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3302, 5lajG, 0.8667, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3303, 5l62G, 0.8667, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3304, 5l5wG, 0.8667, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3305, 4y8uG, 0.8667, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3306, 4y82U, 0.8667, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3307, 4y82G, 0.8667, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3308, 4qlqU, 0.8667, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3309, 4qlqG, 0.8667, 2.14, 0.242, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3310, 5vfsG, 0.8666, 2.15, 0.242, 241, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3311, 5vfrM, 0.8666, 2.15, 0.242, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3312, 5l5qU, 0.8666, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3313, 5l5eU, 0.8666, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3314, 5fgiU, 0.8666, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3315, 5fgiG, 0.8666, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3316, 4y8jU, 0.8666, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3317, 4y8jG, 0.8666, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3318, 4y74U, 0.8666, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3319, 4y74G, 0.8666, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3320, 4qvwU, 0.8666, 2.15, 0.242, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3321, 4g4sA, 0.8666, 2.14, 0.238, 241, 231, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3322, 5m2bU, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3323, 5m2bG, 0.8665, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3324, 5l5xU, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3325, 5l5xG, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3326, 5l5tU, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3327, 5l5qG, 0.8665, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3328, 5l5eG, 0.8665, 2.13, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3329, 5cz5U, 0.8665, 2.31, 0.339, 242, 233, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3330, 5cz5G, 0.8665, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3331, 4y80U, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3332, 4y80G, 0.8665, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3333, 4y7xU, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3334, 4y7xG, 0.8665, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3335, 4y6aU, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3336, 4y6aG, 0.8665, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3337, 4qz2U, 0.8665, 2.15, 0.238, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3338, 4qz2G, 0.8665, 2.15, 0.238, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3339, 4qwxU, 0.8665, 2.59, 0.333, 240, 234, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3340, 4qwxG, 0.8665, 2.38, 0.336, 240, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3341, 4qwjU, 0.8665, 2.15, 0.242, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3342, 4qwjG, 0.8665, 2.15, 0.242, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3343, 4qvwG, 0.8665, 2.14, 0.238, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3344, 4eu2O, 0.8665, 2.14, 0.238, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3345, 3mg8T, 0.8665, 2.14, 0.238, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3346, 5vfqFA, 0.8664, 2.14, 0.238, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3347, 5l5vU, 0.8664, 2.14, 0.238, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3348, 5l5vG, 0.8664, 2.14, 0.238, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3349, 5l5tG, 0.8664, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3350, 5fgdU, 0.8664, 2.25, 0.250, 241, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3351, 5fgdG, 0.8664, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3352, 5d0tU, 0.8664, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3353, 4zzgT, 0.8664, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3354, 4qwiU, 0.8664, 2.15, 0.242, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3355, 4qlvU, 0.8664, 2.15, 0.242, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3356, 4qlvG, 0.8664, 2.15, 0.242, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3357, 5l5sU, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3358, 5l5sG, 0.8663, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3359, 5d0tG, 0.8663, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3360, 4y6vU, 0.8663, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3361, 4y6vG, 0.8663, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3362, 4qwiG, 0.8663, 2.14, 0.238, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3363, 4qwfU, 0.8663, 2.15, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3364, 4qwfG, 0.8663, 2.15, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3365, 4inrS, 0.8663, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3366, 4inrE, 0.8663, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3367, 4cr2G, 0.8663, 2.14, 0.238, 241, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3368, 1z7qO, 0.8663, 2.14, 0.238, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3369, 1z7qA, 0.8663, 2.14, 0.238, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3370, 5l5zU, 0.8662, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3371, 4y69U, 0.8662, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3372, 4y69G, 0.8662, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3373, 4qvqU, 0.8662, 2.08, 0.243, 241, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3374, 4qvqG, 0.8662, 2.33, 0.336, 237, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3375, 4jsqS, 0.8662, 2.39, 0.332, 240, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3376, 4jsqE, 0.8662, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3377, 4cr4D, 0.8662, 2.15, 0.242, 241, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3378, 5nifT, 0.8661, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3379, 5l5zG, 0.8661, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3380, 5l5jU, 0.8661, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3381, 4y6zU, 0.8661, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3382, 4hrdE, 0.8661, 1.62, 0.345, 232, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3383, 3oevT, 0.8661, 2.14, 0.238, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3384, 3oeuT, 0.8661, 2.15, 0.238, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3385, 3mg6T, 0.8661, 2.15, 0.238, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3386, 3dy3E, 0.8661, 2.15, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3387, 3bdmS, 0.8661, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3388, 3bdmE, 0.8661, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3389, 5l68U, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3390, 5l68G, 0.8660, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3391, 5l5jG, 0.8660, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3392, 5l5iU, 0.8660, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3393, 5l5iG, 0.8660, 2.14, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3394, 5bouU, 0.8660, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3395, 5bouG, 0.8660, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3396, 4y8nU, 0.8660, 2.31, 0.329, 245, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3397, 4y8nG, 0.8660, 2.10, 0.237, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3398, 4y6zG, 0.8660, 2.10, 0.237, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3399, 4qwkU, 0.8660, 2.15, 0.242, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3400, 4qwkG, 0.8660, 2.16, 0.242, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3401, 4hnpE, 0.8660, 2.16, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3402, 3mg7T, 0.8660, 2.15, 0.242, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3403, 3dy3S, 0.8660, 2.15, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3404, 5m32T, 0.8659, 1.63, 0.341, 233, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3405, 5dkjU, 0.8659, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3406, 5dkjG, 0.8659, 2.27, 0.335, 242, 233, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3407, 4rurU, 0.8659, 1.63, 0.345, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3408, 4qw0U, 0.8659, 2.15, 0.242, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3409, 1z7qT, 0.8659, 2.15, 0.242, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3410, 1z7qF, 0.8659, 2.15, 0.238, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3411, 5vfuIA, 0.8658, 1.64, 0.341, 233, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3412, 5vftj, 0.8658, 2.33, 0.336, 237, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3413, 4ya5U, 0.8658, 2.34, 0.336, 237, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3414, 4y78U, 0.8658, 2.34, 0.336, 237, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3415, 4y78G, 0.8658, 1.62, 0.345, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3416, 4rurG, 0.8658, 1.62, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3417, 4qw0G, 0.8658, 1.62, 0.341, 233, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3418, 4inuE, 0.8658, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3419, 4hrdS, 0.8658, 2.15, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3420, 4eu2F, 0.8658, 2.15, 0.242, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3421, 5t0iK, 0.8657, 2.15, 0.242, 241, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3422, 5l5yU, 0.8657, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3423, 4ya5G, 0.8657, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3424, 4y8iU, 0.8657, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3425, 4y8iG, 0.8657, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3426, 4qxjU, 0.8657, 2.16, 0.242, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3427, 4qxjG, 0.8657, 2.15, 0.238, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3428, 4ltcS, 0.8657, 2.14, 0.238, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3429, 4inuS, 0.8657, 2.14, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3430, 4hnpS, 0.8657, 1.63, 0.341, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3431, 3d29S, 0.8657, 2.33, 0.336, 237, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
3432, 3d29E, 0.8657, 1.62, 0.345, 233, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
3433, 1rypF, 0.8657, 2.47, 0.341, 240, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3434, 5lajS, 0.8656, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3435, 5lajE, 0.8656, 2.15, 0.242, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3436, 5l60U, 0.8656, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3437, 5l60G, 0.8656, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3438, 5l5yG, 0.8656, 1.64, 0.345, 234, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3439, 4qw4U, 0.8656, 1.64, 0.345, 234, 223, YCP IN COMPLEX WITH CARFILZOMIB
3440, 4qw4G, 0.8656, 2.24, 0.343, 239, 233, YCP IN COMPLEX WITH CARFILZOMIB
3441, 4qvvU, 0.8656, 2.24, 0.343, 239, 233, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3442, 4ltcE, 0.8656, 2.16, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3443, 3sdkS, 0.8656, 2.15, 0.238, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3444, 3nzjS, 0.8656, 2.15, 0.238, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3445, 3nzjE, 0.8656, 2.16, 0.242, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3446, 5t0cY, 0.8655, 2.16, 0.242, 241, 231, 
3447, 5t0cEB, 0.8655, 1.63, 0.341, 233, 223, 
3448, 5d0xU, 0.8655, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3449, 4qvvG, 0.8655, 1.63, 0.341, 232, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3450, 3mg7F, 0.8655, 1.76, 0.608, 228, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3451, 3gpjE, 0.8655, 2.16, 0.242, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3452, 6epfB, 0.8654, 2.16, 0.242, 241, 231, GROUND STATE 26S PROTEASOME (GS1)
3453, 5laiU, 0.8654, 2.15, 0.238, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3454, 5laiG, 0.8654, 2.15, 0.238, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3455, 5d0xG, 0.8654, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3456, 4r18S, 0.8654, 2.15, 0.238, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3457, 4r18E, 0.8654, 1.64, 0.341, 233, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3458, 3un4S, 0.8654, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3459, 3un4E, 0.8654, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3460, 3sdkE, 0.8654, 1.63, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3461, 3oevF, 0.8654, 1.63, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3462, 3mg4S, 0.8654, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3463, 3mg0S, 0.8654, 1.64, 0.341, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3464, 3gpjS, 0.8654, 1.64, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3465, 5mp9a, 0.8653, 2.16, 0.242, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3466, 5lttS, 0.8653, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3467, 5lttE, 0.8653, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3468, 5fg7S, 0.8653, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3469, 5dkjS, 0.8653, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3470, 5dkjE, 0.8653, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3471, 5cz7S, 0.8653, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3472, 5cz7E, 0.8653, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3473, 4zzgF, 0.8653, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3474, 4ya3U, 0.8653, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3475, 4ya3G, 0.8653, 2.12, 0.268, 240, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3476, 4y81U, 0.8653, 2.46, 0.339, 240, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3477, 4y81G, 0.8653, 2.46, 0.339, 240, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3478, 4r02G, 0.8653, 2.16, 0.242, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3479, 4r00S, 0.8653, 2.16, 0.238, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3480, 4r00E, 0.8653, 2.32, 0.336, 237, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3481, 4qzzS, 0.8653, 1.63, 0.341, 233, 223, YCP IN COMPLEX WITH OMURALIDE
3482, 4qzzE, 0.8653, 2.00, 0.308, 234, 227, YCP IN COMPLEX WITH OMURALIDE
3483, 4qv8S, 0.8653, 2.16, 0.242, 241, 231, YCP BETA5-C52F MUTANT
3484, 4qv8E, 0.8653, 2.17, 0.242, 241, 231, YCP BETA5-C52F MUTANT
3485, 4qv7S, 0.8653, 2.16, 0.242, 241, 231, YCP BETA5-A50V MUTANT
3486, 4qv7E, 0.8653, 1.64, 0.341, 231, 223, YCP BETA5-A50V MUTANT
3487, 4qv3E, 0.8653, 1.64, 0.341, 231, 223, YCP BETA5-M45V MUTANT
3488, 4fzgS, 0.8653, 1.64, 0.341, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3489, 4fzgE, 0.8653, 1.64, 0.341, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3490, 3mg6S, 0.8653, 1.64, 0.341, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3491, 1fntF, 0.8653, 2.30, 0.336, 237, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3492, 5l6cS, 0.8652, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3493, 5l6cE, 0.8652, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3494, 5l69U, 0.8652, 1.63, 0.341, 233, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3495, 5l69G, 0.8652, 2.15, 0.242, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3496, 5l67S, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3497, 5l67E, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3498, 5l62S, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3499, 5l62E, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3500, 5l61S, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3501, 5l61E, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3502, 5l5vS, 0.8652, 1.65, 0.341, 231, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3503, 5l5vE, 0.8652, 1.63, 0.345, 232, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3504, 5l5uS, 0.8652, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3505, 5l5uE, 0.8652, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3506, 5l5pS, 0.8652, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3507, 5l5pE, 0.8652, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3508, 5l5bS, 0.8652, 2.18, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3509, 5l5bE, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3510, 5fgfS, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3511, 5fgfE, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3512, 5fg7E, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3513, 5czaS, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3514, 5czaE, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3515, 5cggS, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3516, 5cggE, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3517, 4qz1U, 0.8652, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3518, 4qwsU, 0.8652, 1.64, 0.341, 233, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3519, 4qv3S, 0.8652, 1.64, 0.341, 233, 223, YCP BETA5-M45V MUTANT
3520, 4quyS, 0.8652, 1.64, 0.341, 233, 223, YCP BETA5-A49S-MUTANT
3521, 4quyE, 0.8652, 1.64, 0.345, 233, 223, YCP BETA5-A49S-MUTANT
3522, 4q1sE, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3523, 4jt0S, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3524, 4jt0E, 0.8652, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3525, 4fzcS, 0.8652, 2.16, 0.242, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3526, 4fzcE, 0.8652, 1.65, 0.341, 231, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3527, 3dy4S, 0.8652, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3528, 3dy4E, 0.8652, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3529, 2zcyS, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3530, 2zcyE, 0.8652, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3531, 2fakE, 0.8652, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3532, 1fntT, 0.8652, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3533, 5nifF, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3534, 5l6aS, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3535, 5l6aE, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3536, 5l64S, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3537, 5l64E, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3538, 5l5tS, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3539, 5l5tE, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3540, 5l5qS, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3541, 5l5qE, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3542, 5l5oS, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3543, 5l5oE, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3544, 5l5hS, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3545, 5l5hE, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3546, 5fgeS, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3547, 5fgeE, 0.8651, 2.16, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3548, 5fgaS, 0.8651, 2.15, 0.238, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3549, 5fgaE, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3550, 5fg9S, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3551, 5fg9E, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3552, 5cz9S, 0.8651, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3553, 5cz9E, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3554, 5cgfS, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3555, 5cgfE, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3556, 4z1lS, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3557, 4z1lE, 0.8651, 1.64, 0.345, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3558, 4ya1S, 0.8651, 1.64, 0.345, 233, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3559, 4ya1E, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3560, 4y8kE, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3561, 4y6aS, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3562, 4y6aE, 0.8651, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3563, 4x6zT, 0.8651, 1.64, 0.345, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3564, 4qz1G, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3565, 4qwsG, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3566, 4qvyS, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3567, 4qvyE, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3568, 4qvmU, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3569, 4qvmG, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3570, 4qv9S, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT
3571, 4qv9E, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT
3572, 4qv1S, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT
3573, 4qv0S, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3574, 4qv0E, 0.8651, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3575, 4j70S, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3576, 4j70E, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3577, 3wxrF, 0.8651, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3578, 3sdiE, 0.8651, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3579, 3oeuF, 0.8651, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3580, 3nzxS, 0.8651, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3581, 3nzxE, 0.8651, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3582, 2fakS, 0.8651, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3583, 1g65E, 0.8651, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3584, 5vfoj, 0.8650, 1.65, 0.341, 231, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3585, 5t0hH, 0.8650, 1.65, 0.341, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3586, 5mpbD, 0.8650, 1.65, 0.341, 231, 223, 
3587, 5l6bS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3588, 5l6bE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3589, 5l66S, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3590, 5l66E, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3591, 5l63S, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3592, 5l63E, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3593, 5l5zS, 0.8650, 1.63, 0.341, 232, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3594, 5l5zE, 0.8650, 2.16, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3595, 5l5xS, 0.8650, 2.16, 0.238, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3596, 5l5xE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3597, 5l5wS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3598, 5l5wE, 0.8650, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3599, 5l5sS, 0.8650, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3600, 5l5sE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3601, 5l5rS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3602, 5l5rE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3603, 5l5fS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3604, 5l5fE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3605, 5l5aS, 0.8650, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3606, 5l5aE, 0.8650, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3607, 5jhsS, 0.8650, 1.64, 0.341, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3608, 5jhsE, 0.8650, 1.64, 0.345, 230, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3609, 5fhsS, 0.8650, 2.30, 0.336, 237, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3610, 5fhsE, 0.8650, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3611, 5fgiS, 0.8650, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3612, 5fgiE, 0.8650, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3613, 5fggS, 0.8650, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3614, 5fggE, 0.8650, 2.24, 0.343, 239, 233, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3615, 5d0zS, 0.8650, 1.82, 0.310, 232, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3616, 5d0zE, 0.8650, 2.14, 0.348, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3617, 5d0tS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3618, 5d0tE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3619, 5d0sS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3620, 5d0sE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3621, 5cz4U, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3622, 5cz4G, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3623, 5bxlS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3624, 5bxlE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3625, 4y9yS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3626, 4y9yE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3627, 4y8uS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3628, 4y8uE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3629, 4y8mS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3630, 4y8mE, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3631, 4y8kS, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3632, 4y69S, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3633, 4y69E, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3634, 4x6zF, 0.8650, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3635, 4qvpS, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3636, 4qvpE, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3637, 4qvnE, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3638, 4qvlS, 0.8650, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3639, 4qvlE, 0.8650, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3640, 4qv4S, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT
3641, 4qv4E, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45T MUTANT
3642, 4qv1E, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT
3643, 4quxS, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT
3644, 4quxE, 0.8650, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT
3645, 3tddE, 0.8650, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3646, 3nzwS, 0.8650, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3647, 3nzwE, 0.8650, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3648, 3mg8F, 0.8650, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3649, 3mg0E, 0.8650, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3650, 3gpwE, 0.8650, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3651, 5t0gM, 0.8649, 2.17, 0.242, 241, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3652, 5mp9A, 0.8649, 2.17, 0.242, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3653, 5m2bS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3654, 5ln3B, 0.8649, 1.65, 0.341, 231, 223, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3655, 5l65S, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3656, 5l65E, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3657, 5l60S, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3658, 5l60E, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3659, 5l5jS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3660, 5l5jE, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3661, 5fgdS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3662, 5fgdE, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3663, 5d0wS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3664, 5d0wE, 0.8649, 1.64, 0.341, 232, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3665, 5cz6S, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3666, 5cghS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3667, 5cghE, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3668, 5bxnS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3669, 5bxnE, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3670, 4ya4S, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3671, 4ya4E, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3672, 4y8rS, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3673, 4y8rE, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3674, 4y8oU, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3675, 4y8oG, 0.8649, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3676, 4qwlE, 0.8649, 1.65, 0.341, 233, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3677, 4qvnS, 0.8649, 1.65, 0.341, 233, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3678, 4qv5S, 0.8649, 2.32, 0.336, 237, 229, YCP BETA5-M45I MUTANT
3679, 4qv5E, 0.8649, 1.65, 0.341, 233, 223, YCP BETA5-M45I MUTANT
3680, 4no8S, 0.8649, 1.65, 0.341, 233, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3681, 4no8E, 0.8649, 2.43, 0.343, 240, 233, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3682, 4hrcS, 0.8649, 2.14, 0.247, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3683, 4gk7S, 0.8649, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3684, 4gk7E, 0.8649, 1.98, 0.308, 234, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3685, 4eu2T, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3686, 3tddS, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3687, 3shjS, 0.8649, 1.65, 0.341, 231, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3688, 3shjE, 0.8649, 1.65, 0.341, 231, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3689, 3mg8S, 0.8649, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3690, 3mg4E, 0.8649, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3691, 3gpwS, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3692, 3gptS, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3693, 3gptE, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3694, 3e47S, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3695, 3e47E, 0.8649, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3696, 2gplE, 0.8649, 1.65, 0.341, 231, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3697, 6gopS, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3698, 6gopE, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3699, 5wvkU, 0.8648, 1.65, 0.341, 231, 223, 
3700, 5vfsFA, 0.8648, 1.66, 0.341, 231, 223, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3701, 5m2bE, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3702, 5l5yS, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3703, 5l5yE, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3704, 5l5iS, 0.8648, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3705, 5l5iE, 0.8648, 2.16, 0.242, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3706, 5l5eS, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3707, 5l5eE, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3708, 5l5dS, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3709, 5l5dE, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3710, 5l55S, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3711, 5l55E, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3712, 5l52S, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3713, 5l52E, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3714, 5d0xS, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3715, 5d0xE, 0.8648, 1.64, 0.341, 232, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3716, 5cz8S, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3717, 5cz8E, 0.8648, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3718, 5cz6E, 0.8648, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3719, 5bouS, 0.8648, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3720, 5bouE, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3721, 5ahjS, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3722, 5ahjE, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3723, 4ya5S, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3724, 4ya5E, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3725, 4y8nS, 0.8648, 1.64, 0.341, 233, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3726, 4y8nE, 0.8648, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3727, 4y6vS, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3728, 4y6vE, 0.8648, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3729, 4rurS, 0.8648, 2.46, 0.332, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3730, 4rurE, 0.8648, 2.61, 0.333, 240, 234, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3731, 4r02S, 0.8648, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3732, 4qz7E, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3733, 4qwrS, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3734, 4qwrE, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3735, 4qwlS, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3736, 4qw0S, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3737, 4qw0E, 0.8648, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3738, 4qvwS, 0.8648, 1.66, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3739, 4qvwE, 0.8648, 1.66, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3740, 4lqiS, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3741, 4lqiE, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3742, 4jsuS, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3743, 4jsuE, 0.8648, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3744, 2gplS, 0.8648, 1.65, 0.341, 231, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3745, 2f16S, 0.8648, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3746, 2f16E, 0.8648, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3747, 1rypT, 0.8648, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3748, 6avoN, 0.8647, 1.65, 0.341, 231, 223, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3749, 5vfrm, 0.8647, 1.65, 0.341, 231, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3750, 5l69S, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3751, 5l69E, 0.8647, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3752, 5l68S, 0.8647, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3753, 5l68E, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3754, 5jhrS, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3755, 5jhrE, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3756, 5fghU, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3757, 5fghG, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3758, 5d0vS, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3759, 5d0vE, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3760, 5cz5S, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3761, 5cz5E, 0.8647, 1.67, 0.341, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3762, 4y8qE, 0.8647, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3763, 4qz7S, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3764, 4qz6S, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3765, 4qz6E, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3766, 4qz3S, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3767, 4qz3E, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3768, 4qz0S, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3769, 4qz0E, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3770, 4qwuS, 0.8647, 1.64, 0.341, 233, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3771, 4qwuE, 0.8647, 1.64, 0.341, 233, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3772, 4qw7S, 0.8647, 1.65, 0.341, 233, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3773, 4qw7E, 0.8647, 1.65, 0.341, 233, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3774, 4qw6S, 0.8647, 1.65, 0.341, 233, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3775, 4qw6E, 0.8647, 1.65, 0.341, 233, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3776, 4qw5S, 0.8647, 1.65, 0.341, 233, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3777, 4qw5E, 0.8647, 1.65, 0.341, 233, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3778, 4qw1S, 0.8647, 2.01, 0.352, 232, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3779, 4qw1E, 0.8647, 2.52, 0.330, 240, 233, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3780, 4qvvS, 0.8647, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3781, 4qvvE, 0.8647, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3782, 4qvqS, 0.8647, 1.66, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3783, 4qvqE, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3784, 4qvmS, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3785, 4qvmE, 0.8647, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3786, 3okjS, 0.8647, 2.17, 0.242, 241, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3787, 3okjE, 0.8647, 2.17, 0.242, 241, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3788, 3mg6F, 0.8647, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3789, 3hyeS, 0.8647, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3790, 3hyeE, 0.8647, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3791, 5fghS, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3792, 5fghE, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3793, 5cgiS, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3794, 5cgiE, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3795, 4ya0U, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3796, 4ya0G, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3797, 4y8qS, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3798, 4y8pS, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3799, 4y8pE, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3800, 4y8lS, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3801, 4y8lE, 0.8646, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3802, 4qzwE, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3803, 4qwjS, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3804, 4qwjE, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3805, 4qwiS, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3806, 4qwiE, 0.8646, 1.65, 0.341, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3807, 3mg6E, 0.8646, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3808, 1g0uE, 0.8646, 1.66, 0.341, 231, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3809, 6avoI, 0.8645, 1.66, 0.341, 231, 223, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3810, 5dkiS, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3811, 5dkiE, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3812, 4ya7S, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3813, 4ya7E, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3814, 4y82S, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3815, 4y82E, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3816, 4y80S, 0.8645, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3817, 4y80E, 0.8645, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3818, 4y7xS, 0.8645, 2.33, 0.336, 237, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3819, 4y7xE, 0.8645, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3820, 4y77S, 0.8645, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3821, 4y77E, 0.8645, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3822, 4qzwS, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3823, 4qz5S, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3824, 4qz5E, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3825, 4qz2S, 0.8645, 2.17, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3826, 4qz2E, 0.8645, 2.17, 0.242, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3827, 4qwfS, 0.8645, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3828, 4qw4S, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
3829, 4qw4E, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
3830, 4nnnS, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH MG132
3831, 4nnnE, 0.8645, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH MG132
3832, 3oevE, 0.8645, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3833, 3mg8E, 0.8645, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3834, 3mg7E, 0.8645, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3835, 5vfuLA, 0.8644, 1.65, 0.341, 231, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3836, 5vftm, 0.8644, 1.65, 0.341, 231, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3837, 5cz4S, 0.8644, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3838, 5cz4E, 0.8644, 1.65, 0.345, 230, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3839, 4ya9S, 0.8644, 2.02, 0.352, 232, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3840, 4ya9E, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3841, 4ya3S, 0.8644, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3842, 4ya3E, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3843, 4y9zS, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3844, 4y9zE, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3845, 4y8jS, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3846, 4y8jE, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3847, 4y7yS, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3848, 4y7yE, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3849, 4y7wS, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3850, 4y7wE, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3851, 4y75S, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3852, 4y75E, 0.8644, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3853, 4r02E, 0.8644, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3854, 4qzxS, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3855, 4qzxE, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3856, 4qwxS, 0.8644, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3857, 4qwxE, 0.8644, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3858, 4qwkS, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3859, 4qwkE, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3860, 4qwfE, 0.8644, 1.65, 0.341, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3861, 4eu2A, 0.8644, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3862, 6epcF, 0.8643, 1.66, 0.341, 233, 223, GROUND STATE 26S PROTEASOME (GS2)
3863, 4y8iS, 0.8643, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3864, 4y8iE, 0.8643, 1.65, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3865, 4y81S, 0.8643, 2.59, 0.329, 240, 234, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3866, 4y81E, 0.8643, 2.59, 0.329, 240, 234, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3867, 4y78S, 0.8643, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3868, 4y74S, 0.8643, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3869, 4y74E, 0.8643, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3870, 4y70S, 0.8643, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3871, 4y70E, 0.8643, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3872, 4y6zS, 0.8643, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3873, 4y6zE, 0.8643, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3874, 4r17E, 0.8643, 1.65, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3875, 4qz4S, 0.8643, 1.65, 0.341, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3876, 4qz4E, 0.8643, 1.65, 0.341, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3877, 4qw3S, 0.8643, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3878, 4qw3E, 0.8643, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3879, 4qv6S, 0.8643, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT
3880, 4qv6E, 0.8643, 1.65, 0.341, 231, 223, YCP BETA5-A49V MUTANT
3881, 4hrcE, 0.8643, 1.66, 0.341, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3882, 5m32F, 0.8642, 1.66, 0.341, 231, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3883, 4ya0S, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3884, 4ya0E, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3885, 4y8sS, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3886, 4y8sE, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3887, 4y8hS, 0.8642, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3888, 4y8hE, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3889, 4y78E, 0.8642, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3890, 4r17S, 0.8642, 1.66, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3891, 4qz1S, 0.8642, 2.13, 0.243, 241, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3892, 4qz1E, 0.8642, 2.06, 0.311, 238, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3893, 4qxjS, 0.8642, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3894, 4qxjE, 0.8642, 1.65, 0.341, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3895, 4qw3U, 0.8642, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3896, 4qw3G, 0.8642, 1.65, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3897, 4qlsS, 0.8642, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3898, 4qlsE, 0.8642, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3899, 3mg7S, 0.8642, 1.65, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3900, 3jcoPA, 0.8642, 1.65, 0.341, 231, 223, 
3901, 1g65S, 0.8642, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3902, 5laiS, 0.8641, 1.65, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3903, 5laiE, 0.8641, 1.65, 0.341, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3904, 4y8oS, 0.8641, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3905, 4y8oE, 0.8641, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3906, 4qwsS, 0.8641, 1.66, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3907, 4qwsE, 0.8641, 1.66, 0.341, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3908, 4qlqS, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3909, 4qlqE, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3910, 4no1S, 0.8641, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3911, 4no1E, 0.8641, 1.65, 0.341, 233, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3912, 3oeuE, 0.8641, 1.87, 0.350, 232, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3913, 3jcpOA, 0.8641, 1.66, 0.341, 231, 223, 
3914, 3jcpO, 0.8641, 1.66, 0.341, 231, 223, 
3915, 3jcoP, 0.8641, 1.65, 0.341, 231, 223, 
3916, 5dsvJ, 0.8640, 1.65, 0.341, 231, 223, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3917, 4y8gS, 0.8640, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3918, 4y8gE, 0.8640, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3919, 4q1sS, 0.8640, 1.65, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3920, 4nnwS, 0.8640, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3921, 4nnwE, 0.8640, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3922, 3wxrT, 0.8640, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3923, 3oevS, 0.8640, 1.66, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3924, 5mpbU, 0.8639, 1.66, 0.341, 231, 223, 
3925, 5l54S, 0.8639, 2.18, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3926, 5l54E, 0.8639, 2.18, 0.242, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3927, 4y84S, 0.8639, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3928, 4y84E, 0.8639, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3929, 4qwgS, 0.8639, 1.66, 0.341, 233, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3930, 4qwgE, 0.8639, 2.38, 0.323, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3931, 5dkiU, 0.8638, 1.67, 0.341, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3932, 5dkiG, 0.8638, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3933, 4y8tS, 0.8638, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3934, 4y8tE, 0.8638, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3935, 4qwgU, 0.8638, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3936, 4qluE, 0.8638, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3937, 3sdiS, 0.8638, 1.66, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3938, 3oeuS, 0.8638, 1.66, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3939, 4ya2S, 0.8637, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3940, 4ya2E, 0.8637, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3941, 4qwgG, 0.8637, 1.66, 0.341, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3942, 4qluS, 0.8637, 1.66, 0.341, 233, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3943, 4no9S, 0.8637, 1.67, 0.341, 233, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3944, 4no9E, 0.8637, 1.67, 0.341, 233, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3945, 4no6S, 0.8637, 1.67, 0.341, 233, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3946, 4no6E, 0.8637, 2.38, 0.323, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3947, 4qltE, 0.8636, 2.38, 0.323, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3948, 5vfqD, 0.8635, 2.34, 0.352, 239, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3949, 4qltS, 0.8635, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3950, 4qlvS, 0.8634, 1.66, 0.341, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3951, 4qlvE, 0.8634, 1.66, 0.341, 233, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3952, 4qbyS, 0.8634, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3953, 4qbyE, 0.8634, 1.65, 0.341, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3954, 3sdkT, 0.8634, 1.65, 0.341, 232, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3955, 1jd2E, 0.8634, 1.66, 0.341, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3956, 6epfF, 0.8633, 2.33, 0.328, 243, 232, GROUND STATE 26S PROTEASOME (GS1)
3957, 5mp9f, 0.8633, 1.66, 0.341, 231, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3958, 5a0qS, 0.8632, 1.66, 0.341, 231, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3959, 5a0qE, 0.8632, 1.66, 0.341, 231, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3960, 1g0uS, 0.8632, 1.66, 0.341, 231, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3961, 6epcA, 0.8631, 1.66, 0.341, 231, 223, GROUND STATE 26S PROTEASOME (GS2)
3962, 5vfoJ, 0.8631, 1.66, 0.341, 231, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3963, 5vfuFA, 0.8630, 2.18, 0.242, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3964, 5vftg, 0.8630, 2.18, 0.242, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3965, 4cr4G, 0.8630, 1.66, 0.341, 231, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3966, 3wxrG, 0.8627, 1.66, 0.341, 231, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3967, 5vfqCA, 0.8626, 2.17, 0.242, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3968, 5t0gG, 0.8626, 1.67, 0.341, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3969, 5t0gJ, 0.8625, 1.66, 0.345, 230, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3970, 5mpcR, 0.8625, 1.66, 0.341, 233, 223, 
3971, 5m32U, 0.8625, 1.67, 0.341, 231, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3972, 4v7oT, 0.8625, 1.67, 0.341, 231, 223, 
3973, 3wxrU, 0.8625, 2.17, 0.242, 241, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3974, 5wvkT, 0.8624, 1.67, 0.341, 231, 223, 
3975, 5mpbG, 0.8624, 1.66, 0.341, 231, 223, 
3976, 4v7oF, 0.8624, 1.66, 0.341, 231, 223, 
3977, 5a5bG, 0.8623, 1.66, 0.341, 231, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3978, 4v7oNA, 0.8623, 1.66, 0.341, 231, 223, 
3979, 4v7oBB, 0.8623, 1.67, 0.341, 231, 223, 
3980, 4cr3G, 0.8623, 1.18, 0.606, 228, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3981, 4cr2A, 0.8622, 2.25, 0.346, 239, 234, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3982, 1fntO, 0.8622, 1.67, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3983, 3sdkF, 0.8621, 1.67, 0.341, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3984, 1jd2Z, 0.8620, 1.67, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3985, 1fntA, 0.8620, 1.67, 0.341, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3986, 1ya7F, 0.8618, 1.67, 0.341, 231, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3987, 6epeC, 0.8617, 2.32, 0.338, 236, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3988, 5wvkO, 0.8617, 1.67, 0.341, 233, 223, 
3989, 5vfpBA, 0.8616, 2.03, 0.311, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3990, 5t0jG, 0.8616, 1.64, 0.341, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3991, 5m32G, 0.8616, 1.01, 0.609, 215, 215, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3992, 5vfpD, 0.8613, 1.01, 0.609, 215, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3993, 5vfrJ, 0.8612, 1.68, 0.345, 230, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3994, 1ya7C, 0.8611, 2.24, 0.250, 246, 232, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3995, 5vfrj, 0.8608, 2.27, 0.342, 239, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3996, 5mpcU, 0.8608, 2.17, 0.268, 240, 231, 
3997, 5lf0G, 0.8608, 2.17, 0.268, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3998, 5lexG, 0.8608, 2.45, 0.328, 245, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3999, 6epdE, 0.8607, 2.35, 0.336, 237, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4000, 5leyG, 0.8606, 2.26, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4001, 1ya7G, 0.8606, 2.20, 0.264, 240, 231, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4002, 5lf3G, 0.8605, 2.27, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4003, 5lezG, 0.8605, 2.17, 0.342, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4004, 3j9iU, 0.8603, 2.03, 0.259, 241, 228, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4005, 3j9iT, 0.8603, 1.69, 0.341, 234, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4006, 3j9iS, 0.8603, 2.39, 0.336, 237, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4007, 3j9iR, 0.8603, 1.65, 0.341, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4008, 3j9iQ, 0.8603, 2.46, 0.336, 243, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4009, 3j9iP, 0.8603, 1.69, 0.341, 234, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4010, 3j9iO, 0.8603, 2.47, 0.328, 245, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4011, 3j9iG, 0.8603, 1.69, 0.341, 234, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4012, 3j9iF, 0.8603, 1.69, 0.341, 234, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4013, 3j9iE, 0.8603, 2.47, 0.328, 245, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4014, 3j9iD, 0.8603, 2.18, 0.246, 243, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4015, 3j9iC, 0.8603, 2.06, 0.222, 238, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4016, 3j9iB, 0.8603, 2.30, 0.338, 236, 228, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4017, 3j9iA, 0.8603, 1.68, 0.341, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4018, 1ya7A, 0.8601, 2.06, 0.222, 238, 230, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4019, 5a5bB, 0.8600, 1.73, 0.404, 227, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4020, 4cr3B, 0.8600, 2.42, 0.323, 249, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4021, 5mpbF, 0.8598, 2.20, 0.237, 243, 232, 
4022, 5le5G, 0.8598, 2.27, 0.343, 239, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4023, 5lf7G, 0.8597, 2.14, 0.264, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4024, 5mpaF, 0.8596, 2.16, 0.258, 233, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4025, 5mpaa, 0.8595, 1.92, 0.317, 238, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4026, 5lf4G, 0.8595, 2.28, 0.342, 239, 234, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4027, 5lf6G, 0.8594, 2.27, 0.342, 239, 234, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4028, 5t0hM, 0.8593, 1.73, 0.408, 227, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4029, 5lf1G, 0.8593, 2.28, 0.343, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4030, 2ku1F, 0.8593, 2.41, 0.336, 243, 232, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4031, 3jseF, 0.8592, 2.03, 0.264, 241, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4032, 3jseG, 0.8591, 2.03, 0.264, 241, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4033, 3jseE, 0.8591, 2.23, 0.578, 233, 232, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4034, 3jseC, 0.8590, 2.04, 0.264, 241, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4035, 3jseB, 0.8590, 1.74, 0.404, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4036, 3jseA, 0.8590, 2.04, 0.264, 241, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4037, 5mpcG, 0.8589, 2.03, 0.264, 241, 227, 
4038, 5m32B, 0.8589, 1.73, 0.396, 224, 222, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4039, 3jseD, 0.8589, 1.73, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4040, 1ya7D, 0.8589, 1.73, 0.396, 224, 222, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4041, 1ya7B, 0.8589, 1.73, 0.396, 224, 222, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4042, 6epfG, 0.8583, 1.73, 0.396, 224, 222, GROUND STATE 26S PROTEASOME (GS1)
4043, 2ku1G, 0.8582, 1.73, 0.396, 224, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4044, 2ku1E, 0.8582, 1.73, 0.396, 224, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4045, 2ku2E, 0.8579, 1.73, 0.396, 224, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4046, 2ku2D, 0.8579, 1.73, 0.396, 224, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4047, 4cr4A, 0.8577, 1.73, 0.396, 224, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4048, 3jrmG, 0.8577, 1.73, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4049, 3jrmC, 0.8577, 1.73, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4050, 3jrmA, 0.8577, 1.73, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4051, 3jrmD, 0.8576, 1.73, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4052, 3jrmB, 0.8576, 1.74, 0.408, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4053, 6epfA, 0.8575, 1.95, 0.326, 250, 227, GROUND STATE 26S PROTEASOME (GS1)
4054, 3jrmF, 0.8575, 1.95, 0.326, 250, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4055, 3jrmE, 0.8575, 1.71, 0.341, 231, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4056, 2ku2F, 0.8574, 2.04, 0.264, 241, 227, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4057, 6epeA, 0.8572, 2.05, 0.264, 241, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4058, 6epeE, 0.8571, 1.71, 0.345, 233, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4059, 2ku1C, 0.8571, 2.20, 0.247, 241, 231, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4060, 5wvkAA, 0.8567, 2.05, 0.264, 241, 227, 
4061, 1ya7E, 0.8567, 2.05, 0.264, 241, 227, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4062, 5mpaA, 0.8566, 2.53, 0.343, 240, 233, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4063, 3jcoOA, 0.8564, 2.05, 0.264, 241, 227, 
4064, 3jcoO, 0.8564, 1.77, 0.399, 237, 223, 
4065, 5t0jM, 0.8562, 1.75, 0.408, 227, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4066, 5wviX, 0.8559, 1.75, 0.408, 227, 223, 
4067, 5le5Q, 0.8558, 1.75, 0.408, 227, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4068, 4cr2F, 0.8557, 1.75, 0.408, 227, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4069, 5t0hJ, 0.8556, 1.75, 0.408, 227, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4070, 2ku2G, 0.8556, 1.75, 0.408, 227, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4071, 3c92U, 0.8554, 2.48, 0.332, 243, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4072, 3c92T, 0.8554, 2.02, 0.342, 234, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4073, 3c92S, 0.8554, 1.75, 0.408, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4074, 3c92R, 0.8554, 1.76, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4075, 3c92Q, 0.8554, 1.76, 0.408, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4076, 3c92P, 0.8554, 2.48, 0.346, 245, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4077, 3c92O, 0.8554, 1.78, 0.404, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4078, 3c92G, 0.8554, 1.78, 0.404, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4079, 3c92F, 0.8554, 1.79, 0.399, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4080, 3c92E, 0.8554, 1.79, 0.399, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4081, 3c92D, 0.8554, 2.24, 0.237, 243, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4082, 3c92C, 0.8554, 1.79, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4083, 3c92B, 0.8554, 1.79, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4084, 3c92A, 0.8554, 1.78, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4085, 3c91U, 0.8554, 1.79, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4086, 3c91T, 0.8554, 1.79, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4087, 3c91S, 0.8554, 2.32, 0.258, 246, 233, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4088, 3c91R, 0.8554, 1.79, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4089, 3c91Q, 0.8554, 1.80, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4090, 3c91P, 0.8554, 1.81, 0.399, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4091, 3c91O, 0.8554, 2.22, 0.258, 246, 233, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4092, 3c91G, 0.8554, 2.27, 0.591, 233, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4093, 3c91F, 0.8554, 1.82, 0.404, 237, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4094, 3c91E, 0.8554, 1.73, 0.345, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4095, 3c91D, 0.8554, 1.82, 0.404, 227, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4096, 3c91C, 0.8554, 2.22, 0.242, 241, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4097, 3c91B, 0.8554, 1.76, 0.341, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4098, 3c91A, 0.8554, 1.76, 0.341, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4099, 6epeF, 0.8552, 1.76, 0.341, 233, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4100, 5mpcD, 0.8552, 2.65, 0.329, 240, 234, 
4101, 3jtlC, 0.8552, 2.32, 0.333, 245, 231, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4102, 3jtlA, 0.8552, 2.17, 0.352, 233, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4103, 3jtlG, 0.8551, 1.73, 0.341, 233, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4104, 3jtlD, 0.8551, 2.31, 0.339, 239, 233, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4105, 3jtlB, 0.8551, 1.86, 0.399, 237, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4106, 5lexQ, 0.8550, 1.77, 0.396, 224, 222, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4107, 3jtlF, 0.8550, 1.77, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4108, 3jtlE, 0.8550, 1.77, 0.396, 224, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4109, 2ku1D, 0.8549, 1.77, 0.396, 224, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4110, 5a5bF, 0.8543, 1.77, 0.396, 224, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4111, 4cr3F, 0.8543, 1.77, 0.396, 224, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4112, 5mpbT, 0.8542, 1.77, 0.396, 224, 222, 
4113, 5ln3G, 0.8542, 1.77, 0.396, 224, 222, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4114, 5lezQ, 0.8541, 1.77, 0.396, 224, 222, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4115, 5dsvM, 0.8541, 1.77, 0.396, 224, 222, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4116, 1yauA, 0.8539, 1.77, 0.396, 224, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4117, 5mpbR, 0.8534, 1.77, 0.396, 224, 222, 
4118, 1yauF, 0.8532, 1.77, 0.396, 224, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4119, 2ku2A, 0.8529, 1.77, 0.396, 224, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4120, 6epeB, 0.8528, 1.82, 0.404, 227, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4121, 5t0hG, 0.8527, 1.82, 0.404, 227, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4122, 6epfD, 0.8526, 1.82, 0.404, 227, 223, GROUND STATE 26S PROTEASOME (GS1)
4123, 1yauG, 0.8526, 1.82, 0.404, 227, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4124, 1yauC, 0.8523, 1.82, 0.404, 227, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4125, 2ku2C, 0.8519, 1.82, 0.404, 227, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4126, 2ku1A, 0.8516, 1.82, 0.404, 227, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4127, 5wviF, 0.8514, 1.82, 0.404, 227, 223, 
4128, 2ku2B, 0.8514, 1.82, 0.404, 227, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4129, 2ku1B, 0.8514, 1.82, 0.404, 227, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4130, 5mpcO, 0.8512, 1.82, 0.404, 227, 223, 
4131, 5lf0U, 0.8511, 1.82, 0.404, 227, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4132, 5lexU, 0.8506, 1.82, 0.404, 227, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4133, 1yauB, 0.8506, 1.82, 0.404, 227, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4134, 5lezU, 0.8504, 2.12, 0.311, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4135, 5leyU, 0.8504, 2.42, 0.349, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4136, 5mpbO, 0.8502, 1.82, 0.408, 227, 223, 
4137, 5lf7U, 0.8502, 1.82, 0.408, 227, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4138, 5lf3U, 0.8502, 1.82, 0.408, 227, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4139, 1yauE, 0.8502, 1.82, 0.408, 227, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4140, 5t0jJ, 0.8501, 1.82, 0.408, 227, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4141, 5lf1U, 0.8498, 2.17, 0.352, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4142, 1yauD, 0.8498, 1.83, 0.408, 227, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4143, 1yarC, 0.8498, 1.83, 0.408, 227, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4144, 1yarG, 0.8496, 1.90, 0.404, 237, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4145, 5lf6U, 0.8495, 1.76, 0.341, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4146, 5lf4U, 0.8495, 1.76, 0.341, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4147, 5ln3A, 0.8494, 1.78, 0.341, 233, 223, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4148, 4v7oP, 0.8494, 2.42, 0.341, 242, 232, 
4149, 4v7oB, 0.8494, 2.20, 0.352, 234, 227, 
4150, 5wviI, 0.8493, 2.43, 0.346, 239, 228, 
4151, 5wviD, 0.8493, 1.67, 0.405, 222, 220, 
4152, 5mpbA, 0.8493, 2.28, 0.354, 240, 229, 
4153, 4v7oXA, 0.8492, 1.67, 0.405, 222, 220, 
4154, 4v7oJA, 0.8492, 1.83, 0.401, 237, 222, 
4155, 1yarD, 0.8492, 2.13, 0.301, 234, 226, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4156, 6epdB, 0.8489, 2.28, 0.264, 240, 231, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4157, 1yarF, 0.8489, 2.31, 0.323, 246, 232, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4158, 1yarA, 0.8489, 1.69, 0.405, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4159, 5mpcT, 0.8486, 1.69, 0.405, 222, 220, 
4160, 1yarB, 0.8482, 1.90, 0.401, 237, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4161, 6epcG, 0.8481, 1.86, 0.401, 237, 222, GROUND STATE 26S PROTEASOME (GS2)
4162, 5wviY, 0.8481, 2.39, 0.325, 245, 231, 
4163, 6epeG, 0.8478, 1.90, 0.401, 237, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4164, 4cr4F, 0.8477, 1.90, 0.401, 237, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4165, 5mpcF, 0.8475, 2.25, 0.226, 241, 230, 
4166, 4v7oZA, 0.8475, 2.14, 0.267, 235, 225, 
4167, 4v7oR, 0.8475, 2.16, 0.267, 235, 225, 
4168, 4v7oLA, 0.8475, 1.72, 0.405, 222, 220, 
4169, 4v7oD, 0.8475, 2.15, 0.267, 235, 225, 
4170, 5vy3Y, 0.8472, 2.15, 0.267, 235, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4171, 5vy3S, 0.8472, 2.25, 0.226, 241, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4172, 5vy3Q, 0.8472, 2.15, 0.267, 235, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4173, 5vy3O, 0.8472, 2.15, 0.267, 235, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4174, 5vy3M, 0.8472, 1.74, 0.405, 222, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4175, 5vy3K, 0.8472, 2.37, 0.338, 239, 234, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4176, 5vy3C, 0.8472, 2.16, 0.267, 235, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4177, 5vy30, 0.8472, 1.73, 0.405, 222, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4178, 5vy3W, 0.8471, 1.67, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4179, 5vy3U, 0.8471, 1.67, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4180, 5vy3I, 0.8471, 2.16, 0.267, 235, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4181, 5vy3G, 0.8471, 2.16, 0.267, 235, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4182, 5vy3E, 0.8471, 2.35, 0.275, 239, 233, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4183, 5vy3A, 0.8471, 1.40, 0.321, 231, 215, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4184, 6bdfY, 0.8470, 1.69, 0.341, 234, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4185, 6bdfW, 0.8470, 1.40, 0.321, 231, 215, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4186, 6bdfU, 0.8470, 2.34, 0.354, 242, 229, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4187, 6bdfS, 0.8470, 1.93, 0.325, 250, 228, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4188, 6bdfQ, 0.8470, 2.30, 0.233, 243, 232, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4189, 6bdfO, 0.8470, 2.33, 0.247, 241, 231, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4190, 6bdfM, 0.8470, 1.41, 0.321, 231, 215, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4191, 6bdfK, 0.8470, 1.41, 0.321, 231, 215, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4192, 6bdfI, 0.8470, 1.68, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4193, 6bdfG, 0.8470, 2.16, 0.308, 234, 227, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4194, 6bdfE, 0.8470, 1.71, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4195, 6bdfC, 0.8470, 1.69, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4196, 6bdfA, 0.8470, 1.85, 0.345, 233, 223, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4197, 6bdf0, 0.8470, 1.69, 0.406, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4198, 5dsvC, 0.8467, 2.58, 0.342, 245, 234, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4199, 1yarE, 0.8467, 2.35, 0.237, 243, 232, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4200, 5vy4Y, 0.8463, 2.36, 0.335, 245, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4201, 5vy4W, 0.8463, 1.84, 0.345, 233, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4202, 5vy4U, 0.8463, 1.87, 0.336, 231, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4203, 5vy4S, 0.8463, 1.94, 0.324, 227, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4204, 5vy4Q, 0.8463, 1.93, 0.324, 227, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4205, 5vy4O, 0.8463, 1.93, 0.324, 227, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4206, 5vy4M, 0.8463, 1.93, 0.324, 227, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4207, 5vy4K, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4208, 5vy4I, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4209, 5vy4G, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4210, 5vy4E, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4211, 5vy4C, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4212, 5vy4AA, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4213, 5vy4A, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4214, 5vy40, 0.8463, 1.71, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4215, 5t0iG, 0.8456, 1.71, 0.406, 221, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4216, 5ln3F, 0.8455, 1.71, 0.406, 221, 219, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4217, 5fmgS, 0.8451, 1.71, 0.406, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4218, 5fmgE, 0.8451, 1.71, 0.406, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4219, 5fmgQ, 0.8446, 1.71, 0.406, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4220, 5fmgC, 0.8446, 1.71, 0.406, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4221, 1pmaO, 0.8444, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4222, 1pmaN, 0.8443, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4223, 1pmaD, 0.8443, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4224, 1pmaL, 0.8442, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4225, 1pmaG, 0.8442, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4226, 1pmaF, 0.8442, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4227, 1pmaH, 0.8441, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4228, 1pmaM, 0.8440, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4229, 1pmaK, 0.8440, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4230, 1pmaJ, 0.8440, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4231, 1pmaA, 0.8440, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4232, 6epdA, 0.8439, 1.73, 0.406, 221, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4233, 1pmaI, 0.8439, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4234, 1pmaE, 0.8436, 1.73, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4235, 1pmaC, 0.8436, 2.29, 0.356, 234, 225, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4236, 5le5U, 0.8431, 1.73, 0.406, 221, 219, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4237, 6epcB, 0.8429, 1.73, 0.406, 221, 219, GROUND STATE 26S PROTEASOME (GS2)
4238, 5wviG, 0.8429, 1.73, 0.406, 221, 219, 
4239, 5wviAA, 0.8429, 1.73, 0.406, 221, 219, 
4240, 5mpcA, 0.8429, 1.73, 0.406, 221, 219, 
4241, 6epdF, 0.8420, 1.73, 0.406, 221, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4242, 5t0iM, 0.8408, 1.73, 0.406, 221, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4243, 5wviZ, 0.8405, 1.73, 0.406, 221, 219, 
4244, 5ln3D, 0.8400, 1.73, 0.406, 221, 219, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4245, 3ipmF, 0.8396, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4246, 3ipmE, 0.8396, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4247, 3ipmD, 0.8396, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4248, 3ipmA, 0.8396, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4249, 3ipmG, 0.8395, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4250, 3ipmC, 0.8395, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4251, 3ipmB, 0.8395, 1.73, 0.406, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4252, 5fmgT, 0.8392, 1.73, 0.406, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4253, 5fmgF, 0.8392, 2.28, 0.270, 240, 230, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4254, 5t0iJ, 0.8377, 1.92, 0.314, 233, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4255, 6epeD, 0.8368, 1.46, 0.509, 217, 216, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4256, 5a5bA, 0.8324, 1.46, 0.509, 217, 216, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4257, 4cr3A, 0.8324, 1.78, 0.404, 220, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4258, 4g4sD, 0.8312, 1.78, 0.404, 220, 218, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4259, 6epcD, 0.8282, 1.76, 0.402, 221, 219, GROUND STATE 26S PROTEASOME (GS2)
4260, 6epdG, 0.8281, 1.77, 0.402, 221, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4261, 5t0jH, 0.8254, 1.76, 0.402, 221, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4262, 5a0qP, 0.8242, 1.77, 0.402, 221, 219, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4263, 5a0qB, 0.8242, 1.77, 0.402, 221, 219, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4264, 5fmgO, 0.8174, 1.76, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4265, 5fmgA, 0.8174, 1.76, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4266, 5a0qR, 0.8170, 1.77, 0.402, 221, 219, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4267, 5a0qD, 0.8170, 1.77, 0.402, 221, 219, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4268, 5fmgP, 0.8117, 1.76, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4269, 5fmgB, 0.8117, 1.77, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4270, 5fmgR, 0.8083, 2.45, 0.267, 246, 232, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4271, 5fmgD, 0.8083, 1.77, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4272, 5fmgU, 0.8060, 1.77, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4273, 5fmgG, 0.8060, 1.78, 0.402, 221, 219, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4274, 6epdD, 0.7995, 2.03, 0.270, 232, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4275, 5a0qU, 0.7963, 2.30, 0.301, 234, 226, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4276, 5a0qG, 0.7963, 1.88, 0.341, 233, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4277, 5ts0G, 0.7920, 2.19, 0.344, 242, 227, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4278, 5trgP, 0.7916, 2.32, 0.218, 241, 229, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4279, 3mkaA, 0.7911, 2.26, 0.316, 238, 228, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4280, 3mkaF, 0.7895, 2.74, 0.343, 240, 233, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4281, 3mi0F, 0.7895, 1.91, 0.341, 233, 223, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4282, 5trsA, 0.7885, 2.52, 0.328, 248, 232, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4283, 2fhgW, 0.7882, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4284, 2fhgM, 0.7882, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4285, 2fhgF, 0.7882, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4286, 2fhgD, 0.7882, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4287, 2fhgB, 0.7882, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4288, 2fhgA, 0.7882, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4289, 2fhgU, 0.7881, 2.04, 0.396, 227, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4290, 2fhgS, 0.7881, 1.73, 0.350, 219, 217, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4291, 2fhgQ, 0.7881, 1.73, 0.350, 219, 217, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4292, 2fhgK, 0.7881, 2.48, 0.338, 239, 234, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4293, 2fhgI, 0.7881, 2.61, 0.341, 246, 232, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4294, 2fhg1, 0.7881, 2.49, 0.225, 243, 231, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4295, 2fhgY, 0.7880, 2.49, 0.225, 243, 231, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4296, 2fhgO, 0.7880, 1.76, 0.344, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4297, 5thoS, 0.7876, 2.63, 0.316, 246, 231, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4298, 2fhhW, 0.7871, 2.77, 0.338, 245, 231, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4299, 2fhhO, 0.7870, 2.50, 0.301, 232, 226, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4300, 2fhhM, 0.7870, 1.60, 0.322, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4301, 2fhhD, 0.7870, 1.60, 0.322, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4302, 2fhhA, 0.7870, 2.04, 0.245, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4303, 5trrA, 0.7869, 2.04, 0.245, 219, 216, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4304, 2fhhU, 0.7869, 1.94, 0.360, 214, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4305, 2fhhF, 0.7869, 1.94, 0.360, 214, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4306, 5thoG, 0.7868, 1.79, 0.314, 212, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4307, 2fhhY, 0.7868, 1.79, 0.314, 212, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4308, 2fhhS, 0.7868, 2.14, 0.308, 215, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4309, 2fhhQ, 0.7868, 2.14, 0.308, 215, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4310, 2fhhK, 0.7868, 2.16, 0.255, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4311, 2fhhI, 0.7868, 2.16, 0.255, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4312, 2fhhB, 0.7868, 3.00, 0.341, 246, 232, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4313, 5trgA, 0.7867, 1.84, 0.353, 209, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4314, 3mkaK, 0.7866, 1.84, 0.353, 209, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4315, 2fhh1, 0.7866, 2.23, 0.160, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4316, 5thoA, 0.7864, 2.17, 0.161, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4317, 5tryA, 0.7863, 2.31, 0.164, 222, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4318, 5ts0A, 0.7859, 2.34, 0.164, 221, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4319, 3h6iQ, 0.7857, 2.28, 0.165, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4320, 5trsP, 0.7854, 2.20, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4321, 2h6jB, 0.7852, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4322, 5ts0T, 0.7848, 2.25, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4323, 3mkaQ, 0.7848, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4324, 3mkaU, 0.7846, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4325, 3mfeI, 0.7846, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4326, 2h6jG, 0.7846, 2.25, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4327, 2h6jF, 0.7846, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4328, 2h6jA, 0.7846, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4329, 5trsD, 0.7845, 2.25, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4330, 2h6jD, 0.7845, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4331, 5tryS, 0.7844, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4332, 2h6jE, 0.7844, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4333, 2h6jC, 0.7843, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4334, 5trsC, 0.7841, 2.26, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4335, 5thoO, 0.7841, 2.24, 0.160, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4336, 5thoE, 0.7840, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4337, 3mka1, 0.7839, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4338, 5tryF, 0.7838, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4339, 5ts0U, 0.7836, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4340, 5ts0Q, 0.7836, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4341, 5tryQ, 0.7836, 2.16, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4342, 5trrP, 0.7835, 2.28, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4343, 1q5rF, 0.7835, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4344, 1q5rD, 0.7835, 2.20, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4345, 1q5rB, 0.7835, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4346, 1q5rG, 0.7834, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4347, 1q5rE, 0.7834, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4348, 1q5rC, 0.7834, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4349, 1q5rA, 0.7834, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4350, 1q5qF, 0.7833, 2.28, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME
4351, 1q5qE, 0.7833, 2.17, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4352, 1q5qD, 0.7833, 2.30, 0.160, 221, 212, THE RHODOCOCCUS 20S PROTEASOME
4353, 1q5qC, 0.7833, 2.29, 0.156, 220, 212, THE RHODOCOCCUS 20S PROTEASOME
4354, 1q5qA, 0.7833, 2.18, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4355, 1q5qG, 0.7832, 2.18, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4356, 1q5qB, 0.7832, 2.19, 0.162, 218, 210, THE RHODOCOCCUS 20S PROTEASOME
4357, 5trrT, 0.7828, 2.18, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4358, 5trgS, 0.7828, 2.15, 0.162, 219, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4359, 5trgO, 0.7828, 2.20, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4360, 5trgE, 0.7828, 2.23, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4361, 5ts0E, 0.7827, 2.35, 0.156, 222, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4362, 3mkaY, 0.7825, 2.40, 0.165, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4363, 3mkaB, 0.7825, 2.12, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4364, 5trrE, 0.7824, 2.21, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4365, 5thoT, 0.7824, 2.21, 0.161, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4366, 3mkaM, 0.7824, 2.21, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4367, 3h6iF, 0.7822, 2.22, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4368, 5ts0P, 0.7821, 2.21, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4369, 5trrS, 0.7821, 2.29, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4370, 3mfeK, 0.7821, 2.21, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4371, 5ts0B, 0.7820, 2.21, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4372, 3mfeB, 0.7820, 2.25, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4373, 5tryP, 0.7819, 2.24, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4374, 3h6fQ, 0.7817, 2.24, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4375, 5ts0C, 0.7816, 2.32, 0.166, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4376, 5trrC, 0.7816, 2.22, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4377, 5trsS, 0.7815, 2.18, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4378, 5trsE, 0.7815, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4379, 5trrU, 0.7815, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4380, 5trgT, 0.7815, 2.18, 0.162, 219, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4381, 5thoC, 0.7813, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4382, 3mkaD, 0.7812, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4383, 5trsU, 0.7811, 2.22, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4384, 5lzpD, 0.7811, 2.22, 0.156, 219, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4385, 5tryE, 0.7810, 2.22, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4386, 5trgD, 0.7810, 2.22, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4387, 3mkaW, 0.7810, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4388, 3mkaS, 0.7810, 2.28, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4389, 3mkaO, 0.7810, 2.28, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4390, 5trsT, 0.7809, 2.28, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4391, 5trgU, 0.7809, 2.28, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4392, 5thoR, 0.7808, 2.28, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4393, 3h6iK, 0.7807, 2.28, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4394, 5ts0D, 0.7806, 2.28, 0.156, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4395, 5thoF, 0.7806, 2.18, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4396, 5tryR, 0.7805, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4397, 3h6fW, 0.7805, 2.26, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4398, 5tryU, 0.7804, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4399, 5thoU, 0.7803, 2.26, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4400, 5trsB, 0.7802, 2.41, 0.160, 224, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4401, 3h6iW, 0.7802, 2.37, 0.161, 220, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4402, 5ts0S, 0.7799, 2.21, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4403, 5ts0R, 0.7799, 2.20, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4404, 5trgQ, 0.7799, 2.42, 0.165, 224, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4405, 5tryD, 0.7794, 2.18, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4406, 5tryC, 0.7794, 2.14, 0.163, 218, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4407, 3h6iA, 0.7794, 2.26, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4408, 5trrO, 0.7792, 2.12, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4409, 3h6fF, 0.7792, 2.16, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4410, 3hfaB, 0.7791, 2.13, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4411, 5trsO, 0.7787, 2.10, 0.163, 217, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4412, 5thoP, 0.7787, 2.18, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4413, 5trrD, 0.7786, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4414, 5trrG, 0.7785, 2.19, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4415, 3mi0K, 0.7785, 2.28, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4416, 5trgG, 0.7784, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4417, 5trgB, 0.7784, 2.14, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4418, 5trsG, 0.7780, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4419, 5thoQ, 0.7780, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4420, 5tryT, 0.7779, 2.38, 0.166, 222, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4421, 5trsQ, 0.7779, 2.15, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4422, 3mi0S, 0.7778, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4423, 5ts0O, 0.7775, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4424, 5tryG, 0.7775, 2.66, 0.155, 223, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4425, 3krdF, 0.7775, 2.35, 0.162, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4426, 3h6fK, 0.7775, 2.26, 0.157, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4427, 5thoB, 0.7772, 2.29, 0.157, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4428, 5trrB, 0.7770, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4429, 3h6iM, 0.7770, 2.16, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4430, 3h6iI, 0.7770, 2.24, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4431, 3h6i1, 0.7770, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4432, 5thoD, 0.7769, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4433, 3mi0Y, 0.7769, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4434, 3mi0O, 0.7769, 2.24, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4435, 3mfeS, 0.7768, 2.20, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4436, 3h6f1, 0.7767, 2.16, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4437, 3mi0I, 0.7766, 2.17, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4438, 3h6fA, 0.7766, 2.18, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4439, 3mi0U, 0.7765, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4440, 3krdY, 0.7765, 2.16, 0.163, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4441, 5tryB, 0.7763, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4442, 3h6iU, 0.7763, 2.26, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4443, 3mi0M, 0.7760, 2.25, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4444, 5trsR, 0.7758, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4445, 5trgF, 0.7755, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4446, 3mi01, 0.7755, 2.24, 0.158, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4447, 5trsF, 0.7754, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4448, 5trgC, 0.7754, 2.07, 0.165, 214, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4449, 3h6fS, 0.7754, 2.25, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4450, 3krdI, 0.7751, 2.13, 0.163, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4451, 3h6fO, 0.7750, 2.21, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4452, 3h6iO, 0.7749, 2.19, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4453, 3mkaI, 0.7748, 2.20, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4454, 3hfaA, 0.7748, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4455, 5trrQ, 0.7747, 2.14, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4456, 3h6iS, 0.7746, 2.20, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4457, 3mi0Q, 0.7745, 2.23, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4458, 5lzpH, 0.7744, 2.20, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4459, 5lzp2, 0.7743, 2.23, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4460, 5lzp4, 0.7742, 2.21, 0.159, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4461, 5lzp0, 0.7742, 2.23, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4462, 3hfaM, 0.7742, 2.20, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4463, 3h6fI, 0.7742, 2.19, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4464, 3hfaW, 0.7741, 2.11, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4465, 5lzp6, 0.7740, 2.16, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4466, 5lzpY, 0.7739, 2.17, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4467, 5lzp8, 0.7739, 2.21, 0.159, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4468, 5lzpW, 0.7738, 2.13, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4469, 3hfaQ, 0.7738, 2.13, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4470, 3hfaK, 0.7737, 2.23, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4471, 3mi0W, 0.7736, 2.22, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4472, 3hfaS, 0.7736, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4473, 3hfaO, 0.7736, 2.15, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4474, 5lzpJ, 0.7735, 2.13, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4475, 3hfaI, 0.7735, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4476, 5ts0F, 0.7734, 2.13, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4477, 5tryO, 0.7734, 2.23, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4478, 3hfaF, 0.7734, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4479, 3hfa1, 0.7734, 2.17, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4480, 3krdS, 0.7731, 2.15, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4481, 3h6fM, 0.7731, 2.25, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4482, 5trrR, 0.7729, 2.26, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4483, 5lzpS, 0.7729, 2.20, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4484, 3krd1, 0.7729, 2.19, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4485, 3mi0A, 0.7727, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4486, 5trgR, 0.7726, 2.26, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4487, 3mfeA, 0.7726, 2.16, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4488, 3h6fB, 0.7726, 2.20, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4489, 3krdW, 0.7725, 2.17, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4490, 3krdK, 0.7723, 2.17, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4491, 3hfaY, 0.7723, 2.33, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4492, 3h6fD, 0.7723, 2.14, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4493, 5trrF, 0.7722, 2.22, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4494, 3hfaU, 0.7721, 2.18, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4495, 3h6iB, 0.7717, 2.21, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4496, 3mi0D, 0.7714, 2.19, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4497, 3h6iD, 0.7713, 2.20, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4498, 3h6fU, 0.7713, 2.20, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4499, 3mfeY, 0.7712, 2.20, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4500, 6bgoM, 0.7709, 2.15, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4501, 3krdQ, 0.7709, 2.11, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4502, 6bgoO, 0.7707, 2.15, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4503, 3krdO, 0.7707, 2.20, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4504, 6bgoN, 0.7706, 2.20, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4505, 6bgoA, 0.7706, 2.20, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4506, 3hfaD, 0.7705, 2.20, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4507, 6bgoJ, 0.7704, 2.16, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4508, 6bgoL, 0.7702, 2.16, 0.165, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4509, 5lzpM, 0.7701, 2.35, 0.163, 216, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4510, 5lzpB, 0.7701, 2.17, 0.165, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4511, 5lzpQ, 0.7700, 2.16, 0.165, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4512, 6bgoK, 0.7699, 2.22, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4513, 3h6fY, 0.7699, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4514, 3krdA, 0.7692, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4515, 2z5cF, 0.7690, 2.27, 0.159, 216, 208, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4516, 2z5cC, 0.7690, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4517, 3mfeO, 0.7688, 2.18, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4518, 3krdU, 0.7682, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4519, 3hf9I, 0.7680, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4520, 3mfe1, 0.7679, 2.24, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4521, 6bgoI, 0.7674, 2.21, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4522, 6bgoH, 0.7674, 2.22, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4523, 6bgoG, 0.7674, 2.22, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4524, 6bgoF, 0.7674, 2.24, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4525, 6bgoE, 0.7674, 2.14, 0.160, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4526, 6bgoD, 0.7674, 2.15, 0.160, 214, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4527, 6bgoC, 0.7674, 2.23, 0.159, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4528, 6bglO, 0.7674, 2.23, 0.159, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4529, 6bglN, 0.7674, 2.20, 0.165, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4530, 6bglM, 0.7674, 2.14, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4531, 6bglL, 0.7674, 2.22, 0.159, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4532, 6bglK, 0.7674, 2.18, 0.165, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4533, 6bglJ, 0.7674, 2.16, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4534, 6bglI, 0.7674, 2.19, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4535, 6bglH, 0.7674, 2.10, 0.161, 213, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4536, 6bglG, 0.7674, 2.17, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4537, 6bglF, 0.7674, 2.07, 0.161, 213, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4538, 6bglE, 0.7674, 2.54, 0.162, 219, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4539, 6bglD, 0.7674, 2.20, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4540, 6bglC, 0.7674, 2.37, 0.163, 217, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4541, 6bglA, 0.7674, 2.21, 0.160, 214, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4542, 3mfeD, 0.7672, 2.53, 0.167, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4543, 3krdM, 0.7671, 2.36, 0.163, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4544, 3mfeQ, 0.7666, 2.15, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4545, 3mi0B, 0.7665, 2.54, 0.167, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4546, 3krdD, 0.7662, 2.40, 0.163, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4547, 3krdB, 0.7659, 2.20, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4548, 3h6iY, 0.7657, 2.20, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4549, 3hf9y, 0.7656, 2.21, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4550, 3hf9s, 0.7646, 2.57, 0.167, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4551, 3hf9B, 0.7646, 2.12, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4552, 3hf9d, 0.7643, 2.22, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4553, 3hf9i, 0.7642, 0.74, 1.000, 189, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4554, 3hf9b, 0.7639, 0.74, 1.000, 189, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4555, 3hf9f, 0.7638, 2.17, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4556, 3hf9S, 0.7637, 2.23, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4557, 3hf9w, 0.7636, 2.09, 0.162, 212, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, 3hf9K, 0.7636, 2.08, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4559, 3hf91, 0.7636, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4560, 3hf9u, 0.7635, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4561, 3hf9k, 0.7634, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4562, 3hf9A, 0.7633, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4563, 3hf9a, 0.7632, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4564, 3hf9O, 0.7629, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4565, 3hf9o, 0.7628, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4566, 3hf9U, 0.7625, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4567, 3mfeU, 0.7624, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4568, 3hf9q, 0.7621, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4569, 3hf9Q, 0.7619, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, 3hf9Y, 0.7605, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, 3hf93, 0.7602, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4572, 3mfeW, 0.7585, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4573, 3hf9D, 0.7566, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4574, 5a0qT, 0.7550, 2.26, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4575, 5a0qF, 0.7545, 2.26, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4576, 3hf9m, 0.7527, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4577, 5a0qO, 0.7490, 2.26, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4578, 5a0qA, 0.7490, 2.26, 0.164, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4579, 3hf9M, 0.7458, 2.26, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4580, 3h4pf, 0.7363, 2.18, 0.161, 213, 205, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4581, 3h4pl, 0.7360, 2.25, 0.160, 214, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4582, 3h4pe, 0.7360, 2.18, 0.161, 213, 205, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4583, 3h4pj, 0.7359, 2.20, 0.161, 213, 205, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4584, 3h4pc, 0.7359, 2.22, 0.161, 213, 205, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4585, 3h4pa, 0.7359, 2.21, 0.161, 213, 205, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4586, 3j9iZ, 0.7358, 2.20, 0.161, 213, 205, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4587, 3j9iY, 0.7358, 2.07, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4588, 3j9iX, 0.7358, 2.13, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4589, 3j9iW, 0.7358, 2.04, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4590, 3j9iV, 0.7358, 2.08, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4591, 3j9iN, 0.7358, 2.09, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4592, 3j9iM, 0.7358, 2.05, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4593, 3j9iL, 0.7358, 2.12, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4594, 3j9iK, 0.7358, 2.11, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4595, 3j9iJ, 0.7358, 2.08, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4596, 3j9iI, 0.7358, 2.07, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4597, 3j9iH, 0.7358, 2.10, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4598, 3j9i2, 0.7358, 2.11, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4599, 3j9i1, 0.7358, 2.12, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4600, 3h4pn, 0.7358, 2.11, 0.163, 211, 203, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4601, 5vy3Z, 0.7357, 2.10, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4602, 5vy3X, 0.7357, 2.10, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4603, 5vy3V, 0.7357, 2.10, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4604, 5vy3T, 0.7357, 2.13, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4605, 5vy3R, 0.7357, 2.21, 0.162, 212, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4606, 5vy3P, 0.7357, 2.11, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4607, 5vy3N, 0.7357, 2.08, 0.163, 211, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4608, 5vy3L, 0.7357, 2.09, 0.163, 210, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4609, 5vy3J, 0.7357, 2.04, 0.163, 210, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4610, 5vy3H, 0.7357, 1.99, 0.164, 209, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4611, 5vy3F, 0.7357, 2.16, 0.163, 210, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4612, 5vy3D, 0.7357, 1.69, 0.330, 195, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4613, 5vy3B, 0.7357, 1.70, 0.330, 195, 194, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4614, 5vy31, 0.7357, 2.10, 0.160, 208, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4615, 3h4pg, 0.7357, 1.75, 0.290, 195, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4616, 3h4pk, 0.7356, 1.75, 0.290, 195, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4617, 3h4pb, 0.7355, 1.95, 0.162, 205, 197, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4618, 5vy4Z, 0.7354, 2.23, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4619, 5vy4X, 0.7354, 2.22, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4620, 5vy4V, 0.7354, 2.25, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4621, 5vy4T, 0.7354, 2.23, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4622, 5vy4R, 0.7354, 2.23, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4623, 5vy4P, 0.7354, 2.23, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4624, 5vy4N, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4625, 5vy4L, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4626, 5vy4J, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4627, 5vy4H, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4628, 5vy4F, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4629, 5vy4D, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4630, 5vy4BA, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4631, 5vy4B, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4632, 5vy41, 0.7354, 2.34, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4633, 3h4pd, 0.7354, 2.34, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4634, 3h4ph, 0.7353, 2.34, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4635, 3h4pi, 0.7352, 2.34, 0.209, 203, 196, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4636, 6bdfZ, 0.7351, 2.34, 0.209, 203, 196, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4637, 6bdfX, 0.7351, 2.34, 0.209, 203, 196, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4638, 6bdfV, 0.7351, 2.23, 0.246, 202, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4639, 6bdfT, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4640, 6bdfR, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4641, 6bdfP, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4642, 6bdfN, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4643, 6bdfL, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4644, 6bdfJ, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4645, 6bdfH, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4646, 6bdfF, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4647, 6bdfD, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4648, 6bdfB, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4649, 6bdf1, 0.7351, 2.19, 0.210, 203, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4650, 3h4pm, 0.7345, 2.19, 0.210, 203, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4651, 1yauM, 0.7345, 2.19, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4652, 1yarM, 0.7341, 2.19, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4653, 1ya7M, 0.7337, 2.22, 0.246, 202, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4654, 3jseM, 0.7332, 2.24, 0.246, 202, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4655, 3jrmM, 0.7332, 2.23, 0.246, 202, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4656, 1yauJ, 0.7332, 2.20, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4657, 1pmaX, 0.7331, 2.20, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4658, 3jrmK, 0.7330, 2.20, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4659, 3jrmJ, 0.7330, 2.20, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4660, 3jrmI, 0.7330, 2.20, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4661, 3jseK, 0.7329, 2.20, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4662, 3jrmL, 0.7329, 2.20, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4663, 3jrmH, 0.7329, 2.20, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4664, 3c92X, 0.7329, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4665, 3c92J, 0.7329, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4666, 3c91X, 0.7329, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4667, 3c91J, 0.7329, 2.20, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4668, 1ya7K, 0.7329, 2.20, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4669, 1ya7J, 0.7329, 2.20, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4670, 1pmaY, 0.7329, 2.20, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4671, 1pmaQ, 0.7329, 2.20, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4672, 3c92W, 0.7328, 2.23, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4673, 3c92N, 0.7328, 2.24, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4674, 3c92M, 0.7328, 2.25, 0.246, 202, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4675, 3c92I, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4676, 3c922, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4677, 3c921, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4678, 3c91W, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4679, 3c91N, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4680, 3c91M, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4681, 3c91I, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4682, 3c912, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4683, 3c911, 0.7328, 2.19, 0.210, 201, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4684, 1pmaU, 0.7328, 2.19, 0.210, 201, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4685, 1pmaP, 0.7328, 2.19, 0.210, 201, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4686, 3jseL, 0.7327, 2.19, 0.210, 201, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4687, 3jseJ, 0.7327, 2.19, 0.210, 201, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4688, 3jseI, 0.7327, 2.19, 0.210, 201, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4689, 1ya7I, 0.7327, 2.25, 0.246, 202, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4690, 1pmaT, 0.7327, 2.22, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4691, 1pma1, 0.7327, 2.23, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4692, 3jseN, 0.7326, 2.23, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4693, 3jseH, 0.7326, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4694, 1pmaV, 0.7326, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4695, 1pma2, 0.7326, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4696, 1yauK, 0.7325, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4697, 1yauI, 0.7325, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4698, 3jtlM, 0.7324, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4699, 1yarK, 0.7324, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4700, 1ya7L, 0.7324, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4701, 1pmaZ, 0.7324, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4702, 3jtlK, 0.7323, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4703, 3jtlI, 0.7323, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4704, 3c92Z, 0.7323, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4705, 3c92L, 0.7323, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4706, 3c91Z, 0.7323, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4707, 3c91L, 0.7323, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4708, 1yauH, 0.7323, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4709, 1pmaS, 0.7323, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4710, 3jtlN, 0.7322, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4711, 3jtlL, 0.7322, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4712, 3jtlJ, 0.7322, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4713, 3jtlH, 0.7322, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4714, 3c92V, 0.7322, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4715, 3c92H, 0.7322, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4716, 3c91V, 0.7322, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4717, 3c91H, 0.7322, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4718, 1yarJ, 0.7322, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4719, 1ya7H, 0.7322, 2.24, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4720, 1pmaB, 0.7322, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4721, 1yauL, 0.7321, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4722, 1yarL, 0.7321, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4723, 1yarI, 0.7321, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4724, 1pmaW, 0.7321, 2.24, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4725, 3jrmN, 0.7320, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4726, 1ya7N, 0.7320, 2.25, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4727, 3c92Y, 0.7319, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4728, 3c92K, 0.7319, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4729, 3c91Y, 0.7319, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4730, 3c91K, 0.7319, 2.25, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4731, 1pmaR, 0.7319, 2.25, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4732, 1yarN, 0.7316, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4733, 1yarH, 0.7316, 2.24, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4734, 2h6jN, 0.7311, 2.24, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4735, 2h6jK, 0.7311, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4736, 2h6jM, 0.7310, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4737, 2h6jJ, 0.7310, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4738, 2h6jI, 0.7308, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4739, 2h6jH, 0.7306, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4740, 1yauN, 0.7306, 2.25, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4741, 2h6jL, 0.7305, 2.26, 0.210, 203, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4742, 1q5rN, 0.7302, 2.26, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4743, 1q5rM, 0.7301, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4744, 1q5rL, 0.7301, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4745, 1q5rK, 0.7301, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4746, 1q5rJ, 0.7301, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4747, 1q5rI, 0.7301, 2.26, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4748, 1q5rH, 0.7301, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4749, 5fgdY, 0.7277, 2.26, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4750, 5fgeY, 0.7276, 2.26, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4751, 5fgeK, 0.7274, 2.26, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4752, 1j2qN, 0.7267, 2.26, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4753, 1j2qJ, 0.7267, 2.25, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4754, 3hfaV, 0.7266, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4755, 1j2qL, 0.7266, 2.25, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4756, 1j2qK, 0.7265, 2.25, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4757, 1j2qI, 0.7265, 2.25, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4758, 5fgdK, 0.7264, 2.26, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4759, 1j2qM, 0.7264, 2.25, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4760, 1j2qH, 0.7264, 2.25, 0.210, 203, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4761, 5cz7Y, 0.7263, 2.25, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4762, 5cz7K, 0.7263, 2.26, 0.210, 203, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4763, 5ts0K, 0.7258, 2.25, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4764, 1q5qM, 0.7255, 2.32, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4765, 1q5qN, 0.7254, 2.26, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4766, 1q5qL, 0.7254, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4767, 1q5qK, 0.7254, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4768, 1q5qH, 0.7254, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4769, 3mkaL, 0.7253, 2.25, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4770, 1q5qJ, 0.7253, 2.25, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4771, 1q5qI, 0.7253, 2.27, 0.210, 203, 195, THE RHODOCOCCUS 20S PROTEASOME
4772, 3ipmM, 0.7252, 2.27, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4773, 3ipmL, 0.7252, 2.49, 0.194, 242, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4774, 3ipmK, 0.7252, 2.49, 0.194, 242, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4775, 3ipmJ, 0.7252, 2.49, 0.194, 242, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4776, 5trgK, 0.7251, 2.49, 0.194, 242, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4777, 3mi0L, 0.7251, 2.50, 0.194, 242, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4778, 3ipmI, 0.7251, 2.50, 0.194, 242, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4779, 3ipmH, 0.7251, 2.35, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4780, 5trsK, 0.7250, 2.50, 0.194, 242, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4781, 5fgfK, 0.7250, 2.71, 0.193, 251, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4782, 3ipmN, 0.7250, 2.71, 0.193, 251, 202, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4783, 3hfaZ, 0.7250, 2.71, 0.193, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4784, 5trgL, 0.7248, 2.71, 0.193, 251, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4785, 5thoL, 0.7247, 2.71, 0.193, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4786, 5fgfY, 0.7247, 2.71, 0.193, 251, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4787, 3hfaX, 0.7247, 2.71, 0.193, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4788, 5trrL, 0.7245, 2.99, 0.216, 216, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4789, 5trsL, 0.7243, 2.97, 0.206, 218, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4790, 3mka2, 0.7242, 2.97, 0.206, 218, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4791, 5lzpN, 0.7241, 2.34, 0.231, 202, 195, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4792, 5lzpI, 0.7241, 2.34, 0.231, 202, 195, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4793, 3hfaT, 0.7241, 2.71, 0.152, 226, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4794, 5trgY, 0.7240, 2.34, 0.231, 202, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4795, 5trgV, 0.7240, 2.34, 0.231, 202, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4796, 3mkaV, 0.7240, 2.48, 0.230, 202, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4797, 5tryK, 0.7239, 2.91, 0.217, 215, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4798, 5trrW, 0.7239, 2.47, 0.230, 202, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4799, 3mkaN, 0.7239, 2.47, 0.230, 202, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4800, 3mkaC, 0.7239, 3.06, 0.206, 217, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4801, 3hfaH, 0.7239, 3.07, 0.206, 217, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4802, 3mkaT, 0.7238, 2.75, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4803, 3hfaE, 0.7238, 2.78, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4804, 5trrb, 0.7237, 2.78, 0.186, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4805, 5trrY, 0.7236, 2.78, 0.186, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4806, 3mi0V, 0.7236, 2.78, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4807, 5trrV, 0.7235, 2.78, 0.186, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4808, 5trrK, 0.7235, 3.07, 0.150, 251, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4809, 5trrI, 0.7235, 2.78, 0.186, 224, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4810, 5thoK, 0.7235, 2.78, 0.186, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4811, 3mkaR, 0.7235, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4812, 3mkaG, 0.7235, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4813, 5trsY, 0.7234, 2.44, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4814, 5trra, 0.7234, 2.44, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4815, 3mi0R, 0.7234, 2.75, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4816, 5thoW, 0.7233, 2.75, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4817, 5thoV, 0.7233, 2.44, 0.210, 203, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4818, 5lzpP, 0.7233, 2.44, 0.210, 203, 195, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4819, 3mkaP, 0.7233, 2.77, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4820, 3mkaE, 0.7233, 2.86, 0.208, 214, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4821, 5ts0L, 0.7231, 2.44, 0.210, 203, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4822, 3mkaJ, 0.7231, 2.77, 0.152, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4823, 5ts0W, 0.7230, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4824, 3mkaH, 0.7230, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4825, 3mi0X, 0.7230, 2.86, 0.208, 214, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4826, 3hfaG, 0.7230, 2.81, 0.147, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4827, 5trsW, 0.7229, 2.68, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4828, 5trsV, 0.7229, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4829, 3hfaC, 0.7229, 3.00, 0.151, 246, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4830, 5tryL, 0.7228, 2.78, 0.157, 234, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4831, 5trgI, 0.7228, 2.71, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4832, 5thoY, 0.7228, 2.78, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4833, 3mi0T, 0.7228, 2.76, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4834, 3hfa2, 0.7228, 2.76, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4835, 5trya, 0.7227, 2.95, 0.155, 249, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4836, 3hfaR, 0.7227, 2.77, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4837, 3hfaP, 0.7227, 2.77, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4838, 3hfaL, 0.7227, 2.94, 0.155, 252, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4839, 5thoa, 0.7226, 2.99, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4840, 3mi0J, 0.7226, 2.77, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4841, 3hfaN, 0.7226, 3.00, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4842, 3hfaJ, 0.7226, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4843, 5tryW, 0.7225, 2.78, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4844, 5tryb, 0.7225, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4845, 5thoI, 0.7225, 2.79, 0.157, 239, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4846, 5tryV, 0.7224, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4847, 5lzpG, 0.7224, 2.79, 0.148, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4848, 5lzpC, 0.7223, 2.70, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4849, 5trsa, 0.7222, 2.72, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4850, 5trrZ, 0.7222, 2.87, 0.157, 246, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4851, 5trgX, 0.7222, 2.90, 0.152, 251, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4852, 3mi0N, 0.7222, 2.81, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4853, 5thob, 0.7221, 2.73, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4854, 5lzpU, 0.7221, 2.79, 0.157, 239, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4855, 5lzpK, 0.7221, 2.78, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4856, 5ts0a, 0.7220, 2.78, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4857, 3mi0E, 0.7220, 2.81, 0.157, 234, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4858, 5ts0I, 0.7219, 2.88, 0.157, 250, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4859, 5lzpO, 0.7219, 3.08, 0.150, 248, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4860, 5tryY, 0.7218, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4861, 5trga, 0.7218, 2.94, 0.156, 252, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4862, 5lzpR, 0.7218, 2.78, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4863, 3mi02, 0.7218, 2.90, 0.152, 249, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4864, 5ts0V, 0.7217, 2.79, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4865, 5lzpE, 0.7217, 2.71, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4866, 3mi0Z, 0.7217, 2.79, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4867, 5trsN, 0.7216, 2.78, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4868, 5trsb, 0.7216, 2.73, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4869, 3mi0G, 0.7216, 2.76, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4870, 5ts0b, 0.7215, 2.70, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4871, 5lzpT, 0.7215, 2.78, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4872, 5tryI, 0.7214, 2.72, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4873, 5trsI, 0.7213, 2.73, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4874, 5ts0Y, 0.7212, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4875, 5thoZ, 0.7212, 2.73, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4876, 5trrN, 0.7211, 2.73, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4877, 5trgN, 0.7211, 2.72, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4878, 5thoM, 0.7209, 2.79, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4879, 3mi0C, 0.7209, 2.71, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4880, 5d0vK, 0.7208, 2.72, 0.153, 223, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4881, 5tryZ, 0.7207, 2.72, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4882, 5thoJ, 0.7207, 2.80, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4883, 3krdL, 0.7207, 2.80, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4884, 5trgZ, 0.7206, 2.72, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4885, 5trgb, 0.7206, 2.79, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4886, 5lzpF, 0.7206, 2.66, 0.154, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4887, 6bgoZ, 0.7205, 2.69, 0.153, 223, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4888, 6bgoY, 0.7205, 2.81, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4889, 6bgoX, 0.7205, 2.71, 0.153, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4890, 6bgoW, 0.7205, 2.73, 0.153, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4891, 6bgoV, 0.7205, 2.71, 0.153, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4892, 6bgoU, 0.7205, 2.81, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4893, 6bgoT, 0.7205, 2.64, 0.154, 223, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4894, 6bgoS, 0.7205, 2.72, 0.153, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4895, 6bgoR, 0.7205, 2.82, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4896, 6bgoQ, 0.7205, 2.70, 0.153, 223, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4897, 6bgoP, 0.7205, 2.73, 0.153, 222, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4898, 6bgoc, 0.7205, 2.72, 0.149, 223, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4899, 6bgob, 0.7205, 2.80, 0.153, 223, 203, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4900, 6bgoa, 0.7205, 2.88, 0.152, 223, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4901, 6bglZ, 0.7205, 2.69, 0.153, 223, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4902, 6bglY, 0.7205, 2.89, 0.152, 223, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4903, 6bglX, 0.7205, 2.80, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4904, 6bglW, 0.7205, 2.72, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4905, 6bglV, 0.7205, 2.81, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4906, 6bglU, 0.7205, 2.80, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4907, 6bglT, 0.7205, 2.82, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4908, 6bglS, 0.7205, 2.72, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4909, 6bglR, 0.7205, 2.81, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4910, 6bglQ, 0.7205, 2.70, 0.153, 223, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4911, 6bglP, 0.7205, 2.73, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4912, 6bglc, 0.7205, 2.74, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4913, 6bglb, 0.7205, 2.80, 0.153, 223, 203, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4914, 6bgla, 0.7205, 2.73, 0.153, 222, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4915, 5trrM, 0.7205, 2.81, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4916, 5trgH, 0.7205, 2.80, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4917, 5thoH, 0.7205, 2.86, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4918, 5ts0N, 0.7204, 2.74, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4919, 5trsH, 0.7204, 2.96, 0.208, 218, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4920, 5trgW, 0.7204, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4921, 5lzpL, 0.7204, 2.75, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4922, 5trsZ, 0.7203, 2.70, 0.154, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4923, 5trrH, 0.7203, 2.73, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4924, 5thoN, 0.7203, 2.83, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4925, 5lzpA, 0.7203, 2.59, 0.150, 222, 200, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4926, 3mi0H, 0.7202, 2.59, 0.150, 222, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4927, 5ts0Z, 0.7201, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4928, 5tryH, 0.7201, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4929, 5trrJ, 0.7201, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4930, 3mi0P, 0.7201, 2.59, 0.150, 222, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4931, 3krdR, 0.7201, 2.59, 0.150, 222, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4932, 5tryN, 0.7200, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4933, 3krdV, 0.7200, 2.59, 0.150, 222, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4934, 5trgM, 0.7197, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4935, 5ts0M, 0.7195, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4936, 5trsJ, 0.7195, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4937, 5ts0H, 0.7194, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4938, 5trsM, 0.7194, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4939, 5l5rK, 0.7193, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4940, 5l5rY, 0.7192, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4941, 4z1lK, 0.7192, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4942, 5l5bY, 0.7191, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4943, 4z1lY, 0.7191, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4944, 5tryM, 0.7190, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4945, 5trgJ, 0.7190, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4946, 5l5bK, 0.7190, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4947, 4y8uY, 0.7190, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4948, 4y8uK, 0.7190, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4949, 4y69K, 0.7190, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4950, 5trrX, 0.7189, 2.59, 0.150, 222, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4951, 4ya5Y, 0.7189, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4952, 4ya5K, 0.7189, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4953, 4ya3Y, 0.7189, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4954, 4ya3K, 0.7189, 2.76, 0.149, 222, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4955, 4ya0Y, 0.7189, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4956, 4ya0K, 0.7189, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4957, 4y69Y, 0.7189, 2.82, 0.153, 223, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4958, 4q1sK, 0.7189, 2.75, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4959, 4j70K, 0.7189, 2.72, 0.153, 223, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4960, 5cgfK, 0.7188, 2.59, 0.150, 222, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4961, 5bouY, 0.7188, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4962, 5bouK, 0.7188, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4963, 4y8tY, 0.7188, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4964, 4y8tK, 0.7188, 2.65, 0.149, 222, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4965, 4y6aY, 0.7188, 2.64, 0.154, 222, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4966, 4y6aK, 0.7188, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4967, 4j70Y, 0.7188, 2.74, 0.153, 222, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4968, 5cgfY, 0.7187, 2.75, 0.153, 222, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4969, 4y6vK, 0.7187, 2.64, 0.154, 222, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4970, 4qv3Y, 0.7187, 2.86, 0.157, 229, 204, YCP BETA5-M45V MUTANT
4971, 4qv3K, 0.7187, 2.84, 0.153, 223, 203, YCP BETA5-M45V MUTANT
4972, 4quxY, 0.7187, 2.86, 0.157, 229, 204, YCP BETA5-A49T-MUTANT
4973, 4quxK, 0.7187, 2.76, 0.153, 222, 202, YCP BETA5-A49T-MUTANT
4974, 3mfeP, 0.7187, 2.71, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4975, 3krdJ, 0.7187, 2.77, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4976, 5l5eY, 0.7186, 2.76, 0.153, 222, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4977, 5l5eK, 0.7186, 2.78, 0.153, 222, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4978, 5cz4Y, 0.7186, 2.81, 0.216, 211, 199, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4979, 5cz4K, 0.7186, 2.81, 0.216, 211, 199, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4980, 4y8nY, 0.7186, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4981, 4y8nK, 0.7186, 2.82, 0.216, 211, 199, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4982, 4y6vY, 0.7186, 2.84, 0.205, 212, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4983, 4qv4Y, 0.7186, 2.78, 0.153, 222, 202, YCP BETA5-M45T MUTANT
4984, 4qv4K, 0.7186, 2.76, 0.153, 222, 202, YCP BETA5-M45T MUTANT
4985, 4qv1K, 0.7186, 2.82, 0.216, 211, 199, YCP BETA5-M45A MUTANT
4986, 4quyY, 0.7186, 2.83, 0.205, 212, 200, YCP BETA5-A49S-MUTANT
4987, 4quyK, 0.7186, 2.83, 0.205, 212, 200, YCP BETA5-A49S-MUTANT
4988, 3wxrL, 0.7186, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4989, 5ts0J, 0.7185, 2.78, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4990, 5fg7K, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4991, 4ya4Y, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4992, 4ya4K, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4993, 4ya1Y, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4994, 4ya1K, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4995, 4y9yY, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4996, 4y9yK, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4997, 4y8rY, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4998, 4y8rK, 0.7185, 2.83, 0.205, 212, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4999, 4qv9Y, 0.7185, 2.84, 0.205, 212, 200, YCP BETA5-C63F MUTANT
5000, 4qv9K, 0.7185, 2.84, 0.205, 212, 200, YCP BETA5-C63F MUTANT
